Eesti Haigekassa ravimite loetelu
Vastu võetud 24.09.2002 nr 112
Määrus kehtestatakse «Ravikindlustuse seaduse» (RT I 2002, 62, 377) paragrahvi 43 lõike 1 alusel.
§ 1. Reguleerimisala
Määrus kehtestab Eesti Haigekassa ravimite loetelu, mis on toodud käesoleva määruse lisas ning mille korral võtab haigekassa üle tasu maksmise kohustuse kindlustatud isiku ambulatoorseks raviks vajalike ravimite jaemüügi eest.
§ 2. Ravimite piirhind
Kuni ravimite piirhinna kehtestamiseni loetakse piirhinnaks jaemüügi hind.
§ 3. Määruse jõustumine
Käesolev määrus jõustub 1. oktoobril 2002. a.
Minister Siiri OVIIR |
Kantsler Maarja MÄNDMAA |
Sotsiaalministri 24. septembri 2002. a määruse nr 112 «Eesti Haigekassa
ravimite loetelu» lisa |
EESTI HAIGEKASSA RAVIMITE LOETELU
Nr | Toimeained | ATC kood | Ravim | Müügiloa hoidja | 50% soodustus | Märkused | 75% soodustus | Diagnoosid | Märkused | 100% soodustus | Diagnoosid | Märkused |
1 | adapaleen | D10AD03 | DIFFERIN 0,1% CREAM kreem 0,1% 30g N1 | Galderma | 50% | |||||||
2 | adapaleen | D10AD03 | DIFFERIN 0,1% CREAM kreem 0,1% 5g N1 | Galderma | 50% | |||||||
3 | adapaleen | D10AD03 | DIFFERIN 0,1% GEL geel 0,1% 30g N1 | Galderma | 50% | |||||||
4 | adapaleen | D10AD03 | DIFFERIN 0,1% GEL geel 0,1% 5g N1 | Galderma | 50% | |||||||
5 | alendroonhape | M05BA04 | FOSAMAX 70 MG ÜKS KORD NÄDALAS tablett 70mg N2 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
6 | alendroonhape | M05BA04 | FOSAMAX 70 MG ÜKS KORD NÄDALAS tablett 70mg N4 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
7 | alendroonhape | M05BA04 | FOSAMAX tablett 10mg N14 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
8 | alendroonhape | M05BA04 | FOSAMAX tablett 10mg N28 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
9 | alendroonhape | M05BA04 | FOSAMAX tablett 5mg N14 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
10 | alendroonhape | M05BA04 | FOSAMAX tablett 5mg N28 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
11 | alfakaltsidool | A11CC03 | ALPHA D3-TEVA kapsel 0,25mcg 1TK N30 | Teva | 50% | 75% | N18* | *rv nefroloogil | ||||
12 | alfakaltsidool | A11CC03 | ALPHA D3-TEVA kapsel 1mcg N10 | Teva | 50% | 75% | N18* | *rv nefroloogil | ||||
13 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 0,25mcg N100 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
14 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 0,25mcg N30 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
15 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N10 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
16 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N100 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
18 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N30 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
19 | alfusosiin | G04CA01 | XATRAL retardtablett 5mg N28 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
20 | alfusosiin | G04CA01 | XATRAL retardtablett 5mg N56 | LABORATOIRES SYNT- HELABO/ |
50% | |||||||
17 | alfusosiin | G04CA01 | XATRAL SR retardtablett 10mg N10 | Sanofi-Synthelabo France | 50% | |||||||
21 | alfusosiin | G04CA01 | XATRAL SR retardtablett 10mg N30 | Sanofi-Synthelabo France | 50% | |||||||
22 | allopurinool | M04AA01 | ALLOPURINOL ALPHARMA TABLETS 100 MG tablett 100mg N100 | ALPHARMA | 50% | 75% | M10; N20-N23 | |||||
25 | allopurinool | M04AA01 | ALLOPURINOL ALPHARMA TABLETS 100 MG tablett 100mg N50 | ALPHARMA | 50% | 75% | M10; N20-N23 | |||||
26 | allopurinool | M04AA01 | ALLOPURINOL NYCOMED tablett 100mg N50 | Nycomed SEFA | 50% | 75% | M10; N20-N23 | |||||
23 | allopurinool | M04AA01 | ALLOPURINOL NYCOMED tablett 300mg N50 | Nycomed SEFA | 50% | 75% | M10; N20-N23 | |||||
24 | alumiiniumkloriid-hüdroksiid kompleks | A12CX81 | PHOSPHONORM kapsel 300mg N100 | Medice | 50% | |||||||
29 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N100 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
30 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N20 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
31 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N50 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
32 | amantadiin | N04BB01 | PK-MERZ TABLETS tablett 100mg N30 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
33 | amantadiin | N04BB01 | PK-MERZ TABLETS tablett 100mg N90 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
34 | aminogluteetimiid | L02BG01 | ORIMETENE tablett 250mg N100 | Novartis Pharma | 50% | |||||||
35 | amiodaroon | C01BD01 | AMIODARONE ALPHARMA tablett 200 mg N30 | ALPHARMA | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
36 | amiodaroon | C01BD01 | CORDARONE 200 MG tablett 200mg N30 | Sanofi | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
37 | amisulpiriid | N05AL05 | SOLIAN tablett 100mg N30 | Sanofi-Synthelabo France | 50% | |||||||
38 | amisulpiriid | N05AL05 | SOLIAN tablett 200mg N150 | LABORATOIRES SYNT-HELABO/ | 50% | |||||||
39 | amisulpiriid | N05AL05 | SOLIAN tablett 200mg N30 | LABORATOIRES SYNT-HELABO/ | 50% | |||||||
40 | amisulpiriid | N05AL05 | SOLIAN tablett 400mg N30 | Sanofi-Synthelabo France | 50% | |||||||
41 | amisulpiriid | N05AL05 | SOLIAN tablett 50mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
42 | amitriptüliin | N06AA09 | AMITRIPTILINS-GRINDEKS 10 MG tablett 10mg N50 | Grindeks | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
44 | amitriptüliin | N06AA09 | AMITRIPTILINS-GRINDEKS 25 MG tablett 25mg N50 | Grindeks | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
45 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 10 MG tablett 10mg N100 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
46 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 10 MG tablett 10mg N50 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
47 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 25 MG tablett 25mg N100 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
27 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 25 MG tablett 25mg N50 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
28 | amitriptüliin | N06AA09 | SAROTEN RETARD retardkapsel 50mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
43 | amitriptüliin | N06AA09 | SAROTEN tablett 10mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
48 | amitriptüliin | N06AA09 | SAROTEN tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
49 | amlodipiin | C08CA01 | NORMODIPINE tablett 10mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
50 | amlodipiin | C08CA01 | NORMODIPINE tablett 5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
51 | amlodipiin | C08CA01 | NORVASC tablett 10mg N100 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
52 | amlodipiin | C08CA01 | NORVASC tablett 10mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
53 | amlodipiin | C08CA01 | NORVASC tablett 5mg N100 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
54 | amlodipiin | C08CA01 | NORVASC tablett 5mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
56 | amoksitsilliin | J01CA04 | AMOCILEKS kapsel 250mg N20 | Grindeks | 50% | 75% | J13-J15; H66 | |||||
57 | amoksitsilliin | J01CA04 | AMOCILEKS kapsel 500mg N10 | Grindeks | 50% | 75% | J13-J15; H66 | |||||
58 | amoksitsilliin | J01CA04 | AMOXICILLIN 1000 STADA tablett 1g N10 | Stada | 50% | 75% | J13-J15; H66 | |||||
59 | amoksitsilliin | J01CA04 | AMOXICILLIN 1000 STADA tablett 1g N20 | Stada | 50% | 75% | J13-J15; H66 | |||||
60 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 tablett 1000mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
55 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 tablett 1000mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
61 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 250 TS suspensioonigraanulid 50mgml 100ml N1 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
62 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 500 tablett 500mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
63 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 500 tablett 500mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
64 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 750 tablett 750mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
65 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 750 tablett 750mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
66 | amoksitsilliin | J01CA04 | BACTOX 125MG/5ML pulber suspensiooniks 25mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
67 | amoksitsilliin | J01CA04 | BACTOX 250MG/5ML pulber suspensiooniks 50mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
68 | amoksitsilliin | J01CA04 | BACTOX 500MG/5ML pulber suspensiooniks 100mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
69 | amoksitsilliin | J01CA04 | BACTOX pulber suspensiooniks 1g N6 | Laboratoire Innotech int | 50% | 75% | J13-J15; H66 | |||||
70 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N10 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
71 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N100 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
73 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N30 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
74 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 250mg N14 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
75 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 250mg N20 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
76 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N14 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
77 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N20 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
78 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N30 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
79 | amoksitsilliin | J01CA04 | HICONCIL 100 MG/ML graanulid tilkade valm. 100mgml 10ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
80 | amoksitsilliin | J01CA04 | HICONCIL 125 MG/5 ML suspensioonigraanulid 25mgml 60ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
81 | amoksitsilliin | J01CA04 | HICONCIL 250 MG/5 ML suspensioonigraanulid 50mgml 100ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
82 | amoksitsilliin | J01CA04 | OSPAMOX 125 MG/5 ML suspensioonigraanulid 25mgml 60ml N1 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
83 | amoksitsilliin | J01CA04 | OSPAMOX 250 MG/5 ML suspensioonigraanulid 50mgml 60ml N1 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
84 | amoksitsilliin | J01CA04 | OSPAMOX kapsel 250mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
85 | amoksitsilliin | J01CA04 | OSPAMOX kapsel 250mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
86 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
87 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N100 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
88 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
89 | amoksitsilliin | J01CA04 | OSPAMOX tablett 500mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
90 | amoksitsilliin | J01CA04 | OSPAMOX tablett 500mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
91 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 250mg N12 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
92 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 250mg N24 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
93 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 500mg N12 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
94 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 500mg N24 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
72 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 25mgml 100ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
95 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 25mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
96 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 50mgml 100ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
97 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
98 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 1000 MG FILM COATED TABLETS tablett 875mg+125mg N10 | LEK d.d | 50% | |||||||
99 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 1000 MG FILM COATED TABLETS tablett 875mg+125mg N14 | LEK d.d | 50% | |||||||
100 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 457MG/5ML POWDER FOR ORAL SUSPENSION suspensioon 400mg+57mg 5ml 35ml N1 | LEK d.d | 50% | |||||||
101 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 457MG/5ML POWDER FOR ORAL SUSPENSION suspensioon 400mg+57mg 5ml 70ml N1 | LEK d.d | 50% | |||||||
102 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 625 MG FILM COATED TABLETS tablett 500mg+125mg N10 | LEK d.d | 50% | |||||||
103 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 625 MG FILM COATED TABLETS tablett 500mg+125mg N14 | LEK d.d | 50% | |||||||
104 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV FORTE suspensiooni- graanulid 50mg+12,5mgml 100ml N1 |
LEK d.d | 50% | |||||||
105 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV tilgad 50mg+12,5mgml 20ml N1 | LEK d.d | 50% | |||||||
106 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN suspensioonigraanulid 80mg+11,4mgml 70ml N1 | GlaxoSmithKline | 50% | |||||||
107 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 500mg+125mg N14 | GlaxoSmith Kline |
50% | |||||||
108 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N12 | GlaxoSmith Kline |
50% | |||||||
109 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N14 | GlaxoSmith Kline |
50% | |||||||
110 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N2 | GlaxoSmith Kline |
50% | |||||||
111 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV tablett 500 mg+125 mg N14 | KRKA, d.d. | 50% | |||||||
112 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV tablett 500 mg+125 mg N21 | KRKA, d.d. | 50% | |||||||
113 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV pulber suspensiooni valmistamiseks 250 mg+62,5 mg/5 ml 13,6 g | KRKA, d.d. | 50% | |||||||
114 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 100ml N1 | Biochemie GmbH | 50% | |||||||
115 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 60ml N1 | Biochemie GmbH | 50% | |||||||
116 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 75ml N1 | Biochemie GmbH | 50% | |||||||
117 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 100ml N1 | Biochemie GmbH | 50% | |||||||
118 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 60ml N1 | Biochemie GmbH | 50% | |||||||
119 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 75ml N1 | Biochemie GmbH | 50% | |||||||
120 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N10 | Biochemie GmbH | 50% | |||||||
121 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N100 | Biochemie GmbH | 50% | |||||||
122 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N12 | Biochemie GmbH | 50% | |||||||
123 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N14 | Biochemie GmbH | 50% | |||||||
124 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N15 | Biochemie GmbH | 50% | |||||||
125 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N16 | Biochemie GmbH | 50% | |||||||
125a | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N20 | Biochemie GmbH | 50% | |||||||
126 | amorolfiin | D01AE16 | LOCERYL kreem 0,25% 20g N1 | Galderma | 50% | |||||||
126a | amorolfiin | D01AE16 | LOCERYL küünelakk 5% 2.5ml N1 | Galderma | 50% | |||||||
127 | amorolfiin | D01AE16 | LOCERYL küünelakk 5% 5ml N1 | Galderma | 50% | |||||||
128 | ampitsilliin | J01CA01 | PENTREXYL kapsel 250mg N12 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
129 | ampitsilliin | J01CA01 | PENTREXYL kapsel 500mg N12 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
130 | ampitsilliin | J01CA01 | PENTREXYL suspensioonigraanulid 25mgml 60ml N1 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
130a | ampitsilliin | J01CA01 | PENTREXYL suspensiooni- graanulid 50mgml 100ml N1 |
Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
131 | ampitsilliin | J01CA01 | PENTREXYL suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15 | |||||
131a | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N10 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
132 | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N1000 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
133 | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
134 | anastrosool | L02BG03 | ARIMIDEX tablett 1mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
135 | artemeeter+lumefantriin | P01BX80 | RIAMET tablett 20mg+120mg N16 | Novartis Pharma | 50% | |||||||
136 | artemeeter+lumefantriin | P01BX80 | RIAMET tablett 20mg+120mg N24 | Novartis Pharma | 50% | |||||||
137 | asatiopriin | L04AX01 | IMURAN TABLETS 25 MG tablett 25mg N100 | Glaxo Wellcome | 50% | 75% | K50*; K51*; K73*; K74*; L10**; L12**; L13.0**; L40***; M07***; M05****; M06****; M08****; M45****; M46****; (M30-M33)****; M35****; (N00-N008)***** | *rv gastroentero- loogil; **rv dermatovenero- loogil; ***rv dermatovenero- loogil ja reumatoloogil; ****rv reumato- loogil; *****rv nefroloogil ja pediaatril |
100% | G70*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
138 | asatiopriin | L04AX01 | IMURAN TABLETS 50 MG tablett 50mg N100 | Glaxo Wellcome | 50% | 75% | K50*; K51*; K73*; K74*; L10**; L12**; L13.0**; L40***; M07***; M05****; M06****; M08****; M45****; M46****; (M30-M33)****; M35****; (N00-N008)***** | *rv gastroentero- loogil; **rv dermatovenero- loogil; ***rv dermatovenero- loogil ja reumatoloogil; ****rv reumato- loogil; *****rv nefroloogil ja pediaatril |
100% | G70*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
138a | aselaiinhape | D10AX03 | SKINOREN kreem 20% 30g N1 | Schering AG | 50% | |||||||
139 | aselastiin | S01GX80 | ALLERGODIL silmatilgad 0,05% 6ml N1 | Asta Medica | 50% | |||||||
139A | asitromütsiin | J01FA10 | SUMAMED FORTE suspensioonigraanulid 40mg/ml 40ml N1 | Pliva | 50% | |||||||
140 | asitromütsiin | J01FA10 | SUMAMED kapsel 250mg N6 | Pliva | 50% | |||||||
141 | asitromütsiin | J01FA10 | SUMAMED suspensioonigraanulid 20mg/ml 20ml N1 | Pliva | 50% | |||||||
142 | asitromütsiin | J01FA10 | SUMAMED tablett 500mg N3 | Pliva | 50% | |||||||
142a | atenolool | C07AB03 | ATENODEKS 100 MG TABLETES tablett 100mg N28 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
143 | atenolool | C07AB03 | ATENODEKS 25 MG TABLETES tablett 25mg N20 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
144 | atenolool | C07AB03 | ATENODEKS 50 MG TABLETES tablett 50mg N28 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
144a | atenolool | C07AB03 | ATENOLAN tablett 100mg N20 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
146 | atenolool | C07AB03 | ATENOLAN tablett 100mg N50 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
149 | atenolool | C07AB03 | ATENOLAN tablett 50mg N20 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
149a | atenolool | C07AB03 | ATENOLAN tablett 50mg N50 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
147 | atenolool | C07AB03 | ATENOLOL ALPHARMA TABLETS 50 MG tablett 50mg N30 | ALPHARMA | 50% | 75% | I10-I13; I15; I20 | |||||
147a | atenolool | C07AB03 | ATENOLOL NYCOMED 50 MG tablett 50mg N30 | Nycomed SEFA | 50% | 75% | I10-I13; I15; I20 | |||||
150 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
151 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
152 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
145 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
148 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
148a | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
153 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
154 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
155 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
155a | atenolool | C07AB03 | ATENOSAN tablett 100mg N28 | Sanofi | 50% | 75% | I10-I13; I15; I20 | |||||
156 | atenolool | C07AB03 | ATENOSAN tablett 50mg N28 | Sanofi | 50% | 75% | I10-I13; I15; I20 | |||||
157 | atenolool | C07AB03 | TENORMIN tablett 100mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I20 | |||||
157a | atenolool | C07AB03 | TENORMIN tablett 50mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I20 | |||||
158 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
159 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
160 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
161 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
162 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
163 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
164 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
165 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
166 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
167 | atropiin | S01FA01 | ISOPTO ATROPINE silmatilgad 1% 5 ml N1 | Alcon | 50% | |||||||
170 | atsetüülsalit- süülhape+ metoklop- ramiid |
N02BA92 | MIGPRIV pulber lahuseks 900mg+10mg N6 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
171 | atsetüül- tsüsteiin |
R05CB01 | ACC 600 HOT graanulid lahuseks 600mg 1annus N6 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
174 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N10 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
172 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N100 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
173 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N20 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
168 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N50 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
169 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N10 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
175 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N20 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
176 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N50 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
177 | atsitretiin | D05BB02 | NEOTIGASON kapsel 10mg N30 | Roche | 50% | 75% | L40*; L86*; M07*; Q80*; Q82.8* | *rv dermatovenero- loogil |
||||
178 | atsükloviir | D06BB03 | ACYCLOVIR STADA, CREAM kreem 5% 20g N1 | Stada | 50% | |||||||
179 | atsükloviir | D06BB03 | SUPRAVIRAN kreem 5% 20g N1 | Grünenthal GmbH | 50% | |||||||
180 | atsükloviir | J05AB01 | ACIC 200 tablett 200mg N100 | Hexal AG | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
181 | atsükloviir | J05AB01 | ACIC 200 tablett 200mg N25 | Hexal AG | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
182 | atsükloviir | J05AB01 | ACICLOVIR tablett 200 mg N20 | Balkanpharma- Troyan |
50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
183 | atsükloviir | J05AB01 | ACICLOVIR tablett 400 mg N10 | Balkanpharma- Troyan |
50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
184 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 200 MG tablett 200mg N30 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
185 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 400 MG tablett 400mg N30 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
186 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 800 MG tablett 800mg N35 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
187 | atsükloviir | J05AB01 | ACYCLOVIR TFT tablett 200mg N25 | TFT | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
188 | atsükloviir | J05AB01 | ACYCLOVIR TFT tablett 200mg N30 | TFT | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
189 | atsükloviir | J05AB01 | PROVIRSAN tablett 200mg N30 | PRO. MED. CS. PRAHA a.s. | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
190 | atsükloviir | J05AB01 | ZOVIRAX TABLETS 200 MG tablett 200mg N25 | Glaxo Wellcome | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
191 | atsükloviir | J05AB01 | VIROLEX tablett 200mg N20 | KRKA, d.d. | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
192 | atsükloviir | J05AB01 | XOROX tablett 200mg N25 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
193 | atsükloviir | J05AB01 | XOROX tablett 400mg N60 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
194 | atsükloviir | J05AB01 | XOROX tablett 800mg N35 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
195 | atsükloviir | S01AD03 | ZOVIRAX OPHTHALMIC OINTMENT 3% silmasalv 3% 4.5g N1 | Glaxo Wellcome | 50% | |||||||
196 | atsükloviir | S01AD03 | VIROLEX silmasalv 3% 4.5g N1 | KRKA, d.d. | 50% | |||||||
197 | atsükloviir | S01AD03 | XOROX silmasalv 3% 4.5g N1 | Kwizda | 50% | |||||||
198 | auranofiin | M01CB03 | RIDAURA tablett 3mg N100 | Goldshield | 50% | 75% | M05*; M06*; M08*; M45*; M46* | *rv reumatoloogil | ||||
199 | batsiratsiin+ neomütsiin |
D06AX80 | BANEOCIN OINTMENT salv 250TÜ+mg+5TÜ+mgg 20g N1 | Biochemie GmbH | 50% | |||||||
200 | batsiratsiin+ neomütsiin |
D06AX80 | BANEOCIN POWDER puistepulber 250TÜ+mg+5TÜ+mgg 10g N1 | Biochemie GmbH | 50% | |||||||
201 | beetahistiin | N07CA01 | BETASERC tablett 16mg N60 | Solvay Pharmaceuticals | 50% | |||||||
202 | beetahistiin | N07CA01 | BETASERC tablett 8mg N100 | Solvay Pharmaceuticals | 50% | |||||||
203 | beetametasoon | D07AC01 | BETNOVATE CREAM kreem 0,1% 15g N1 | Glaxo Wellcome | 50% | |||||||
204 | beetametasoon | D07AC01 | BETNOVATE OINTMENT salv 0,1% 15g N1 | Glaxo Wellcome | 50% | |||||||
205 | beetametasoon | D07AC01 | CELESTODERM-V kreem 1mgg 30g N1 | Schering-Plough | 50% | |||||||
206 | beetametasoon | D07AC01 | CELESTODERM-V kreem 1mgg 50g N1 | Schering-Plough | 50% | |||||||
207 | beetametasoon | D07AC01 | CELESTODERM-V salv 1mgg 30g N1 | Schering-Plough | 50% | |||||||
208 | beetametasoon+fusiidhape | D07CC80 | FUCICORT kreem 0,1%+2% 15g N1 | Leo | 50% | |||||||
209 | beetametasoon+neomütsiin | D07CC81 | BETNOVATE N CREAM kreem 0,1%+0,5% 15g N1 | Glaxo Wellcome | 50% | |||||||
210 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC lahus 0,05%+2% 30ml N1 | Schering-Plough | 50% | |||||||
211 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC lahus 0,05%+2% 50ml N1 | Schering-Plough | 50% | |||||||
212 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 20g N1 | Schering-Plough | 50% | |||||||
213 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 30g N1 | Schering-Plough | 50% | |||||||
215 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 50g N1 | Schering-Plough | 50% | |||||||
219 | bekaplermiin | D03AX06 | REGRANEX geel 0,01% 15g N1 | Cilag | 50% | |||||||
220 | beklometasoon | R01AD01 | BECLONASAL FORTE AQUA ninasprei 0,1mg/annuses 30ml N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
223 | beklometasoon | R01AD01 | BECONASE AQUEOUS NASAL SPRAY 50 MCG ninasprei 50mcg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
224 | beklometasoon | R03BA01 | BECLOFORTE inhal aeros 0,25mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
214 | beklometasoon | R03BA01 | BECLOMET EASYHALER inhalatsioonipulber 200mcg/annuses 200annust N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
216 | beklometasoon | R03BA01 | BECLOMET inhal aeros 0,05mg/annuses 200annust N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
217 | beklometasoon | R03BA01 | BECOTIDE BECODISKS inhalatsioonipulber 0,1mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
218 | beklometasoon | R03BA01 | BECOTIDE BECODISKS inhalatsioonipulber 0,2mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
221 | beklometasoon | R03BA01 | BECOTIDE inhal aeros 0,05mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
222 | beklometasoon | R03BA01 | ECOBEC 100 MCG EASI-BREATHE inhal aeros 100mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
225 | beklometasoon | R03BA01 | ECOBEC 100 MCG EASI-BREATHE inhal aeros 100mcg/annus 200annust N3 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
226 | beklometasoon | R03BA01 | ECOBEC 100 MCG inhal aeros 100mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
227 | beklometasoon | R03BA01 | ECOBEC 250 MCG EASI-BREATHE inhal aeros 250mcg/annus N200 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
228 | beklometasoon | R03BA01 | ECOBEC 250 MCG inhal aeros 250mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
229 | beklometasoon | R03BA01 | NASOBEC sprei 50 mcg/1 annuses 200 annust 30 ml | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
230 | bensatiinbensüülpenitsilliin | J01CE08 | RETARPEN 2.4 injektsioonisubstants 2,4miljTÜ N1 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
231 | bensatiinbensüülpenitsilliin | J01CE08 | RETARPEN 2.4 injektsioonisubstants 2,4miljTÜ N50 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
232 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N10 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
233 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N100 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
234 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N50 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
235 | bensüülpenitsilliin | J01CE01 | PENICILLIN G SODIUM “BIOCHEMIE” 1000000 IU VIAL injektsioonisubstants 1000000TÜ N1 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
236 | betaksolool | S01ED02 | BETOPTIC S silmasuspensioon 0,25% 5ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
237 | betaksolool | S01ED02 | BETOPTIC silmatilgad 0,5% 5 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
238 | bikalutamiid | L02BB03 | CASODEX 150 tablett 150mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
239 | bikalutamiid | L02BB03 | CASODEX tablett 50mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
240 | biperideen | N04AA02 | AKINETON tablett 2mg N100 | Abbott GmbH & Co. KG | 50% | 100% | G20* | *rev neuroloogil | ||||
241 | biperideen | N04AA02 | AKINETON tablett 2mg N50 | Abbott GmbH & Co. KG | 50% | 100% | G20* | *rev neuroloogil | ||||
242 | brinsolamiid | S01EC04 | AZOPT silmatilgad 1% 5ml N1 | Alcon Inc. | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
243 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N1 | Berlin-Chemie | 50% | |||||||
244 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N7 | Berlin-Chemie | 50% | |||||||
245 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N35 | Berlin-Chemie | 50% | |||||||
246 | bromokriptiin | G02CB01 | BROMERGON 10 MG TABLETS tablett 10mg N30 | LEK d.d | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
247 | bromokriptiin | G02CB01 | BROMERGON 2,5 MG TABLETS tablett 2,5mg N30 | LEK d.d | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
248 | bromokriptiin | G02CB01 | BROMOCRIPTIN-RICHTER tablett 2,5mg N30 | Richter | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
249 | bromokriptiin | G02CB01 | PARLODEL tablett 2,5mg N100 | Novartis Pharma | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
250 | bromokriptiin | G02CB01 | PARLODEL tablett 2,5mg N30 | Novartis Pharma | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
251 | budesoniid | A07EA06 | ENTOCORT 3 MG retardkapsel 3mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
252 | budesoniid | A07EA06 | ENTOCORT 3 MG retardkapsel 3mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
253 | budesoniid | A07EA06 | ENTOCORT lahustuv tabl+ lahusti 2mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K50-K51)* | *rv gastroenteroloogil | ||||
254 | budesoniid | D07AC09 | APULEIN 0,025% CREAM kreem 0,025% 15g N1 | Richter | 50% | |||||||
255 | budesoniid | D07AC09 | APULEIN 0,025% OINTMENT salv 0,025% 15g N1 | Richter | 50% | |||||||
256 | budesoniid | R01AD05 | RHINOCORT AQUA 32 MCG/DOSE ninasprei 32mcg/annuses 10ml N120 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
257 | budesoniid | R01AD05 | RHINOCORT AQUA 50 MCG/DOSE ninasprei 50mcg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
258 | budesoniid | R01AD05 | RHINOCORT AQUA 64 MCG/DOSE ninasprei 64mcg/annuses 10ml N120 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
259 | budesoniid | R01AD05 | TAFEN NASAL ninasprei 50mcg/annuses 200annust N1 | LEK d.d | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
260 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 100mcg/annuses 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
261 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 200mcg/annus 100 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
262 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 200mcg/annus 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
263 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 50 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
264 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 100 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
265 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
266 | budesoniid | R03BA02 | PULMICORT inhal aeros 50mcg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
267 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,125 MG/ML nebulisaatori susp. 0,125mg/ml 2ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
268 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,25 MG/ML nebulisaatori susp. 0,25mg/ml 2ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
269 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,5 MG/ML nebulisaatori susp. 0,5mg/ml 2 ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
270 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,1mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
271 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,2mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
272 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,4mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
273 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 160mcg+4,5mcg/annus 120annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
274 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 160mcg+4,5mcg/annus 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
275 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 80mcg+4,5mcgannus 120annus N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
276 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 80mcg+4,5mcgannus 60annus N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
277 | busereliin | L02AE01 | SUPRECUR ninasprei 0,15mg/annuses 10g N2 | Aventis Pharma Deutschland | 50% | |||||||
278 | busereliin | L02AE01 | SUPREFACT DEPOT implantaat 6,3mg 2 N1 | Aventis Pharma Deutschland | 50% | |||||||
279 | buspiroon | N05BE01 | BUSPAR tablett 10mg N60 | Bristol-Myers Squibb | 50% | |||||||
280 | busulfaan | L01AB01 | MYLERAN TABLETS tablett 2mg N100 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
281 | butenafiin | D01AE82 | MENTAX kreem 1% 10g N1 | KAKEN PHARMACEUTICAL Co., | 50% | |||||||
282 | butüülskopolamiin | A03BB01 | BUSCOPAN drazhee 10mg N20 | Boehringer Ingelheim | 50% | |||||||
283 | butüülskopolamiin | A03BB01 | BUSCOPAN suposiit 10mg N10 | Boehringer Ingelheim | 50% | |||||||
284 | candesartaan | C09CA80 | ATACAND tablett 16mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
285 | candesartaan | C09CA80 | ATACAND tablett 16mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
286 | candesartaan | C09CA80 | ATACAND tablett 4mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
287 | candesartaan | C09CA80 | ATACAND tablett 4mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
288 | candesartaan | C09CA80 | ATACAND tablett 8mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
289 | candesartaan | C09CA80 | ATACAND tablett 8mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
290 | daltepariin | B01AB04 | FRAGMIN süstelahus 10000TÜ 0.4ml N5 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
291 | daltepariin | B01AB04 | FRAGMIN süstelahus 12500TÜ 0.5ml N5 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
292 | daltepariin | B01AB04 | FRAGMIN süstelahus 12500TÜ anti Xa/ml 0.2ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
293 | daltepariin | B01AB04 | FRAGMIN süstelahus 25000TÜ anti Xa/ml 0.2ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
294 | daltepariin | B01AB04 | FRAGMIN süstelahus 7500TÜ 0.3ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
295 | danasool | G03XA01 | DANOL kapsel 100mg N100 | Sanofi | 50% | 75% | N80* | *rv günekoloogil | ||||
296 | danasool | G03XA01 | DANOL kapsel 200mg N100 | Sanofi | 50% | 75% | N80* | *rv günekoloogil | ||||
297 | deksametasoon | H02AB02 | DEXAMETASON tablett 0,5mg N100 | Orion | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
298 | deksametasoon | H02AB02 | DEXAMETASON tablett 0,5mg N30 | Orion | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
299 | deksametasoon | H02AB02 | DEXAMETHASON 4 MG/ML süstelahus 4mgml 1ml N25 | KRKA, d.d. | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
300 | deksametasoon | H02AB02 | DEXAMETHASONE tablett 0,5mg N10 | KRKA, d.d. | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
301 | deksametasoon | S01BA01 | MAXIDEX OINTMENT silmasalv 1mg/g 3.5g N1 | Alcon n.v. | 50% | |||||||
302 | deksametasoon | S01BA01 | MAXIDEX silmasuspensioon 0,1% 5 ml N1 | Alcon | 50% | |||||||
303 | deksametasoon | S01BA01 | OFTAN DEXA silmatilgad 0,1% 5 ml N1 | Santen | 50% | |||||||
304 | deksametasoon+gramitsidiin+framütsetiin | S03CA01 | SOFRADEX silma- ja kõrvatilgad 0,05%+0,005%+0,5% 8 ml N1 | Aventis Pharma Ltd. | 50% | |||||||
305 | deksametasoon+klooramfenikool | S01CA82 | OFTAN DEXA-CHLORA silmasalv 0,1%+0,2% 3.5g N1 | Santen | 50% | |||||||
306 | deksametasoon+klooramfenikool | S01CA82 | OFTAN DEXA-CHLORA silmatilgad 0,1%+0,2% 10 ml N1 | Santen | 50% | |||||||
307 | deksametasoon+neomütsiin+polümüksiin B | S01CA80 | MAXITROL silmasuspensioon 6000TÜ/ml+0,1%+3500TÜ/ml 5 ml N1 | Alcon | 50% | |||||||
308 | deksametasoon+tobramütsiin | S01CA81 | TOBRADEX silmasuspensioon 0,1%+0,3% 5 ml N1 | Alcon | 50% | |||||||
309 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N10 | Berlin-Chemie | 50% | |||||||
310 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N30 | Berlin-Chemie | 50% | |||||||
311 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N50 | Berlin-Chemie | 50% | |||||||
312 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 30 ml | Schering-Plough | 50% | |||||||
313 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 50 ml | Schering-Plough | 50% | |||||||
314 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 60 ml | Schering-Plough | 50% | |||||||
315 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 100 ml | Schering-Plough | 50% | |||||||
316 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 120 ml | Schering-Plough | 50% | |||||||
317 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 150 ml | Schering-Plough | 50% | |||||||
318 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 225 ml | Schering-Plough | 50% | |||||||
319 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 300 ml | Schering-Plough | 50% | |||||||
320 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N10 | Schering-Plough | 50% | |||||||
321 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N2 | Schering-Plough | 50% | |||||||
322 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N30 | Schering-Plough | 50% | |||||||
323 | desmopressiin | H01BA02 | MINIRIN ninasprei 10mcg/annuses 2.5ml N1 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
324 | desmopressiin | H01BA02 | MINIRIN ninasprei 10mcg/annuses 5ml N1 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
325 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N15 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
326 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N30 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
327 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N90 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
328 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N15 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
329 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N30 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
330 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N90 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
331 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 1ml N10 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
332 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 1ml N5 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
333 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 2ml N10 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
334 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 2ml N5 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
335 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N168 | N.V. ORGANON | 50% | 75% | Z30 | |||||
336 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N28 | N.V. ORGANON | 50% | 75% | Z30 | |||||
337 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N84 | N.V. ORGANON | 50% | 75% | Z30 | |||||
338 | desogestreel+etünüülöstradiool | G03AA09 | JENETTEN drazhee 0,15mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
339 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N126 | N.V. ORGANON | 50% | 75% | Z30 | |||||
340 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
341 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N63 | N.V. ORGANON | 50% | 75% | Z30 | |||||
342 | desogestreel+etünüülöstradiool | G03AA09 | MERCILON tablett 0,15mg+0,02mg N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
343 | desogestreel+etünüülöstradiool | G03AA09 | MERCILON tablett 0,15mg+0,02mg N63 | N.V. ORGANON | 50% | 75% | Z30 | |||||
344 | desogestreel+etünüülöstradiool | G03AA09 | NOVYNETTE tablett 0,15mg+0,02mg N21 | Richter | 50% | 75% | Z30 | |||||
345 | desogestreel+etünüülöstradiool | G03AA09 | NOVYNETTE tablett 0,15mg+0,02mg N63 | Richter | 50% | 75% | Z30 | |||||
346 | desogestreel+etünüülöstradiool | G03AA09 | REGULON tablett 0,15mg+0,03mg N21 | Richter | 50% | 75% | Z30 | |||||
347 | desogestreel+etünüülöstradiool | G03AA09 | REGULON tablett 0,15mg+0,03mg N63 | Richter | 50% | 75% | Z30 | |||||
348 | desogestreel+etünüülöstradiool | G03AA09 | VILONET tablett 0,15mg+0,03mg N21 | Wyeth-Pharma | 50% | 75% | Z30 | |||||
349 | kloormadinoon+etünüülöstradiool | G03AA80 | BELARA filmtabletid 2 mg+30 mcg N21 | Grünenthal GmbH | 50% | 75% | Z30 | |||||
350 | kloormadinoon+etünüülöstradiool | G03AA80 | BELARA filmtabletid 2 mg+30 mcg N3X21 | Grünenthal GmbH | 50% | 75% | Z30 | |||||
351 | desogestreel+etünüülöstradiool | G03AB05 | GRACIAL tablett N22 | N.V. ORGANON | 50% | 75% | Z30 | |||||
352 | desogestreel+etünüülöstradiool | G03AB05 | TRIMIRON tablett N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
353 | diasepaam | N05BA01 | DIAZEPAM DESITIN rektaaltuub 10mg N5 | Desitin | 50% | |||||||
354 | diasepaam | N05BA01 | DIAZEPAM DESITIN rektaaltuub 5mg N5 | Desitin | 50% | |||||||
355 | didanosiin | J05AB07 | VIDEX EC 125 MG gastroresistentne kapsel 125mg N30 | Bristol-Myers Squibb | 50% | |||||||
356 | didanosiin | J05AB07 | VIDEX EC 200 MG gastroresistentne kapsel 200mg N30 | Bristol-Myers Squibb | 50% | |||||||
357 | didanosiin | J05AB07 | VIDEX EC 250 MG gastroresistentne kapsel 250mg N30 | Bristol-Myers Squibb | 50% | |||||||
358 | didanosiin | J05AB07 | VIDEX EC 400 MG gastroresistentne kapsel 400mg N30 | Bristol-Myers Squibb | 50% | |||||||
359 | didanosiin | J05AB07 | VIDEX tablett 100mg N60 | Bristol-Myers Squibb | 50% | |||||||
360 | didanosiin | J05AB07 | VIDEX tablett 150mg N60 | Bristol-Myers Squibb | 50% | |||||||
361 | didanosiin | J05AB07 | VIDEX tablett 200mg N60 | Bristol-Myers Squibb | 50% | |||||||
362 | didanosiin | J05AB07 | VIDEX tablett 25mg N60 | Bristol-Myers Squibb | 50% | |||||||
363 | didanosiin | J05AB07 | VIDEX tablett 50mg N60 | Bristol-Myers Squibb | 50% | |||||||
364 | dienogest+etünüülöstradiool | G03AA81 | JEANINE tablett 2mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
365 | dienogest+etünüülöstradiool | G03AA81 | JEANINE tablett 2mg+0,03mg N63 | Jenapharm | 50% | 75% | Z30 | |||||
366 | dienogest+östradiool | G03FA15 | KLIMODIEN kaetud tablett 2mg N3x28 | Schering AG | 50% | |||||||
367 | dienogest+östradiool | G03FA15 | KLIMODIEN kaetud tablett 2mg N28 | Schering AG | 50% | |||||||
368 | difenhüdramiin | R06AA02 | DIMEDROL tablett 50mg tabl N10 | TFT | 50% | |||||||
369 | digoksiin | C01AA05 | DIGOXIN NYCOMED 0,25 MG tablett 0,25mg N50 | Nycomed SEFA | 50% | 75% | I50 | |||||
370 | digoksiin | C01AA05 | DIGOXIN NYCOMED 62,5 MCG tablett 62,5mcg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
371 | digoksiin | C01AA05 | DIGOXIN TFT tablett 0,25mg N25 | TFT | 50% | 75% | I50 | |||||
372 | digoksiin | C01AA05 | DIGOXIN TFT tablett 0,25mg N50 | TFT | 50% | 75% | I50 | |||||
373 | digoksiin | C01AA05 | LANOXIN tablett 0,25mg N100 | Glaxo Wellcome | 50% | 75% | I50 | |||||
374 | dihüdroergotamiin | N02CA01 | NEOMIGRAN ninasprei 4mg/ml 1ml N1 | Novartis Pharma | 50% | |||||||
375 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 120mg N56 | Mundipharma Austria | 50% | |||||||
376 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 60mg N56 | Mundipharma Austria | 50% | |||||||
377 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 90mg N56 | Mundipharma Austria | 50% | |||||||
378 | dihüdrotahhüsterool | A11CC02 | TACHYSTIN LIQUIDUM suukaudne lahus 1mg/ml 20ml N1 | ANKERPHARM | 50% | 100% | E20*; E89.2* | *rv endokrinoloogil | ||||
379 | diklofenak | M01AB05 | CATAFLAM tablett 25mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
380 | diklofenak | M01AB05 | CATAFLAM tablett 25mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
381 | diklofenak | M01AB05 | CATAFLAM tablett 50mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
382 | diklofenak | M01AB05 | CATAFLAM tablett 50mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
383 | diklofenak | M01AB05 | DICLAC 100 suposiit 100mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
384 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
385 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
386 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
387 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
388 | diklofenak | M01AB05 | DICLAC 50 suposiit 50mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
389 | diklofenak | M01AB05 | DICLAC 50 suposiit 50mg N5 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
390 | diklofenak | M01AB05 | DICLAC 50 TABL tablett 50mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
391 | diklofenak | M01AB05 | DICLAC 50 TABL tablett 50mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
392 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
393 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
394 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
395 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
396 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
397 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
398 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
399 | diklofenak | M01AB05 | DICLOBERL RETARD retardkapsel 100mg N50 | Berlin-Chemie | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
400 | diklofenak | M01AB05 | DICLOFENAC 100 STADA RETARD retardtablett 100mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
401 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N100 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
402 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
403 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N50 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
404 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N100 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
405 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
406 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N50 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
407 | diklofenak | M01AB05 | DICLOFENAC DUO BMS retardkapsel 75mg N30 | Bristol-Myers Squibb | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
408 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 25 enterotablett 25mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
409 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 25 enterotablett 25mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
410 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 50 enterotablett 50mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
411 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 50 enterotablett 50mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
412 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 100 suposiit 100mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
413 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 50 suposiit 50mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
414 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 50 suposiit 50mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
415 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
416 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N100 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
417 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
418 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
419 | diklofenak | M01AB05 | DICLOMELAN 50 mg tablett 50mg N10 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
420 | diklofenak | M01AB05 | DICLOMELAN RETARD 100 mg retardtablett 100mg N30 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
421 | diklofenak | M01AB05 | DICLOMELAN suposiit 100mg N6 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
422 | diklofenak | M01AB05 | INFLAMAC 50 gastroresistentne kapsel 50mg N20 | Spirig | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
423 | diklofenak | M01AB05 | INFLAMAC 75 SR retardkapsel 75mg N20 | Spirig | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
424 | diklofenak | M01AB05 | NAKLOFEN DUO kapsel 75mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
425 | diklofenak | M01AB05 | NAKLOFEN ENTEROTABLETT enterotablett 50mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
426 | diklofenak | M01AB05 | NAKLOFEN RETARD retardtablett 100mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
427 | diklofenak | M01AB05 | NAKLOFEN SUPOSIIT suposiit 50mg N10 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
428 | diklofenak | M01AB05 | OLFEN-100 RECTOCAPS rektaalkapsel 100 mg N 5 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
429 | diklofenak | M01AB05 | OLFEN-100 SR DEPOCAPS retardkapsel 100mg N20 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
430 | diklofenak | M01AB05 | OLFEN-25 LACTAB enterotablett 25mg N30 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
431 | diklofenak | M01AB05 | OLFEN-50 LACTAB enterotablett 50mg N20 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
432 | diklofenak | M01AB05 | OLFEN-50 RECTOCAPS rektaalkapsel 50 mg N10 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
433 | diklofenak | M01AB05 | OLFEN-75 SR DEPOTABS retardtablett 75mg N30 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
434 | diklofenak | M01AB05 | SANFINAC tablett 25mg N100 | Sanofi | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
435 | diklofenak | M01AB05 | SANFINAC tablett 50mg N100 | Sanofi | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
436 | diklofenak | M01AB05 | VERAL 100 MG suposiit 100mg N10 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
437 | diklofenak | M01AB05 | VERAL 50 MG enterotablett 50mg N20 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
438 | diklofenak | M01AB05 | VERAL 50 MG enterotablett 50mg N50 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
439 | diklofenak | M01AB05 | VOLTAREN 100 suposiit 100mg N5 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
440 | diklofenak | M01AB05 | VOLTAREN 25 enterotablett 25mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
441 | diklofenak | M01AB05 | VOLTAREN 25 suposiit 25mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
442 | diklofenak | M01AB05 | VOLTAREN 50 enterotablett 50mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
443 | diklofenak | M01AB05 | VOLTAREN 50 suposiit 50mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
444 | diklofenak | M01AB05 | VOLTAREN RETARD retardtablett 100mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
445 | diklofenak | M01AB05 | VOLTAREN RETARD retardtablett 100mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
446 | diklofenak | M02AA15 | DICLAC 5% GEL geel 5% 100g N1 | Hexal AG | 50% | |||||||
447 | diklofenak | M02AA15 | DICLAC 5% GEL geel 5% 50g N1 | Hexal AG | 50% | |||||||
448 | diklofenak | M02AA15 | FELORAN geel 1% 60g 60g N1 | Balkanpharma-Troyan | 50% | |||||||
449 | diklofenak | M02AA15 | NAKLOFEN geel 1% 60g N1 | KRKA, d.d. | 50% | |||||||
450 | diklofenak | M02AA15 | OLFEN GEL geel 1% 20g N1 | MEPHA Ltd. | 50% | |||||||
451 | diklofenak | M02AA15 | OLFEN GEL geel 1% 50g N1 | MEPHA Ltd. | 50% | |||||||
452 | diklofenak | M02AA15 | OLFEN ROLL-ON roll-on geel 1% 50ml N1 | MEPHA Ltd. | 50% | |||||||
453 | diklofenak | M02AA15 | ORTOFEN salv 2% 30g N1 | TFT | 50% | |||||||
454 | diklofenak | M02AA15 | VERAL geel 1% 55g N1 | Slovakofarma | 50% | |||||||
455 | diklofenak | M02AA15 | VOLTAREN EMULGEL geel 1% 20g N1 | Novartis Consumer Health | 50% | |||||||
456 | diklofenak | M02AA15 | VOLTAREN EMULGEL geel 1% 50g N1 | Novartis Consumer Health | 50% | |||||||
457 | diklofenak | S01BC03 | NACLOF silmatilgad 0,1% 5 ml N1 | H. Faure | 50% | |||||||
458 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N100 | Pharmacia Enterprises | 50% | |||||||
459 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N20 | Pharmacia Enterprises | 50% | |||||||
460 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N60 | Pharmacia Enterprises | 50% | |||||||
461 | diltiaseem | C08DB01 | ALTIAZEM RR retardkapsel 180mg N20 | Lusofarmaco | 50% | |||||||
462 | diltiaseem | C08DB01 | DILRENE 300 MG S.R. retardkapsel 300mg N28 | Sanofi | 50% | |||||||
463 | diltiaseem | C08DB01 | DILTIAZEM tablett 60mg N30 | Pliva | 50% | |||||||
464 | diltiaseem | C08DB01 | DILTIAZEM tablett 90mg N30 | Pliva | 50% | |||||||
465 | diltiaseem | C08DB01 | DILTIKARD DEPOT 120 MG retardkapsel 120mg N28 | Nycomed SEFA | 50% | |||||||
466 | diltiaseem | C08DB01 | DILTIKARD DEPOT 180 MG retardkapsel 180mg N28 | Nycomed SEFA | 50% | |||||||
467 | diltiaseem | C08DB01 | DILTIKARD DEPOT 240 MG retardkapsel 240mg N28 | Nycomed SEFA | 50% | |||||||
468 | diltiaseem | C08DB01 | DILTISAN tablett 60mg N100 | Sanofi | 50% | |||||||
469 | doksasosiin | C02CA04 | CARDURA tablett 1mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
470 | doksasosiin | C02CA04 | CARDURA tablett 2mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
471 | doksasosiin | C02CA04 | CARDURA tablett 4mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
472 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N100 | ratiopharm | 50% | |||||||
473 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N20 | ratiopharm | 50% | |||||||
474 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N50 | ratiopharm | 50% | |||||||
475 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N100 | ratiopharm | 50% | |||||||
476 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N20 | ratiopharm | 50% | |||||||
477 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N50 | ratiopharm | 50% | |||||||
478 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N100 | ratiopharm | 50% | |||||||
479 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N20 | ratiopharm | 50% | |||||||
480 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N50 | ratiopharm | 50% | |||||||
481 | doksasosiin | C02CA04 | KAMIREN tablett 1mg N20 | KRKA, d.d. | 50% | |||||||
482 | doksasosiin | C02CA04 | KAMIREN tablett 1mg N30 | KRKA, d.d. | 50% | |||||||
483 | doksasosiin | C02CA04 | KAMIREN tablett 2mg N20 | KRKA, d.d. | 50% | |||||||
484 | doksasosiin | C02CA04 | KAMIREN tablett 2mg N30 | KRKA, d.d. | 50% | |||||||
485 | doksasosiin | C02CA04 | KAMIREN tablett 4mg N20 | KRKA, d.d. | 50% | |||||||
486 | doksasosiin | C02CA04 | KAMIREN tablett 4mg N30 | KRKA, d.d. | 50% | |||||||
487 | doksasosiin | C02CA04 | ZOXON 1 tablett 1mg N15 | LÉCIVA a.s. | 50% | |||||||
488 | doksasosiin | C02CA04 | ZOXON 1 tablett 1mg N30 | LÉCIVA a.s. | 50% | |||||||
489 | doksasosiin | C02CA04 | ZOXON 2 tablett 2mg N10 | LÉCIVA a.s. | 50% | |||||||
490 | doksasosiin | C02CA04 | ZOXON 2 tablett 2mg N30 | LÉCIVA a.s. | 50% | |||||||
491 | doksasosiin | C02CA04 | ZOXON 4 tablett 4mg N30 | LÉCIVA a.s. | 50% | |||||||
492 | doksütsükliin | J01AA02 | DOXITIN tablett 100mg N10 | Vitabalans | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
493 | doksütsükliin | J01AA02 | DOXITIN tablett 100mg N8 | Vitabalans | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
494 | doksütsükliin | J01AA02 | DOXY M-RATIOPHARM 100 tablett 100mg N10 | ratiopharm | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
495 | doksütsükliin | J01AA02 | DOXY M-RATIOPHARM 100 tablett 100mg N20 | ratiopharm | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
496 | doksütsükliin | J01AA02 | DOXYCYCLIN 100 STADA TABS tablett 100mg N10 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
497 | doksütsükliin | J01AA02 | DOXYCYCLIN 100 STADA TABS tablett 100mg N20 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
498 | doksütsükliin | J01AA02 | DOXYCYCLIN 200 STADA TABS tablett 200mg N10 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
499 | doksütsükliin | J01AA02 | DOXYHEXAL tablett 100mg N10 | Hexal AG | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
500 | doksütsükliin | J01AA02 | DOXYHEXAL tablett 100mg N20 | Hexal AG | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
501 | doksütsükliin | J01AA02 | DOXYLAN tablett 100mg N10 | Lannacher | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
502 | doksütsükliin | J01AA02 | DOXYLAN tablett 100mg N5 | Lannacher | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
503 | doksütsükliin | J01AA02 | VIBRAMYCIN kapsel 100mg N10 | Pfizer H.C.P. Corporation | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
504 | doksütsükliin | J01AA02 | VIBRAMYCIN siirup 10mgml 60ml N1 | Pfizer H.C.P. Corporation | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
505 | domperidoon | A03FA03 | MOTILIUM tablett 10mg N10 | Janssen | 50% | |||||||
506 | domperidoon | A03FA03 | MOTILIUM tablett 10mg N30 | Janssen | 50% | |||||||
507 | donepesiil | N06DA02 | ARICEPT tablett 10mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
508 | donepesiil | N06DA02 | ARICEPT tablett 5mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
509 | dornaas alfa | R05CB13 | PULMOZYME inhalatsioonilahus 1mg/ml 2.5ml N6 | Roche | 50% | 100% | E84* | *rev pulmono- loogil |
||||
510 | dorsolamiid | S01EC03 | TRUSOPT silmatilgad 2% 5 ml N1 | MSD | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
511 | drospirenoon+etünüülöstradiool | G03AA12 | YARINA tablett 3mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
512 | drotaveriin | A03AD02 | NO-SPA tablett 40mg N100 | Chinoin | 50% | |||||||
513 | drotaveriin | A03AD02 | NO-SPA tablett 40mg N20 | Chinoin | 50% | |||||||
514 | düdrogesteroon | G03DB01 | DUPHASTON tablett 10mg N20 | Solvay Pharmaceuticals BV | 50% | |||||||
515 | ebastiin | R06AX22 | KESTINE tablett 10mg N30 | Nycomed SEFA | 50% | |||||||
516 | ebastiin | R06AX22 | KESTINE tablett 20mg N10 | Nycomed SEFA | 50% | |||||||
517 | ebastiin | R06AX22 | KESTINE tablett 20mg N100 | Nycomed SEFA | 50% | |||||||
518 | ebastiin | R06AX22 | KESTINE tablett 20mg N30 | Nycomed SEFA | 50% | |||||||
519 | Efavirenzum | J05AG03 | STOCRIN kapsel 200 mg N90 | MSD | 50% | |||||||
520 | Efavirenzum | J05AG03 | STOCRIN kapsel 100mg N30 | MSD | 50% | |||||||
521 | Efavirenzum | J05AG03 | STOCRIN kapsel 50mg N30 | MSD | 50% | |||||||
522 | Efavirenzum | J05AG03 | STOCRIN suukaudne lahus 30mg/ml 180ml N1 | MSD | 50% | |||||||
523 | ekonasool | D01AC03 | ECOMI kreem 1%/g 30g N1 | Geymonat | 50% | |||||||
524 | ekonasool | D01AC03 | PEVARYL kreem 1%/g 15g N1 | Cilag | 50% | |||||||
525 | ekonasool | D01AC03 | PEVARYL kreem 1%/g 30g N1 | Cilag | 50% | |||||||
526 | ekonasool | D01AC03 | PEVARYL lipogeel 1%/g 15g N1 | Cilag | 50% | |||||||
527 | ekonasool | D01AC03 | PEVARYL sprei 1%/ml 30ml N1 | Cilag | 50% | |||||||
528 | ekonasool | G01AF05 | GYNO-PEVARYL 150 COMBIPACK oovul+kreem 150mg/g N1 | Cilag | 50% | |||||||
529 | ekonasool | G01AF05 | GYNO-PEVARYL 50 vaginaaloovul 50mg N15 | Cilag | 50% | |||||||
530 | ekonasool | G01AF05 | GYNO-PEVARYL oovul 150mg N3 | Cilag | 50% | |||||||
531 | eksemestaan | L02BG06 | AROMASIN tablett 25mg N30 | Pharmacia Enterprises | 50% | |||||||
532 | Emedastiin | S01GX06 | EMADINE silmatilgad 0,05% 10ml N1 | Alcon UK | 50% | |||||||
533 | Emedastiin | S01GX06 | EMADINE silmatilgad 0,05% 5ml N1 | Alcon UK | 50% | |||||||
534 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N100 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
535 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N30 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
536 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N50 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
537 | enalapriil | C09AA02 | EDNYT tablett 10mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
538 | enalapriil | C09AA02 | EDNYT tablett 10mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
539 | enalapriil | C09AA02 | EDNYT tablett 2,5mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
540 | enalapriil | C09AA02 | EDNYT tablett 2,5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
541 | enalapriil | C09AA02 | EDNYT tablett 20mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
542 | enalapriil | C09AA02 | EDNYT tablett 20mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
543 | enalapriil | C09AA02 | EDNYT tablett 5mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
544 | enalapriil | C09AA02 | EDNYT tablett 5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
545 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
546 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
547 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
548 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
549 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
550 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
551 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
552 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
553 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
554 | enalapriil | C09AA02 | ENALAPRIL ALPHARMA TABLETS 10MG tablett 10mg N28 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
555 | enalapriil | C09AA02 | ENALAPRIL ALPHARMA TABLETS 5 MG tablett 5mg N28 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
556 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
557 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
558 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
559 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
560 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
561 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
562 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
563 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
564 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
565 | enalapriil | C09AA02 | ENAP 10 tablett 10mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
566 | enalapriil | C09AA02 | ENAP 2,5 tablett 2,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
567 | enalapriil | C09AA02 | ENAP 20 tablett 20mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
568 | enalapriil | C09AA02 | ENAP 5 tablett 5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
569 | enalapriil | C09AA02 | ENATEC 10 tablett 10mg N28 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
570 | enalapriil | C09AA02 | ENATEC 20 tablett 20mg N28 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
571 | enalapriil | C09AA02 | ENATEC 5 tablett 5mg N30 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
572 | enalapriil | C09AA02 | INVORIL tablett 10mg N10 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
573 | enalapriil | C09AA02 | INVORIL tablett 10mg N100 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
574 | enalapriil | C09AA02 | INVORIL tablett 10mg N30 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
575 | enalapriil | C09AA02 | INVORIL tablett 5mg N10 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
576 | enalapriil | C09AA02 | INVORIL tablett 5mg N100 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
577 | enalapriil | C09AA02 | INVORIL tablett 5mg N30 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
578 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
579 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
580 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N100 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
581 | enalapriil | C09AA02 | RENITEC 5 MG tablett 5mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
582 | enalapriil | C09AA02 | RENITEC 5 MG tablett 5mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
583 | enalapriil | C09AA02 | RENITEC FORTE tablett 20mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
584 | enalapriil | C09AA02 | RENITEC FORTE tablett 20mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
585 | enalapriil | C09AA02 | RENITEC START tablett N25 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
586 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 10mg+25mg N10 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
587 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 10mg+25mg N30 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
588 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 20mg+12,5mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
589 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 20mg+12,5mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
590 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | ENAP-H tablett 10mg+25mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
591 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | ENAP-HL tablett 10mg+12,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
592 | enalapriil+hüdroklorotiasiid | C09BA02 | RENITEC PLUS tablett 20mg+6mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
593 | enalapriil+hüdroklorotiasiid | C09BA02 | RENITEC PLUS tablett 20mg+6mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
594 | entakapoon | N04BX02 | COMTESS tablett 200mg N100 | Orion | 50% | |||||||
595 | entakapoon | N04BX02 | COMTESS tablett 200mg N30 | Orion | 50% | |||||||
596 | entakapoon | N04BX02 | COMTESS tablett 200mg N350 | Orion | 50% | |||||||
597 | entakapoon | N04BX02 | COMTESS tablett 200mg N60 | Orion | 50% | |||||||
598 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N14 | Solvay Pharmaceuticals BV | 50% | |||||||
599 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N28 | Solvay Pharmaceuticals BV | 50% | |||||||
600 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N56 | Solvay Pharmaceuticals BV | 50% | |||||||
601 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N14 | Solvay Pharmaceuticals BV | 50% | |||||||
602 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N28 | Solvay Pharmaceuticals BV | 50% | |||||||
603 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N56 | Solvay Pharmaceuticals BV | 50% | |||||||
604 | Epoetin beta | B03XA80 | NEORECORMON 50 000 MULTIDOSE injektsioonisubstants 50000IU N1 | Roche | 50% | |||||||
605 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 10000TÜ 0.3ml N1 | Roche | 50% | |||||||
606 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 10000TÜ 0.3ml N6 | Roche | 50% | |||||||
607 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 2000TÜ 0.3ml N1 | Roche | 50% | |||||||
608 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 2000TÜ 0.3ml N6 | Roche | 50% | |||||||
609 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 4000TÜ 0.3ml N1 | Roche | 50% | |||||||
610 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 4000TÜ 0.3ml N6 | Roche | 50% | |||||||
611 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 5000TÜ 0.3ml N1 | Roche | 50% | |||||||
612 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 5000TÜ 0.3ml N6 | Roche | 50% | |||||||
613 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 500TÜ 0.3ml N1 | Roche | 50% | |||||||
614 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 500TÜ 0.3ml N6 | Roche | 50% | |||||||
615 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 6000TÜ 0.3ml 0.3ml N1 | Roche | 50% | |||||||
616 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 6000TÜ 0.3ml 0.3ml N6 | Roche | 50% | |||||||
617 | erütromütsiin | D10AF02 | AKNEFUG EL lahus paikseks kasut. 10mgml 60ml N1 | Wolff | 50% | |||||||
618 | erütromütsiin | J01FA01 | ERYTHROMYCIN NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
619 | erütromütsiin | J01FA01 | ERYTHROMYCIN- RATIOPHARM TS suspensioonigraanulid 40mgml 16g N1 | ratiopharm | 50% | 75% | J13-J15 | |||||
620 | erütromütsiin | J01FA01 | ERYTHROMYCIN- RATIOPHARM TS suspensioonigraanulid 40mgml 9.6g N1 | ratiopharm | 50% | 75% | J13-J15 | |||||
621 | erütromütsiin | J01FA01 | ILOSONE suspensioon 25mgml 100ml N1 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
622 | erütromütsiin | J01FA01 | ILOSONE suspensioon 50mgml 100ml N1 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
623 | erütromütsiin | J01FA01 | ILOSONE tablett 500mg N10 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
624 | erütropoetiin | B03XA01 | EPREX 10 000 süstelahus 10000TÜ/ml 1ml N6 | Cilag | 50% | |||||||
625 | erütropoetiin | B03XA01 | EPREX 2000 süstelahus 4000TÜ/ml 0.5ml N6 | Cilag | 50% | |||||||
626 | erütropoetiin | B03XA01 | EPREX 4000 süstelahus 10000TÜ/ml 0.4ml N6 | Cilag | 50% | |||||||
627 | erütropoetiin | B03XA01 | EPREX 5000 süstelahus 5000IU 0.5ml N6 | Cilag | 50% | |||||||
628 | erütropoetiin | B03XA01 | EPREX 6000 süstelahus 6000IU 0.6ml N6 | Cilag | 50% | |||||||
629 | erütropoetiin | B03XA01 | EPREX 7000 süstelahus 7000IU 0.7ml N6 | Cilag | 50% | |||||||
630 | erütropoetiin | B03XA01 | EPREX 8000 süstelahus 8000IU 0.8ml N6 | Cilag | 50% | |||||||
631 | erütropoetiin | B03XA01 | RECORMON injektsioonisubstants 1000TÜ N10 | Roche | 50% | |||||||
632 | erütropoetiin | B03XA01 | RECORMON injektsioonisubstants 2000TÜ N10 | Roche | 50% | |||||||
633 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N14 | AstraZeneca UK Ltd. | 50% | |||||||
634 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N140 | AstraZeneca UK Ltd. | 50% | |||||||
635 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
636 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N3 | AstraZeneca UK Ltd. | 50% | |||||||
637 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N7 | AstraZeneca UK Ltd. | 50% | |||||||
638 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N14 | AstraZeneca UK Ltd. | 50% | |||||||
639 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N140 | AstraZeneca UK Ltd. | 50% | |||||||
640 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N28 | AstraZeneca UK Ltd. | 50% | |||||||
641 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N7 | AstraZeneca UK Ltd. | 50% | |||||||
642 | estsitalopraam | N06AB10 | CIPRALEX tablett 5 mg N14 | Lundbeck | 50% | |||||||
643 | estsitalopraam | N06AB10 | CIPRALEX tablett 5 mg N28 | Lundbeck | 50% | |||||||
644 | estsitalopraam | N06AB10 | CIPRALEX tablett 10 mg N14 | Lundbeck | 50% | |||||||
645 | estsitalopraam | N06AB10 | CIPRALEX tablett 10 mg N28 | Lundbeck | 50% | |||||||
646 | estsitalopraam | N06AB10 | CIPRALEX tablett 15 mg N28 | Lundbeck | 50% | |||||||
647 | estsitalopraam | N06AB10 | CIPRALEX tablett 20 mg N28 | Lundbeck | 50% | |||||||
648 | etidroonhape | M05BA01 | PLEOSTAT tablett 400mg N14 | KRKA, d.d. | 50% | |||||||
649 | etidroonhape | M05BA01 | PLEOSTAT tablett 400mg N56 | KRKA, d.d. | 50% | |||||||
650 | etonogestreel | G03AC08 | IMPLANON implantaat 68mg N1 | N.V. ORGANON | 50% | |||||||
651 | etoposiid | L01CB01 | VEPESID kapsel 100mg N10 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
652 | etoposiid | L01CB01 | VEPESID kapsel 100mg N60 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
653 | etoposiid | L01CB01 | VEPESID kapsel 50mg N20 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
654 | etoposiid | L01CB01 | VEPESID kapsel 50mg N60 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
655 | etorikoksiib | M01AH80 | ARCOXIA tablett 60 mg N14 | MSD | 50% | |||||||
656 | etorikoksiib | M01AH80 | ARCOXIA tablett 60 mg N28 | MSD | 50% | |||||||
657 | etorikoksiib | M01AH80 | ARCOXIA tablett 90 mg N14 | MSD | 50% | |||||||
658 | etorikoksiib | M01AH80 | ARCOXIA tablett 90 mg N28 | MSD | 50% | |||||||
659 | etorikoksiib | M01AH80 | ARCOXIA tablett 120 mg N14 | MSD | 50% | |||||||
660 | etorikoksiib | M01AH80 | ARCOXIA tablett120 mg N28 | MSD | 50% | |||||||
661 | famitsükloviir | J05AB09 | FAMVIR tablett 125mg N10 | Novartis Pharma | 50% | |||||||
662 | famitsükloviir | J05AB09 | FAMVIR tablett 125mg N30 | Novartis Pharma | 50% | |||||||
663 | famitsükloviir | J05AB09 | FAMVIR tablett 250mg N15 | Novartis Pharma | 50% | |||||||
664 | famitsükloviir | J05AB09 | FAMVIR tablett 250mg N21 | Novartis Pharma | 50% | |||||||
665 | famitsükloviir | J05AB09 | FAMVIR tablett 500mg N14 | Novartis Pharma | 50% | |||||||
666 | famitsükloviir | J05AB09 | FAMVIR tablett 500mg N21 | Novartis Pharma | 50% | |||||||
667 | famotidiin | A02BA03 | FAMOSAN tablett 20mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
668 | famotidiin | A02BA03 | FAMOSAN tablett 40mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
669 | famotidiin | A02BA03 | FAMOTIDIN 20-SL kaetud tablett 20mg N30 | Slovakofarma | 50% | |||||||
670 | famotidiin | A02BA03 | FAMOTIDIN 40-SL kaetud tablett 40mg N10 | Slovakofarma | 50% | |||||||
671 | famotidiin | A02BA03 | QUAMATEL tablett 20mg N28 | Richter | 50% | |||||||
672 | famotidiin | A02BA03 | QUAMATEL tablett 40mg N14 | Richter | 50% | |||||||
673 | famotidiin | A02BA03 | ULFAMID tablett 20mg N10 | KRKA, d.d. | 50% | |||||||
674 | famotidiin | A02BA03 | ULFAMID tablett 20mg N20 | KRKA, d.d. | 50% | |||||||
675 | famotidiin | A02BA03 | ULFAMID tablett 40mg N10 | KRKA, d.d. | 50% | |||||||
676 | feksofenadiin | R06AX26 | TELFAST 120MG tablett 120mg N100 | Aventis Pharma Deutschland | 50% | |||||||
677 | feksofenadiin | R06AX26 | TELFAST 120MG tablett 120mg N30 | Aventis Pharma Deutschland | 50% | |||||||
678 | feksofenadiin | R06AX26 | TELFAST 180MG tablett 180mg N100 | Aventis Pharma Deutschland | 50% | |||||||
679 | feksofenadiin | R06AX26 | TELFAST 180MG tablett 180mg N30 | Aventis Pharma Deutschland | 50% | |||||||
680 | felodipiin | C08CA02 | PLENDIL retardtablett 10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
681 | felodipiin | C08CA02 | PLENDIL retardtablett 10mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
682 | felodipiin | C08CA02 | PLENDIL retardtablett 2,5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
683 | felodipiin | C08CA02 | PLENDIL retardtablett 2,5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
684 | felodipiin | C08CA02 | PLENDIL retardtablett 5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
685 | felodipiin | C08CA02 | PLENDIL retardtablett 5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
686 | felodipiin | C08CA02 | PRESID retardtablett 10mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
687 | felodipiin | C08CA02 | PRESID retardtablett 10mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
688 | felodipiin | C08CA02 | PRESID retardtablett 2,5mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
689 | felodipiin | C08CA02 | PRESID retardtablett 2,5mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
690 | felodipiin | C08CA02 | PRESID retardtablett 5mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
691 | felodipiin | C08CA02 | PRESID retardtablett 5mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
692 | fenobarbitaal | N03AA02 | PHENAEMAL 0,1 tablett 100mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
693 | fenobarbitaal | N03AA02 | PHENAEMALETTEN tablett 15mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
694 | fenofibraat | C10AB05 | LIPANTHYL kapsel 200mg N30 | LABORATOIRES FOURNIER S.A | 50% | |||||||
695 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 500 tablett 500 000 TÜ N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
696 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 1000 tablett 1 000 000 TÜ N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
697 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 400 000 IU/5 ml Oral Suspensionsiirup 400 000 TÜ/5 ml 60 ml | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
698 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N10 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
699 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N100 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
700 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N20 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
701 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N30 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
702 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 500 000 TÜ tablett 500000TÜ N20 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
703 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 500 000 TÜ tablett 500000TÜ N30 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
704 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 85 000TÜ/ML graanulid lahuseks 85000TÜ/ml 100ml N1 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
705 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 1000000TÜ N12 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
706 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 300000TÜ N18 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
707 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 500000TÜ N18 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
708 | fenoksümetüülpenitsilliin | J01CE02 | V-PENICILIN 250MG SLOVAKOFARMA tablett 250mg N30 | Slovakofarma | 50% | 75% | J13-J15 | |||||
709 | fenoksümetüülpenitsilliin | J01CE02 | V-PENICILIN 500MG SLOVAKOFARMA tablett 500mg N30 | Slovakofarma | 50% | 75% | J13-J15 | |||||
710 | fenoterool | R03AC04 | BEROTEC 100 annustatud aerosool 100mcg/annuses 300annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
711 | fenoterool | R03AC04 | BEROTEC 200 annustatud aerosool 200mcg/annuses 200annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
712 | fenoterool | R03AC04 | BEROTEC 200 annustatud aerosool 200mcg/annuses 300annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
713 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 0,5mg 2ml 2ml N20 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
714 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 0,5mg 2ml 2ml N60 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
715 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 1,25mg 2ml 2ml N20 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
716 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 1,25mg 2ml 2ml N60 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
717 | fenoterool | R03AC04 | BEROTEC N 100 MCG inhal aeros 100mcg/annuses 200annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
718 | fenoterool+ipratroopiumbromiid | R03AK80 | BERODUAL annustatud aerosool 50mcg+20mcg/annuses 300annust N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
719 | fenoterool+ ipratroopium- bromiid |
R03AK80 | BERODUAL inhalatsioonilahus 0,5mg+0,25mg/ml 20ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
720 | fenoterool+ ipratroopium- bromiid |
R03AK80 | BERODUAL N annustatud aerosool 50mcg+20mcgannus 200annus N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
721 | fentanüül | N02AB03 | DUROGESIC TTS 100mcg/h N5 | Janssen | 50% | |||||||
722 | fentanüül | N02AB03 | DUROGESIC TTS 25mcg/h N5 | Janssen | 50% | |||||||
723 | fentanüül | N02AB03 | DUROGESIC TTS 50mcg/h N5 | Janssen | 50% | |||||||
724 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N100 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
725 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N200 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
726 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
727 | fenüülbutasoon | M02AA01 | BUTADION salv 5% 20g N1 | Richter | 50% | |||||||
728 | finasteriid | G04CB01 | PENESTER tablett 5mg N30 | LÉCIVA a.s. | 50% | |||||||
729 | finasteriid | G04CB01 | PROSCAR 5 MG tablett 5mg N28 | MSD | 50% | |||||||
730 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 100mg N100 | 3M Health Care | 50% | |||||||
731 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 100mg N20 | 3M Health Care | 50% | |||||||
732 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 50mg N100 | 3M Health Care | 50% | |||||||
733 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 50mg N20 | 3M Health Care | 50% | |||||||
734 | fludarabiin | L01BB05 | FLUDARA ORAL tablett 10mg N15 | Schering AG | 50% | |||||||
735 | fludarabiin | L01BB05 | FLUDARA ORAL tablett 10mg N20 | Schering AG | 50% | |||||||
736 | flukonasool | J02AC01 | DIFLAZON 100 kapsel 100mg N28 | KRKA, d.d. | 50% | |||||||
737 | flukonasool | J02AC01 | DIFLAZON 150 kapsel 150mg N1 | KRKA, d.d. | 50% | |||||||
738 | flukonasool | J02AC01 | DIFLAZON 200 kapsel 200mg N20 | KRKA, d.d. | 50% | |||||||
739 | flukonasool | J02AC01 | DIFLAZON 200 kapsel 200mg N7 | KRKA, d.d. | 50% | |||||||
740 | flukonasool | J02AC01 | DIFLAZON 50 kapsel 50mg N7 | KRKA, d.d. | 50% | |||||||
741 | flukonasool | J02AC01 | DIFLUCAN 100MG kapsel 100mg N7 | Pfizer H.C.P. Corporation | 50% | |||||||
742 | flukonasool | J02AC01 | DIFLUCAN 150MG kapsel 150mg N1 | Pfizer H.C.P. Corporation | 50% | |||||||
743 | flukonasool | J02AC01 | DIFLUCAN 50MG kapsel 50mg N7 | Pfizer H.C.P. Corporation | 50% | |||||||
744 | flukonasool | J02AC01 | FLUCONAZOL 150 SLOVAKOFARMA kapsel 150mg N1 | Slovakofarma | 50% | |||||||
745 | flukonasool | J02AC01 | FLUCONAZOL 150 SLOVAKOFARMA kapsel 150mg N2 | Slovakofarma | 50% | |||||||
746 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N10 | Slovakofarma | 50% | |||||||
747 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N14 | Slovakofarma | 50% | |||||||
748 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N20 | Slovakofarma | 50% | |||||||
749 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N7 | Slovakofarma | 50% | |||||||
750 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N28 | LÉCIVA a.s. | 50% | |||||||
751 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N7 | LÉCIVA a.s. | 50% | |||||||
752 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N70 | LÉCIVA a.s. | 50% | |||||||
753 | flukonasool | J02AC01 | MYCOMAX 200 kapsel 200mg N7 | LÉCIVA a.s. | 50% | |||||||
754 | flukonasool | J02AC01 | MYCOMAX kapsel 150mg N1 | LÉCIVA a.s. | 50% | |||||||
755 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N28 | LÉCIVA a.s. | 50% | |||||||
756 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N7 | LÉCIVA a.s. | 50% | |||||||
757 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N70 | LÉCIVA a.s. | 50% | |||||||
758 | flukonasool | J02AC01 | MYCOMAX SIR siirup 5mg/ml 100ml N1 | LÉCIVA a.s. | 50% | |||||||
759 | flukonasool | J02AC01 | MYCOSYST 100 MG kapsel 100mg N28 | Richter | 50% | |||||||
760 | flukonasool | J02AC01 | MYCOSYST 150 MG kapsel 150mg N1 | Richter | 50% | |||||||
761 | flukonasool | J02AC01 | MYCOSYST 150 MG kapsel 150mg N2 | Richter | 50% | |||||||
762 | flukonasool | J02AC01 | MYCOSYST 50 MG kapsel 50mg N7 | Richter | 50% | |||||||
763 | fluoksetiin | N06AB03 | DEPRENON kapsel 20mg N20 | Slovakofarma | 50% | |||||||
764 | fluoksetiin | N06AB03 | DEPRIMAKS kapsel 20mg N14 | Grindeks | 50% | |||||||
765 | fluoksetiin | N06AB03 | FLUVAL kapsel 20mg N14 | KRKA, d.d. | 50% | |||||||
766 | fluoksetiin | N06AB03 | FLUVAL kapsel 20mg N28 | KRKA, d.d. | 50% | |||||||
767 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N100 | Hexal AG | 50% | |||||||
768 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N14 | Hexal AG | 50% | |||||||
769 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N20 | Hexal AG | 50% | |||||||
770 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N28 | Hexal AG | 50% | |||||||
771 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N50 | Hexal AG | 50% | |||||||
772 | fluoksetiin | N06AB03 | FRAMEX kapsel 20mg N14 | Richter | 50% | |||||||
773 | fluoksetiin | N06AB03 | FRAMEX kapsel 20mg N28 | Richter | 50% | |||||||
774 | fluoksetiin | N06AB03 | MAGRILAN kapslid 20 mg N30 | Medochemie Ltd. | 50% | |||||||
775 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N100 | Nycomed SEFA | 50% | |||||||
776 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N30 | Nycomed SEFA | 50% | |||||||
777 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N60 | Nycomed SEFA | 50% | |||||||
778 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N14 | Eli Lilly Export S.A. | 50% | |||||||
779 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N28 | Eli Lilly Export S.A. | 50% | |||||||
780 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N7 | Eli Lilly Export S.A. | 50% | |||||||
781 | fluoksetiin | N06AB03 | PROZAC LIQUID suukaudne lahus 4mg/ml 70ml N1 | Eli Lilly Export S.A. | 50% | |||||||
782 | fluoksetiin | N06AB03 | SALIPAX kapsel 20mg N10 | MEPHA Ltd. | 50% | |||||||
783 | fluoksetiin | N06AB03 | SALIPAX kapsel 20mg N30 | MEPHA Ltd. | 50% | |||||||
784 | fluotsinoloon | D07AC04 | SYNALAR kreem 0,025% 15g N1 | Bioglan | 50% | |||||||
785 | fluotsinoloon | D07AC04 | SYNALAR kreem 0,025% 30g N1 | Bioglan | 50% | |||||||
786 | fluotsinoniid | D07AC08 | METOSYN kreem 0,05% 15g N1 | Bioglan | 50% | |||||||
787 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 100mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
788 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 100mg/ml 1ml N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
789 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 20mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
790 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 20mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
791 | flupentiksool | N05AF01 | FLUANXOL tablett 1mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
792 | flupentiksool | N05AF01 | FLUANXOL tablett 1mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
793 | flupentiksool | N05AF01 | FLUANXOL tilgad 100mg/ml 10ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
794 | flutamiid | L02BB01 | PROFAMID tablett 250mg N84 | Orion | 50% | |||||||
795 | flutikasoon- propionaat |
D07AC17 | CUTIVATE CREAM 0,05% kreem 0,05% 15g N1 | Glaxo Wellcome | 50% | |||||||
796 | flutikasoon- propionaat |
D07AC17 | CUTIVATE CREAM 0,05% kreem 0,05% 30g N1 | Glaxo Wellcome | 50% | |||||||
797 | flutikasoon- propionaat |
D07AC17 | CUTIVATE OINTMENT 0,005% salv 0,005% 15g N1 | Glaxo Wellcome | 50% | |||||||
798 | flutikasoon- propionaat |
D07AC17 | CUTIVATE OINTMENT 0,005% salv 0,005% 30g N1 | Glaxo Wellcome | 50% | |||||||
799 | flutikasoon- propionaat |
R01AD08 | FLIXONASE AQUEOUS NASAL SPRAY 50 MCG ninasprei 50mcg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
800 | flutikasoon- propionaat |
R01AD08 | FLIXONASE NASAL DROPS ninatilgad 1mg/ml 4TK N7 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
801 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 100 MCG inhalatsioonipulber 100mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil rv alla 18-aastasele lapsele |
||||
802 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 250 MCG inhalatsioonipulber 250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
803 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 50 MCG inhalatsioonipulber 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
804 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE INHALER inhal aeros 250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
805 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE INHALER inhal aeros 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
806 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE NEBULES nebulisaatori susp. 0,5mg 2ml 2ml N10 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
807 | flutikasoonpropionaat | R03BA05 | FLIXOTIDE NEBULES nebulisaatori susp. 2mg 2ml 2ml N10 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
808 | fluvastatiin | C10AA04 | LESCOL 20 MG kapsel 20mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
809 | fluvastatiin | C10AA04 | LESCOL 40 MG kapsel 40mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
810 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
811 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N70 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
812 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N98 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
813 | fluvoksamiin | N06AB08 | FEVARIN tablett 100mg N30 | Solvay Pharmaceuticals | 50% | |||||||
814 | fluvoksamiin | N06AB08 | FEVARIN tablett 100mg N50 | Solvay Pharmaceuticals | 50% | |||||||
815 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N30 | Solvay Pharmaceuticals | 50% | |||||||
816 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N50 | Solvay Pharmaceuticals | 50% | |||||||
817 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N60 | Solvay Pharmaceuticals | 50% | |||||||
818 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N1 | Ares-Serono | 50% | |||||||
819 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N10 | Ares-Serono | 50% | |||||||
820 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N3 | Ares-Serono | 50% | |||||||
821 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N5 | Ares-Serono | 50% | |||||||
822 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N1 | ARES TRADING SA | 50% | |||||||
823 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N10 | ARES TRADING SA | 50% | |||||||
824 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N3 | ARES TRADING SA | 50% | |||||||
825 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N1 | N.V. ORGANON | 50% | |||||||
826 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N10 | N.V. ORGANON | 50% | |||||||
827 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N3 | N.V. ORGANON | 50% | |||||||
828 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N5 | N.V. ORGANON | 50% | |||||||
829 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N1 | N.V. ORGANON | 50% | |||||||
830 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N10 | N.V. ORGANON | 50% | |||||||
831 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N3 | N.V. ORGANON | 50% | |||||||
832 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N5 | N.V. ORGANON | 50% | |||||||
833 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N1 | N.V. ORGANON | 50% | |||||||
834 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N10 | N.V. ORGANON | 50% | |||||||
835 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N3 | N.V. ORGANON | 50% | |||||||
836 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N5 | N.V. ORGANON | 50% | |||||||
837 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N1 | N.V. ORGANON | 50% | |||||||
838 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N10 | N.V. ORGANON | 50% | |||||||
839 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N3 | N.V. ORGANON | 50% | |||||||
840 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N5 | N.V. ORGANON | 50% | |||||||
841 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
842 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
843 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
844 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
845 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
846 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
847 | follitropiin beeta | G03GA06 | PUREGON süstelahus 300IU 0.36ml N1 | N.V. ORGANON | 50% | |||||||
848 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
849 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
850 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
851 | follitropiin beeta | G03GA06 | PUREGON süstelahus 600IU 0.72ml N1 | N.V. ORGANON | 50% | |||||||
852 | formoterool | R03AC13 | FORADIL inhalatsioonipulber 12mcg N30 | Novartis Pharma | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
853 | formoterool | R03AC13 | FORADIL inhalatsioonipulber 12mcg N60 | Novartis Pharma | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
854 | formoterool | R03AC13 | OXIS TURBUHALER inhalatsioonipulber 4,5mcg/annuses 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
855 | formoterool | R03AC13 | OXIS TURBUHALER inhalatsioonipulber 9mcg/annuses 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
856 | fosföstrool | L02AA04 | HONVAN tablett 120mg N100 | Asta Medica | 50% | |||||||
857 | fosföstrool | L02AA04 | HONVAN tablett 120mg N50 | Asta Medica | 50% | |||||||
858 | fosinopriil | C09AA09 | MONOPRIL tablett 10mg N28 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50* | *(1) | ||||
859 | fosinopriil | C09AA09 | MONOPRIL tablett 20mg N28 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50* | *(1) | ||||
860 | furosemiid | C03CA01 | FUROSEMIDE ALPHARMA TABLETS 40MG tablett 40mg N28 | ALPHARMA | 50% | 75% | I50 | |||||
861 | furosemiid | C03CA01 | FUROSEMIDE ALPHARMA TABLETS 40MG tablett 40mg N50 | ALPHARMA | 50% | 75% | I50 | |||||
862 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 20mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
863 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 40mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
864 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 40mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
865 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 5mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
866 | furosemiid | C03CA01 | LASIX RETARD retardkapsel 60mg N100 | Aventis Pharma Deutschland | 50% | 75% | I50 | |||||
867 | furosemiid | C03CA01 | LASIX RETARD retardkapsel 60mg N30 | Aventis Pharma Deutschland | 50% | 75% | I50 | |||||
868 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N100 | Orion | 50% | |||||||
869 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N30 | Orion | 50% | |||||||
870 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N50 | Orion | 50% | |||||||
871 | fusiidhape | D06AX01 | FUCIDIN kreem 2% 15g N1 | Leo | 50% | |||||||
872 | fusiidhape | D06AX01 | FUCIDIN salv 2% 15g N1 | Leo | 50% | |||||||
873 | fusiidhape | J01XC01 | FUCIDIN suspensioon 50mgml 90ml N1 | Leo | 50% | |||||||
874 | fusiidhape | J01XC01 | FUCIDIN tablett 250mg N12 | Leo | 50% | |||||||
875 | fusiidhape | S01AA13 | FUCITHALMIC viskoossed silmatilgad 1% 5g N1 | Leo | 50% | |||||||
876 | gabapentiin | N03AX12 | NEURONTIN kapsel 100mg N100 | Pfizer H.C.P | 50% | |||||||
877 | gabapentiin | N03AX12 | NEURONTIN kapsel 100mg N20 | Pfizer H.C.P | 50% | |||||||
878 | gabapentiin | N03AX12 | NEURONTIN kapsel 300mg N100 | Pfizer H.C.P | 50% | |||||||
879 | gabapentiin | N03AX12 | NEURONTIN kapsel 300mg N50 | Pfizer H.C.P | 50% | |||||||
880 | gabapentiin | N03AX12 | NEURONTIN kapsel 400mg N100 | Pfizer H.C.P | 50% | |||||||
881 | gabapentiin | N03AX12 | NEURONTIN kapsel 400mg N50 | Pfizer H.C.P | 50% | |||||||
882 | ganireliks | H01CC01 | ORGALUTRAN süstelahus 0,25mg 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
883 | ganireliks | H01CC01 | ORGALUTRAN süstelahus 0,25mg 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
884 | gantsükloviir | J05AB06 | CYMEVENE kapsel 250mg N84 | Roche | 50% | |||||||
885 | gestodeen+etünüülöstradiool | G03AA10 | FEMODEN tablett 0,075mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
886 | gestodeen+etünüülöstradiool | G03AA10 | HARMONET tablett 0,075mg+0,02mg N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
887 | gestodeen+etünüülöstradiool | G03AA10 | HARMONET tablett 0,075mg+0,02mg N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
888 | gestodeen+etünüülöstradiool | G03AA10 | LOGEST tablett 0,075mg+0,02mg N21 | Schering AG | 50% | 75% | Z30 | |||||
889 | gestodeen+etünüülöstradiool | G03AA10 | MINESSE tablett 0,06mg+0,015mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
890 | gestodeen+etünüülöstradiool | G03AA10 | MINESSE tablett 0,06mg+0,015mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
891 | gestodeen+etünüülöstradiool | G03AA10 | MINULET tablett 0,075mg+0,03mg N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
892 | gestodeen+etünüülöstradiool | G03AA10 | MINULET tablett 0,075mg+0,03mg N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
893 | gestodeen+etünüülöstradiool | G03AA10 | MIRELLE tablett 60mcg+15mcg N28 | Schering AG | 50% | 75% | Z30 | |||||
894 | gestodeen+etünüülöstradiool | G03AA10 | MIRELLE tablett 60mcg+15mcg N56 | Schering AG | 50% | 75% | Z30 | |||||
895 | gestodeen+etünüülöstradiool | G03AB06 | TRI-MINULET tablett -1+-1 N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
896 | gestodeen+etünüülöstradiool | G03AB06 | TRI-MINULET tablett -1+-1 N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
897 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N100 | TFT | 50% | 75% | E11; E14 | |||||
898 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N120 | TFT | 50% | 75% | E11; E14 | |||||
899 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N30 | TFT | 50% | 75% | E11; E14 | |||||
900 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N60 | TFT | 50% | 75% | E11; E14 | |||||
901 | glibenklamiid | A10BB01 | GLIBENCLAMID- RATIOPHARM 3,5 tablett 3,5mg N120 | ratiopharm | 50% | 75% | E11; E14 | |||||
902 | glibenklamiid | A10BB01 | GLIBENCLAMID- RATIOPHARM 3,5 tablett 3,5mg N30 | ratiopharm | 50% | 75% | E11; E14 | |||||
903 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
904 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N30 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
905 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N60 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
906 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
907 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N30 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
908 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N60 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
909 | glibenklamiid | A10BB01 | MANINIL 5 tablett 5mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
910 | gliklasiid | A10BB09 | DIABREZIDE tablett 80mg N40 | Molteni | 50% | 75% | E11; E14 | |||||
911 | gliklasiid | A10BB09 | DIAPREL MR tablett 30mg N60 | Servier | 50% | 75% | E11; E14 | |||||
912 | gliklasiid | A10BB09 | DIAPREL tablett 80mg N60 | Servier | 50% | 75% | E11; E14 | |||||
913 | glimepriid | A10BB12 | AMARYL tablett 1mg N30 | Aventis Pharma Deutschland | 50% | |||||||
914 | glimepriid | A10BB12 | AMARYL tablett 1mg N90 | Aventis Pharma Deutschland | 50% | |||||||
915 | glimepriid | A10BB12 | AMARYL tablett 2mg N30 | Aventis Pharma Deutschland | 50% | |||||||
916 | glimepriid | A10BB12 | AMARYL tablett 2mg N90 | Aventis Pharma Deutschland | 50% | |||||||
917 | glimepriid | A10BB12 | AMARYL tablett 3mg N30 | Aventis Pharma Deutschland | 50% | |||||||
918 | glimepriid | A10BB12 | AMARYL tablett 3mg N90 | Aventis Pharma Deutschland | 50% | |||||||
919 | glipisiid | A10BB07 | GLIBENESE GITS tablett 10mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | E11; E14 | |||||
920 | glipisiid | A10BB07 | GLIBENESE GITS tablett 5mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | E11; E14 | |||||
921 | glipisiid | A10BB07 | MINIDIAB tablett 5mg N30 | Pharmacia Enterprises | 50% | 75% | E11; E14 | |||||
922 | glipisiid | A10BB07 | MINIDIAB tablett 5mg N75 | Pharmacia Enterprises | 50% | 75% | E11; E14 | |||||
923 | glükagoon | H04AA01 | GLUCAGEN 1 MG HYPOKIT injektsioonisubstants 1mg N1 | Novo Nordisk | 50% | |||||||
924 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks | Rottapharm | 50% | |||||||
925 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks 1500mg N20 | Rottapharm | 50% | |||||||
926 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks 1500mg N30 | Rottapharm | 50% | |||||||
927 | glütserüülnitraat | C01DA02 | MINITRAN 10 TTS 10mg 24h N100 | 3M Health Care | 50% | |||||||
928 | glütserüülnitraat | C01DA02 | MINITRAN 10 TTS 10mg 24h N30 | 3M Health Care | 50% | |||||||
929 | glütserüülnitraat | C01DA02 | MINITRAN 5 TTS 5mg 24h N100 | 3M Health Care | 50% | |||||||
930 | glütserüülnitraat | C01DA02 | MINITRAN 5 TTS 5mg 24h N30 | 3M Health Care | 50% | |||||||
931 | glütserüülnitraat | C01DA02 | NITRO MACK RETARD 2,5 MG retardkapsel 2,5mg N50 | H. Mack | 50% | |||||||
932 | glütserüülnitraat | C01DA02 | NITRO MACK RETARD 5 MG retardkapsel 5mg N100 | H. Mack | 50% | |||||||
933 | glütserüülnitraat | C01DA02 | NITRODERM TTS 10 TTS 10mg 24h N10 | Novartis Pharma | 50% | |||||||
934 | glütserüülnitraat | C01DA02 | NITRODERM TTS 5 TTS 5mg 24h N10 | Novartis Pharma | 50% | |||||||
935 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 11.2g N200 | Pohl-Boskamp | 50% | |||||||
936 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 14.2g N250 | Pohl-Boskamp | 50% | |||||||
937 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 4.9g N75 | Pohl-Boskamp | 50% | |||||||
938 | gosereliin | L02AE03 | ZOLADEX depookapsel 3,6mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
939 | gosereliin | L02AE03 | ZOLADEX LA depookapsel 10,8mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
940 | granisetroon | A04AA02 | KYTRIL süstelahus 1mg/ml 1ml N5 | Roche | 50% | |||||||
941 | granisetroon | A04AA02 | KYTRIL süstelahus 1mg/ml 3ml N5 | Roche | 50% | |||||||
942 | granisetroon | A04AA02 | KYTRIL tablett 1mg N10 | Roche | 50% | |||||||
943 | haloperidool | N05AD01 | HALOPERIDOL TABLETS 5 MG tablett 5mg N50 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
944 | haloperidool | N05AD01 | HALOPERIDOL tablett 1,5mg N50 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
945 | haloperidool | N05AD01 | HALOPERIDOL tilgad 2mg/ml 10ml N1 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
946 | haloperidool | N05AD01 | HALOPERIDOL-DECANOATE-RICHTER süstelahus 50mg/ml 1ml N1 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
947 | haloperidool | N05AD01 | HALOPERIDOL-DECANOATE-RICHTER süstelahus 50mg/ml 1ml N5 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
948 | haltsinoniid | D07AD02 | BETACORTON rasvane kreem 0,1% 20g N1 | Spirig | 50% | |||||||
949 | haltsinoniid | D07AD02 | BETACORTON rasvane kreem 0,1% 50g N1 | Spirig | 50% | |||||||
950 | haltsinoniid | D07AD02 | BETACORTON SOLUTION nahalahus 0,1% 100ml N1 | Spirig | 50% | |||||||
951 | haltsinoniid | D07AD02 | BETACORTON SOLUTION nahalahus 0,1% 25ml N1 | Spirig | 50% | |||||||
952 | haltsinoniid+karbamiid | D07XD80 | BETACORTON CREAM kreem 0,1%+5% 20g N1 | Spirig | 50% | |||||||
953 | haltsinoniid+karbamiid | D07XD80 | BETACORTON CREAM kreem 0,1%+5% 50g N1 | Spirig | 50% | |||||||
954 | haltsinoniid+salitsüülhape | D07XD81 | BETACORTON S SOLUTION nahalahus 0,1%+2% 100ml N1 | Spirig | 50% | |||||||
955 | haltsinoniid+salitsüülhape | D07XD81 | BETACORTON S SOLUTION nahalahus 0,1%+2% 25ml N1 | Spirig | 50% | |||||||
956 | Human menopausal gonadotrophin | G03GA02 | PERGONAL injektsioonisubstants 75TÜ N1 | ARES TRADING SA | 50% | |||||||
957 | Human menopausal gonadotrophin | G03GA02 | PERGONAL injektsioonisubstants 75TÜ N10 | ARES TRADING SA | 50% | |||||||
958 | hüdroklorotiasiid | C03AA03 | HYPOTHIAZID tablett 100mg N20 | Chinoin | 50% | 75% | I10-I13; I15; I50*; O10-O16 | *rev kardioloogil | ||||
959 | hüdroklorotiasiid | C03AA03 | HYPOTHIAZID tablett 25mg N20 | Chinoin | 50% | 75% | I10-I13; I15; I50*; O10-O16 | *rev kardioloogil | ||||
960 | hüdroklorotiasiid+amiloriid | C03EA81 | MODURETIC tablett 5mg+50mg N30 | MSD | 50% | |||||||
961 | hüdroklorotiasiid+triamtereen | C03EA80 | TRIAMPUR COMPOSITUM tablett 12,5mg+25mg N50 | AWD | 50% | |||||||
962 | hüdrokortisoon | D07AA02 | HYDROCORTISON DAK salv 1% 30ml N1 | Nycomed SEFA | 50% | |||||||
963 | hüdrokortisoon | H02AB09 | SOLU-CORTEF injektsioonisubstants 100mg N1 | Pharmacia Enterprises | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
964 | hüdrokortisoon | H02AB09 | SOLU-CORTEF injektsioonisubstants 100mg N25 | Pharmacia Enterprises | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
965 | hüdrokortisoon+fusiidhape | D07XA82 | FUCIDIN H kreem 10mg+20mgg 15g N1 | Leo | 50% | |||||||
966 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 100g N1 | Orion | 50% | |||||||
967 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 20g N1 | Orion | 50% | |||||||
968 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 50g N1 | Orion | 50% | |||||||
969 | hüdrokortisoon+lidokaiin | H02AB80 | HYDROCORTISON-RICHTER SUSPENSION FOR INJECTION süstesuspensioon 25mg+5mgml 5ml N1 | Richter | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
970 | hüdrokortisoon+tsiprofloksatsiin | S02CA82 | CIPROBAY HC kõrvatilgad 1%+0,2% 10 ml N1 | Alcon Inc. | 50% | |||||||
971 | hüdrokortisoonbutüraat | D07AB02 | LOCOID CRELO Nahaemulsioon 1mg/g 30g N1 | Yamanouchi | 50% | |||||||
972 | hüdrokortisoonbutüraat | D07AB02 | LOCOID kreem 0,1% 30g N1 | Yamanouchi | 50% | |||||||
973 | hüdrokortisoonbutüraat | D07AB02 | LOCOID rasvane kreem 0,1% 30g N1 | Yamanouchi | 50% | |||||||
974 | hüdroksükarbamiid | L01XX05 | HYDREA kapsel 500mg N100 | Bristol-Myers Squibb | 50% | |||||||
975 | hüdroksüklorokiin | P01BA02 | PLAQUENIL tablett 200mg N60 | Sanofi | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46* | *rv reumatoloogil | ||||
976 | hüdroksüsiin | R06AE80 | ATARAX siirup 2mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
977 | hüdroksüsiin | R06AE80 | ATARAX tablett 25mg N100 | UCB Pharma Oy Finland | 50% | |||||||
978 | hüdroksüsiin | R06AE80 | ATARAX tablett 25mg N25 | UCB Pharma Oy Finland | 50% | |||||||
979 | ibuprofeen | M01AE01 | BURANA tablett 400mg N30 | Orion | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
980 | ibuprofeen | M01AE01 | IBUMAX tablett 400mg N100 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
981 | ibuprofeen | M01AE01 | IBUMAX tablett 400mg N30 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
982 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N10 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
983 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N100 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
984 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N30 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
985 | ibuprofeen | M01AE01 | IBUMETIN 400 tablett 400mg N100 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
986 | ibuprofeen | M01AE01 | IBUMETIN 400 tablett 400mg N50 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
987 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N100 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
988 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N20 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
989 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N50 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
990 | ibuprofeen | M01AE01 | IBUPROFEN 400 TFT tablett 400mg N20 | TFT | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
991 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
992 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N50 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
993 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N84 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
994 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 600MG tablett 600mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
995 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 600MG tablett 600mg N50 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
996 | ibuprofeen | M01AE01 | IBUPROFEN LANNACHER tablett 400mg N30 | Lannacher | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
997 | ibuprofeen | M01AE01 | IBUPROFEN LANNACHER tablett 600mg N30 | Lannacher | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
998 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N24 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
999 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N36 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
1000 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N48 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
1001 | idarubitsiin | L01DB06 | ZAVEDOS kapsel 10mg N1 | Pharmacia Enterprises | 50% | |||||||
1002 | idarubitsiin | L01DB06 | ZAVEDOS kapsel 5mg N1 | Pharmacia Enterprises | 50% | |||||||
1003 | imatinib | L01XX28 | GLIVEC kapsel 100mg N120 | Novartis Pharma | 50% | |||||||
1004 | imatinib | L01XX28 | GLIVEC kapsel 100mg N180 | Novartis Pharma | 50% | |||||||
1005 | imatinib | L01XX28 | GLIVEC kapsel 100mg N24 | Novartis Pharma | 50% | |||||||
1006 | imatinib | L01XX28 | GLIVEC kapsel 100mg N48 | Novartis Pharma | 50% | |||||||
1007 | imatinib | L01XX28 | GLIVEC kapsel 100mg N96 | Novartis Pharma | 50% | |||||||
1008 | imatinib | L01XX28 | GLIVEC kapsel 50mg N30 | Novartis Pharma | 50% | |||||||
1009 | imidapriil | C09AA80 | TANATRIL tablett 10mg N100 | ALGOL OY | 50% | |||||||
1010 | imidapriil | C09AA80 | TANATRIL tablett 10mg N30 | ALGOL OY | 50% | |||||||
1011 | imidapriil | C09AA80 | TANATRIL tablett 5mg N100 | ALGOL OY | 50% | |||||||
1012 | imidapriil | C09AA80 | TANATRIL tablett 5mg N30 | ALGOL OY | 50% | |||||||
1013 | imikute toitesegu | SOIJA TUTTELI 400 g | Valio | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1014 | imikute toitesegu | ISOMIL 400 g (laktoosivaba) | Abbot | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1015 | imikute toitesegu | ALSOY (DS32-A) 450 g | Nestle | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1016 | imikute toitesegu | PEPTIDI TUTTELI 400 g | Valio | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1017 | imikute toitesegu | ALFARE (DS24) 400 g (vadaku) | Nestle | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1018 | imikvimood | D06BB10 | ALDARA kreem 5% 250mg N12 | 3M Health Care | 50% | |||||||
1019 | imipramiin | N06AA02 | IMIPRAMINE ALPHARMA TABLETS 25 MG tablett 25mg N48 | ALPHARMA | 50% | |||||||
1020 | imipramiin | N06AA02 | IMIPRAMINE ALPHARMA TABLETS 25 MG tablett 25mg N50 | ALPHARMA | 50% | |||||||
1021 | indapamiid | C03BA11 | PRO-INDAP kapsel 2,5mg N30 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
1022 | indapamiid | C03BA11 | TERTENSIF SR retardtablett 1,5mg N30 | Servier | 50% | |||||||
1023 | indapamiid | C03BA11 | TERTENSIF tablett 2,5mg N30 | Servier | 50% | |||||||
1024 | indinaviir | J05AE02 | CRIXIVAN kapsel 333 mg N135 | MSD | 50% | |||||||
1025 | indinaviir | J05AE02 | CRIXIVAN kapsel 100mg N180 | MSD | 50% | |||||||
1026 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N180 | MSD | 50% | |||||||
1027 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N270 | MSD | 50% | |||||||
1028 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N360 | MSD | 50% | |||||||
1029 | indinaviir | J05AE02 | CRIXIVAN kapsel 400mg N180 | MSD | 50% | |||||||
1030 | indinaviir | J05AE02 | CRIXIVAN kapsel 400mg N90 | MSD | 50% | |||||||
1031 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N100 | ratiopharm | 50% | 100% | C00-D48 | |||||
1032 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N20 | ratiopharm | 50% | 100% | C00-D48 | |||||
1033 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N50 | ratiopharm | 50% | 100% | C00-D48 | |||||
1034 | indometatsiin | M01AB01 | INDOMETATSIIN NYCOMED kapsel 25mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1035 | indometatsiin | M01AB01 | INDOMETATSIIN NYCOMED kapsel 50mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1036 | indometatsiin | M02AA23 | INDOMET-RATIO- PHARM GEL geel 1% 100g N1 |
ratiopharm | 50% | |||||||
1037 | indometatsiin | M02AA23 | INDOMET-RATIO- PHARM GEL geel 1% 50g N1 |
ratiopharm | 50% | |||||||
1038 | indometatsiin | M02AA23 | MOBILAT AKUT INDO SPRAY lahus paikseks kasut. 8mg/ml 50ml N1 | Sankyo | 50% | |||||||
1039 | insuliin aspart | A10AB05 | NOVOMIX 30 FLEXPEN süstesuspensioon 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1040 | insuliin aspart | A10AB05 | NOVOMIX 30 PENFILL süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1041 | insuliin aspart | A10AB05 | NOVORAPID FLEXPEN süstelahus 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1042 | insuliin aspart | A10AB05 | NOVORAPID NOVOLET 3 ML süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1043 | insuliin aspart | A10AB05 | NOVORAPID PENFILL 3 ML süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1044 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 10ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1045 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1046 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1047 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1048 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1049 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1050 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1051 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N2 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1052 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1053 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 18000000TÜ/ml 1ml N1 | Roche | 50% | |||||||
1054 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 3000000TÜ 0.5ml 0.5ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1055 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 3000000TÜ/ml 1ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1056 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 9000000TÜ 0.5ml 0.5ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1057 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 9000000TÜ/ml 1ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1058 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 10miljTÜ N1 | Schering-Plough | 50% | |||||||
1059 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 3miljTÜ N1 | Schering-Plough | 50% | |||||||
1060 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 5miljTÜ N1 | Schering-Plough | 50% | |||||||
1061 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 15miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1062 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 25miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1063 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 50miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1064 | interferoon beeta | L03AA11 | AVONEX injektsioonisubstants 30mcg N4 | Schering-Plough | 50% | |||||||
1065 | interferoon beeta | L03AA11 | BETAFERON injektsioonisubstants 9600000TÜ N15 | Schering AG | 50% | |||||||
1066 | interferoon beeta | L03AA11 | BETAFERON injektsioonisubstants 9600000TÜ N5 | Schering AG | 50% | |||||||
1067 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N1 | Serono Europe Ltd. | 50% | |||||||
1068 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N15 | Serono Europe Ltd. | 50% | |||||||
1069 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N3 | Serono Europe Ltd. | 50% | |||||||
1070 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N1 | Serono Europe Ltd. | 50% | |||||||
1071 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N15 | Serono Europe Ltd. | 50% | |||||||
1072 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N3 | Serono Europe Ltd. | 50% | |||||||
1073 | ipratroopiumbromiid | R03BB01 | ATROVENT inhal aeros 0,02mg/annuses 15ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
1074 | ipratroopiumbromiid | R03BB01 | ATROVENT inhalatsioonilahus 0,25mg/ml 20ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
1075 | irbesartaan | C09CA04 | APROVEL tablett 150mg N14 | Sanofi Pharma BMS | 50% | |||||||
1076 | irbesartaan | C09CA04 | APROVEL tablett 150mg N28 | Sanofi Pharma BMS | 50% | |||||||
1077 | irbesartaan | C09CA04 | APROVEL tablett 150mg N56 | Sanofi Pharma BMS | 50% | |||||||
1078 | irbesartaan | C09CA04 | APROVEL tablett 150mg N98 | Sanofi Pharma BMS | 50% | |||||||
1079 | irbesartaan | C09CA04 | APROVEL tablett 300mg N14 | Sanofi Pharma BMS | 50% | |||||||
1080 | irbesartaan | C09CA04 | APROVEL tablett 300mg N28 | Sanofi Pharma BMS | 50% | |||||||
1081 | irbesartaan | C09CA04 | APROVEL tablett 300mg N56 | Sanofi Pharma BMS | 50% | |||||||
1082 | irbesartaan | C09CA04 | APROVEL tablett 300mg N98 | Sanofi Pharma BMS | 50% | |||||||
1083 | irbesartaan | C09CA04 | APROVEL tablett 75mg N28 | Sanofi Pharma BMS | 50% | |||||||
1084 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N28 | Sanofi Pharma BMS | 50% | |||||||
1085 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N56 | Sanofi Pharma BMS | 50% | |||||||
1086 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N98 | Sanofi Pharma BMS | 50% | |||||||
1087 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N28 | Sanofi Pharma BMS | 50% | |||||||
1088 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N56 | Sanofi Pharma BMS | 50% | |||||||
1089 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N98 | Sanofi Pharma BMS | 50% | |||||||
1090 | isokonasool | D01AC05 | TRAVOGEN kreem 1%/g 20g N1 | Schering AG | 50% | |||||||
1091 | isokonasool | D01AC05 | TRAVOGEN kreem 1%/g 50g N1 | Schering AG | 50% | |||||||
1092 | isokonasool | G01AF07 | GYNO-TRAVOGEN vaginaaloovul 600mg N1 | Schering AG | 50% | |||||||
1093 | isokonasool+diflukortoloon | D01AC80 | TRAVOCORT kreem 1%+0,1%/g 15g N1 | Schering AG | 50% | |||||||
1094 | isokonasool+diflukortoloon | D01AC80 | TRAVOCORT kreem 1%+0,1%/g 30g N1 | Schering AG | 50% | |||||||
1095 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 20 retardkapsel 20mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1096 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 20 retardkapsel 20mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1097 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 40 RETARDKAPSELN retardkapsel 40mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1098 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 40 RETARDKAPSELN retardkapsel 40mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1099 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 5 tablett 5mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1100 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 5 tablett 5mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1101 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 20 MG retardkapsel 20mg N50 | H. Mack | 50% | 75% | I20 | |||||
1102 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 40 MG retardkapsel 40mg N50 | H. Mack | 50% | 75% | I20 | |||||
1103 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 60 MG retardkapsel 60mg N50 | H. Mack | 50% | 75% | I20 | |||||
1104 | isosorbiiddinitraat | C01DA08 | ISO MACK SPRAY sprei 1,25mg/annuses 20ml N1 | H. Mack | 50% | 75% | I20 | |||||
1105 | isosorbiiddinitraat | C01DA08 | ISOKET 20 retardtablett 20mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1106 | isosorbiiddinitraat | C01DA08 | ISOKET 40 retardtablett 40mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1107 | isosorbiidmononitraat | C01DA14 | ELANTAN 20 tablett 20mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1108 | isosorbiidmononitraat | C01DA14 | ELANTAN 40 tablett 40mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1109 | isosorbiidmononitraat | C01DA14 | ELANTAN LONG retardkapsel 50mg N20 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1110 | isosorbiidmononitraat | C01DA14 | IMDUR retardtablett 60mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I20 | |||||
1111 | isosorbiidmononitraat | C01DA14 | IMDUR retardtablett 60mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I20 | |||||
1112 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1113 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N20 | ratiopharm | 50% | 75% | I20 | |||||
1114 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1115 | isosorbiidmononitraat | C01DA14 | MONO MACK 20 MG tablett 20mg N50 | H. Mack | 50% | 75% | I20 | |||||
1116 | isosorbiidmononitraat | C01DA14 | MONO MACK 40 MG tablett 40mg N50 | H. Mack | 50% | 75% | I20 | |||||
1117 | isosorbiidmononitraat | C01DA14 | MONO MACK DEPOT retardtablett 100mg N20 | H. Mack | 50% | 75% | I20 | |||||
1118 | isosorbiidmononitraat | C01DA14 | OLICARD 40 RETARD retardkapsel 40mg N50 | Solvay | 50% | 75% | I20 | |||||
1119 | isosorbiidmononitraat | C01DA14 | OLICARD 60 RETARD retardkapsel 60mg N50 | Solvay | 50% | 75% | I20 | |||||
1120 | isotretinoiin | D10BA01 | ROACCUTANE kapsel 10mg N30 | Roche | 50% | 75% | L70.1*; L70.2* | *rv dermatovene- roloogil |
||||
1121 | isradipiin | C08CA03 | LOMIR SRO kapsel 5mg N100 | Novartis Pharma | 50% | |||||||
1122 | isradipiin | C08CA03 | LOMIR SRO kapsel 5mg N30 | Novartis Pharma | 50% | |||||||
1123 | isradipiin | C08CA03 | LOMIR tablett 2,5mg N28 | Novartis Pharma | 50% | |||||||
1124 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N15 | Janssen | 50% | |||||||
1125 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N28 | Janssen | 50% | |||||||
1126 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N4 | Janssen | 50% | |||||||
1127 | itrakonasool | J02AC02 | SPORANOX suukaudne lahus 10mg/ml 150ml N1 | Janssen | 50% | |||||||
1128 | kaltsipotriool | D05AX02 | DAIVONEX kreem 50mcgg 30g N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1129 | kaltsipotriool | D05AX02 | DAIVONEX lahus peanahale 50mcgml 60ml N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1130 | kaltsipotriool | D05AX02 | DAIVONEX salv 0,005% 30g N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1131 | kaltsitoniin | H05BA01 | MIACALCIC ninasprei 200TÜ/annuses 2ml N1 | Novartis Pharma | 50% | |||||||
1132 | kaltsitoniin | H05BA01 | MIACALCIC süstelahus 100TÜml 1ml N5 | Novartis Pharma | 50% | |||||||
1133 | kaltsitriool | A11CC04 | ROCALTROL kapsel 0,25mcg N30 | Roche | 50% | 75% | N18* | *rv nefroloogil | 100% | E20*; E89.2*;
N25 |
*rv endokrino- loogil |
|
1134 | kaltsiumatsetaat | A12AA12 | PHOS-EX 250 MG tablette 250 mg N180 | SUOMEEN SAIRAALAPALVELU OY | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1135 | kaltsiumatsetaat | A12AA12 | CALCIUMACETAT-NEFRO tablett 500 mg N100 | MEDICE Chem.-pharm. Fabrik Pütter GmbH & Co. | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1136 | kaltsiumatsetaat | A12AA12 | CALCIUMACETAT-NEFRO tablett 500 mg N500 | MEDICE Chem.-pharm. Fabrik Pütter GmbH & Co. | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1137 | kaltsiumfolinaat | V03AF03 | ANTREX tablett 15mg N10 | Orion | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1138 | kaltsiumfolinaat | V03AF03 | ANTREX tablett 15mg N100 | Orion | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1139 | kaltsiumfolinaat | V03AF03 | CALCIUMFOLINAT “EBEWE” kapsel 15mg N20 | Ebewe | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1140 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N30 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1141 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N60 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1142 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N100 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1143 | kapetsitabiin | L01BC06 | XELODA tablett 150mg N60 | Roche | 50% | |||||||
1144 | kapetsitabiin | L01BC06 | XELODA tablett 500mg N120 | Roche | 50% | |||||||
1145 | kaptopriil | C09AA01 | CAPOTEN tablett 25mg N30 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1146 | kaptopriil | C09AA01 | CAPOTEN tablett 25mg N40 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1147 | kaptopriil | C09AA01 | CAPOTEN tablett 50mg N90 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1148 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1149 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1150 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1151 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1152 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1153 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1154 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1155 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1156 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1157 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 12,5 MG tablett 12,5mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1158 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 25 MG tablett 25mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1159 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 50 MG tablett 50mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1160 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1161 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1162 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1163 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1164 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1165 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1166 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1167 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1168 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1169 | kaptopriil | C09AA01 | KAPTEKS tablett 12,5mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1170 | kaptopriil | C09AA01 | KAPTEKS tablett 25mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1171 | kaptopriil | C09AA01 | KAPTEKS tablett 50mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1172 | kaptopriil | C09AA01 | KAPTOPRIL 12,5 tablett 12,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1173 | kaptopriil | C09AA01 | KAPTOPRIL 25 tablett 25mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1174 | kaptopriil | C09AA01 | KAPTOPRIL 50 tablett 50mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1175 | kaptopriil | C09AA01 | NYCAPRIL 25 MG tablett 25mg N40 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1176 | kaptopriil | C09AA01 | NYCAPRIL 50 MG tablett 50mg N30 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1177 | kaptopriil+hüdroklorotiasiid | C09BA01 | CAPOZIDE tablett 50mg+25mg N30 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1178 | karbamasepiin | N03AF01 | CARBALEX 200 MG TABLET tablett 200 mg N50 | Gerot | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1179 | karbamasepiin | N03AF01 | CARBALEX 400 MG TABLET tablett 400 mg N50 | Gerot | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1180 | karbamasepiin | N03AF01 | CARBAMAZEPIN NYCOMED 200 MG tablett 200mg N50 | Nycomed SEFA | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1181 | karbamasepiin | N03AF01 | CARBASAN RETARD retardtablett 400mg N50 | Sanofi | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1182 | karbamasepiin | N03AF01 | CARBASAN tablett 200mg N50 | Sanofi | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1183 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N100 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1184 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N200 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1185 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1186 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N100 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1187 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N200 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1188 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1189 | karbamasepiin | N03AF01 | FINLEPSIN tablett 200mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1190 | karbamasepiin | N03AF01 | TEGRETOL CR retardtablett 200mg N50 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1191 | karbamasepiin | N03AF01 | TEGRETOL CR retardtablett 400mg N30 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1192 | karbamasepiin | N03AF01 | TEGRETOL tablett 200mg N50 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1193 | karbamasepiin | N03AF01 | TEGRETOL tablett 400mg N30 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1194 | karbamasepiin | N03AF01 | TIMONIL 150 RETARD retardtablett 150mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1195 | karbamasepiin | N03AF01 | TIMONIL 150 RETARD retardtablett 150mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1196 | karbamasepiin | N03AF01 | TIMONIL 200 tablett 200mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1197 | karbamasepiin | N03AF01 | TIMONIL 200 tablett 200mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1198 | karbamasepiin | N03AF01 | TIMONIL 300 RETARD retardtablett 300mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1199 | karbamasepiin | N03AF01 | TIMONIL 300 RETARD retardtablett 300mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1200 | karbamasepiin | N03AF01 | TIMONIL 600 RETARD retardtablett 600mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1201 | karbamasepiin | N03AF01 | TIMONIL 600 RETARD retardtablett 600mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1202 | karbotsüsteiin | R05CB03 | FLUDITEC siirup 20mg/ml 125 ml N1 | Laboratoire Innotech int | 50% | |||||||
1203 | karbotsüsteiin | R05CB03 | FLUDITEC siirup 50mg/ml 125ml N1 | Laboratoire Innotech int | 50% | |||||||
1204 | karbotsüsteiin | R05CB03 | MUCOPRONT kapsel 375mg N20 | H. Mack | 50% | |||||||
1205 | karbotsüsteiin | R05CB03 | MUCOPRONT siirup 50mg/g 200ml N1 | H. Mack | 50% | |||||||
1206 | karbotsüsteiin | R05CB03 | MUCOPRONT siirup 50mg/g 90ml N1 | H. Mack | 50% | |||||||
1207 | karbotsüsteiin | R05CB03 | PULMOCLASE kapsel 375mg N50 | UCB Pharma Oy Finland | 50% | |||||||
1208 | karbotsüsteiin | R05CB03 | PULMOCLASE siirup 50mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
1209 | karbotsüsteiin | R05CB03 | PULMOCLASE siirup 50mg/ml 500ml N1 | UCB Pharma Oy Finland | 50% | |||||||
1210 | karvedilool | C07AG02 | CORYOL tablett 12,5mg N30 | KRKA, d.d. | 50% | |||||||
1211 | karvedilool | C07AG02 | CORYOL tablett 25mg N30 | KRKA, d.d. | 50% | |||||||
1212 | karvedilool | C07AG02 | DILATREND tablett 12,5mg N30 | Roche | 50% | |||||||
1213 | karvedilool | C07AG02 | DILATREND tablett 25mg N30 | Roche | 50% | |||||||
1214 | karvedilool | C07AG02 | DILATREND tablett 6,25mg N30 | Roche | 50% | |||||||
1215 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | HUMAJECT NPH süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1216 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1217 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1218 | Keskmise toimeajaga humaaninsuliin | A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1219 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1220 | Keskmise toimeajaga humaanin- suliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1221 | Keskmise toimeajaga humaanin- suliin |
A10AC01 | MONOTARD HM süstesuspensioon 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1222 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM PENFILL süstesuspensioon 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1223 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1224 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM süstesuspensioon 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1225 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE INNOLET süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1226 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1227 | ketobemidoon | N02AB01 | KETOGAN NOVUM tablett 5mg N100 | Pharmacia Enterprises | 50% | |||||||
1228 | ketobemidoon | N02AB01 | KETOGAN NOVUM tablett 5mg N20 | Pharmacia Enterprises | 50% | |||||||
1229 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 10mg N100 | Pharmacia Enterprises | 50% | |||||||
1230 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 10mg N20 | Pharmacia Enterprises | 50% | |||||||
1231 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 25mg N100 | Pharmacia Enterprises | 50% | |||||||
1232 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 25mg N20 | Pharmacia Enterprises | 50% | |||||||
1233 | ketokonasool | D01AC08 | NIZORAL kreem 2%/g 15g N1 | Janssen | 50% | |||||||
1234 | ketokonasool | D01AC08 | NIZORAL kreem 2%/g 30g N1 | Janssen | 50% | |||||||
1235 | ketokonasool | J02AB02 | NIZORAL tablett 200mg N10 | Janssen | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1236 | ketokonasool | J02AB02 | NIZORAL tablett 200mg N30 | Janssen | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1237 | ketokonasool | J02AB02 | ORONAZOL tablett 200mg N20 | KRKA, d.d. | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1238 | ketoprofeen | M01AE03 | BI-PROFENID retardtablett 150mg N20 | LABORATOIRE AVENTIS | 50% | |||||||
1239 | ketoprofeen | M01AE03 | KETO tablett 100mg N100 | Vitabalans | 50% | |||||||
1240 | ketoprofeen | M01AE03 | KETO tablett 100mg N20 | Vitabalans | 50% | |||||||
1241 | ketoprofeen | M01AE03 | KETO tablett 100mg N30 | Vitabalans | 50% | |||||||
1242 | ketoprofeen | M01AE03 | KETO tablett 50mg N100 | Vitabalans | 50% | |||||||
1243 | ketoprofeen | M01AE03 | KETO tablett 50mg N20 | Vitabalans | 50% | |||||||
1244 | ketoprofeen | M01AE03 | KETO tablett 50mg N30 | Vitabalans | 50% | |||||||
1245 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 ZÄPFCHEN suposiit 100mg N10 | ratiopharm | 50% | |||||||
1246 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 ZÄPFCHEN suposiit 100mg N50 | ratiopharm | 50% | |||||||
1247 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N100 | ratiopharm | 50% | |||||||
1248 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N20 | ratiopharm | 50% | |||||||
1249 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N50 | ratiopharm | 50% | |||||||
1250 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | |||||||
1251 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N20 | ratiopharm | 50% | |||||||
1252 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | |||||||
1253 | ketoprofeen | M01AE03 | PROFENID kapsel 50mg N24 | LABORATOIRE AVENTIS | 50% | |||||||
1254 | ketoprofeen | M01AE03 | PROFENID suposiit 100mg N12 | LABORATOIRE AVENTIS | 50% | |||||||
1255 | ketoprofeen | M01AE03 | PROFENID tablett 100mg N30 | LABORATOIRE AVENTIS | 50% | |||||||
1256 | ketorolak | S01BC05 | ACULAR silmatilgad 0,5% 5 ml N1 | Allergan | 50% | |||||||
1257 | ketotifeen | R06AX17 | ZADITEN siirup 0,2mg/ml 100ml N1 | Novartis Pharma | 50% | |||||||
1258 | ketotifeen | R06AX17 | ZADITEN tablett 1mg N30 | Novartis Pharma | 50% | |||||||
1259 | kinidiin | C01BA01 | KINIDIN DURULES retardtablett 200mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
1260 | klaritromütsiin | J01FA09 | FROMILID 250 tablett 250mg N14 | KRKA, d.d. | 50% | |||||||
1261 | klaritromütsiin | J01FA09 | FROMILID 500 tablett 500mg N14 | KRKA, d.d. | 50% | |||||||
1262 | klaritromütsiin | J01FA09 | FROMILID suspensioonigraanulid 125mg 5ml 25g N1 | KRKA, d.d. | 50% | |||||||
1263 | klaritromütsiin | J01FA09 | KLACID 250 MG TABS tablett 250mg N10 | Sanofi | 50% | |||||||
1264 | klaritromütsiin | J01FA09 | KLACID 250 MG TABS tablett 250mg N14 | Sanofi | 50% | |||||||
1265 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 25mgml 100ml N1 | Sanofi | 50% | |||||||
1266 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 25mgml 60ml N1 | Sanofi | 50% | |||||||
1267 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 50mgml 100ml N1 | Sanofi | 50% | |||||||
1268 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 50mgml 60ml N1 | Sanofi | 50% | |||||||
1269 | klaritromütsiin | J01FA09 | KLACID SR retardtablett 500mg N5 | Sanofi | 50% | |||||||
1270 | klaritromütsiin | J01FA09 | KLACID SR retardtablett 500mg N7 | Sanofi | 50% | |||||||
1271 | klemastiin | R06AA04 | TAVEGYL tablett 1mg N20 | Novartis Consumer Health | 50% | |||||||
1272 | klindamütsiin | D10AF01 | DALACIN T lahus paikseks kasut. 10mgml 30ml N1 | Pharmacia Enterprises | 50% | |||||||
1273 | klindamütsiin | G01AA10 | DALACIN vaginaalkreem 20mgg 40g N1 | Pharmacia Enterprises | 50% | |||||||
1274 | klindamütsiin | G01AA10 | DALACIN VAGINAL OVULE oovul 100mg N3 | Pharmacia Enterprises | 50% | |||||||
1275 | klindamütsiin | J01FF01 | DALACIN C kapsel 150mg N100 | Pharmacia Enterprises | 50% | |||||||
1276 | klindamütsiin | J01FF01 | DALACIN C kapsel 150mg N16 | Pharmacia Enterprises | 50% | |||||||
1277 | klindamütsiin | J01FF01 | DALACIN C kapsel 300mg N16 | Pharmacia Enterprises | 50% | |||||||
1278 | klobetasool | D07AD01 | DERMOVATE kreem 0,05% 25g N1 | Glaxo Wellcome | 50% | |||||||
1279 | klobetasool | D07AD01 | DERMOVATE lahus 0,05% 25ml N1 | Glaxo Wellcome | 50% | |||||||
1280 | klobetasool | D07AD01 | DERMOVATE salv 0,05% 25g N1 | Glaxo Wellcome | 50% | |||||||
1281 | klodroonhape | M05BA02 | BONEFOS kapsel 400mg N100 | Leiras | 50% | |||||||
1282 | klodroonhape | M05BA02 | BONEFOS kapsel 400mg N30 | Leiras | 50% | |||||||
1283 | klodroonhape | M05BA02 | BONEFOS tablett 800mg N60 | Leiras | 50% | |||||||
1284 | klodroonhape | M05BA02 | LODRONAT 520 tablett 520mg N60 | Roche | 50% | |||||||
1285 | klomifeen | G03GB02 | SEROPHENE tablett 50mg N10 | ARES TRADING SA | 50% | |||||||
1286 | klomifeen | G03GB02 | SEROPHENE tablett 50mg N30 | ARES TRADING SA | 50% | |||||||
1287 | klomipramiin | N06AA04 | ANAFRANIL 10 tablett 10mg N30 | Novartis Pharma | 50% | |||||||
1288 | klomipramiin | N06AA04 | ANAFRANIL SR retardtablett 75mg N20 | Novartis Pharma | 50% | |||||||
1289 | klomipramiin | N06AA04 | ANAFRANIL tablett 25mg N30 | Novartis Pharma | 50% | |||||||
1290 | klonasepaam | N03AE01 | RIVOTRIL tablett 0,5mg N50 | Roche | 50% | 100% | G40* | *rev neuroloogil | ||||
1291 | klonasepaam | N03AE01 | RIVOTRIL tablett 2mg N30 | Roche | 50% | 100% | G40* | *rev neuroloogil | ||||
1292 | kloorambutsiil | L01AA02 | LEUKERAN TABLETS 2 MG tablett 2mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1293 | klooram- fenikool |
S01AA01 | OFTAN AKVAKOL silmatilgad 0,5% 10 ml N1 | Santen | 50% | |||||||
1294 | kloor- protikseen |
N05AF03 | TRUXAL tablett 100mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1295 | kloor- protikseen |
N05AF03 | TRUXAL tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1296 | kloor- protikseen |
N05AF03 | TRUXAL tablett 50mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1297 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N28 | Sanofi Pharma BMS | 50% | |||||||
1298 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N50 | Sanofi Pharma BMS | 50% | |||||||
1299 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N84 | Sanofi Pharma BMS | 50% | |||||||
1300 | klosapiin | N05AH02 | LEPONEX tablett 100mg N50 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1301 | klosapiin | N05AH02 | LEPONEX tablett 25mg N50 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1302 | klostrido- peptidaas |
D03BA02 | IRUXOL MONO salv 1,2TÜ 10g N1 | Knoll GmbH | 50% | |||||||
1303 | klostrido- peptidaas |
D03BA02 | IRUXOL MONO salv 1,2TÜ 30g N1 | Knoll GmbH | 50% | |||||||
1304 | klotrimasool | D01AC01 | KLOTRIMASOOL kreem 1%/g 20g N1 | GlaxoSmithKline Pharmaceu | 50% | |||||||
1305 | klotrimasool | G01AF02 | ANTIFUNGOL 3 vagin. tablett 200mg N3 | Hexal AG | 50% | |||||||
1306 | klotrimasool | G01AF02 | ANTIFUNGOL 3 VAGINAALKREEM vaginaalkreem 20mg/g 20g N1 | Hexal AG | 50% | |||||||
1307 | klotrimasool | G01AF02 | ANTIFUNGOL COMBI vagin tab+kreem N23 | Hexal AG | 50% | |||||||
1308 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 100 KOMBI vagin supp/kreem 100mg N6 | Wolff | 50% | |||||||
1309 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 100 vaginaalsuposiit 100mg N6 | Wolff | 50% | |||||||
1310 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 200 vaginaalsuposiit 200mg N3 | Wolff | 50% | |||||||
1311 | klotrimasool | G01AF02 | CANIFUG VAGINALCREME 2% vaginaalkreem 2% 20g N1 | Wolff | 50% | |||||||
1312 | klotrimasool | G01AF02 | KLOTRIMASOOL vagin. tablett 100mg N6 | GlaxoSmithKline Pharmaceu | 50% | |||||||
1313 | kodeiin+ fenüült- oloksamiin |
R05DA80 | CODIPRONT retardkapsel 30mg+10mg N10 | H. Mack | 50% | |||||||
1314 | kodeiin+ fenüül- toloksamiin |
R05DA80 | CODIPRONT SIIRUP retardsuspensioon 2mg+0,66mg/g 100g N1 | H. Mack | 50% | |||||||
1315 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N30 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1316 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N60 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1317 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N100 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1318 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN FORTE närimistablett 400 TÜ + 500 mg N60 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1319 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 0,3 MG kapsel 0,3mg N21 | H. Mack | 50% | |||||||
1320 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 0,6 MG kapsel 0,6mg N21 | H. Mack | 50% | |||||||
1321 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 1,25 MG kapsel 1,25mg N21 | H. Mack | 50% | |||||||
1322 | Konjugeeritud östrogeenid | G03CA57 | PREMARIN tablett 0,625mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1323 | Konjugeeritud östrogeenid | G03CA57 | PREMARIN tablett 0,625mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1324 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMELLE tablett 0,625mg+5mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1325 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,3 tablett 0,3 mg+1,5 mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1326 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,3 tablett 0,3 mg+1,5 mg N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1327 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,45 tablett 0,45 mg+1,5 mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1328 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,45 tablett 0,45 mg+1,5 mg N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1329 | kooriongonadotropiin | G03GA01 | PREGNYL injektsiooni- substants 5000TÜ N3 |
N.V. ORGANON | 50% | |||||||
1330 | kooriongonadotropiin | G03GA01 | PROFASI injektsiooni- substants 2000TÜ N3 |
ARES TRADING SA | 50% | |||||||
1331 | kooriongonadotropiin | G03GA01 | PROFASI injektsioonisubstants 5000TÜ N1 | ARES TRADING SA | 50% | |||||||
1332 | kooriongonadotropiin | G03GA01 | PROFASI injektsiooni- substants 5000TÜ N10 |
ARES TRADING SA | 50% | |||||||
1333 | kromoglütsiinhape | R01AC01 | CROMO-RATIOPHARM NASENSPRAY ninasprei 2%/ml 15ml N1 | ratiopharm | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1334 | kromoglütsiinhape | R01AC01 | LOMUSOL ninasprei 2%/ml 26ml N1 | LABORATOIRE AVENTIS | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1335 | kromoglütsiin- hape |
R01AC01 | STADAGLICIN NINASPREI ninasprei 2%/ml 15ml N1 | Stada | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1336 | kromoglütsiin- hape |
R03BC01 | INTAL NEBSOL nebulisaatori lahus 1%/g 2ml N48 | Aventis Pharma Int | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1337 | kromoglütsiinhape | S01GX01 | LECROLYN silmatilgad 4% 5ml N1 | Santen | 50% | |||||||
1338 | kromoglütsiin- hape |
S01GX01 | LECROLYN silmatilgad üksikannustena 4% 0.25ml N30 | Santen | 50% | |||||||
1339 | kvetiapiin | N05AH04 | SEROQUEL tablett 100mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1340 | kvetiapiin | N05AH04 | SEROQUEL tablett 200mg N60 | AstraZeneca UK Ltd. | 50% | |||||||
1341 | kvetiapiin | N05AH04 | SEROQUEL tablett 200mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1342 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
1343 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1344 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N4 | AstraZeneca UK Ltd. | 50% | |||||||
1345 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N6 | AstraZeneca UK Ltd. | 50% | |||||||
1346 | kvinapriil | C09AA06 | ACCUPRO 10 tablett 10mg N30 | Pfizer H.C.P | 50% | |||||||
1347 | kvinapriil | C09AA06 | ACCUPRO 20 tablett 20mg N30 | Pfizer H.C.P | 50% | |||||||
1348 | kvinapriil | C09AA06 | ACCUPRO 5 tablett 5mg N30 | Pfizer H.C.P | 50% | |||||||
1349 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N100 | Pfizer H.C.P | 50% | |||||||
1350 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N30 | Pfizer H.C.P | 50% | |||||||
1351 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N50 | Pfizer H.C.P | 50% | |||||||
1352 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N100 | Pfizer H.C.P | 50% | |||||||
1353 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N30 | Pfizer H.C.P | 50% | |||||||
1354 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N50 | Pfizer H.C.P | 50% | |||||||
1355 | labetalool | C07AG01 | TRANDATE TABLETS 100 MG tablett 100mg N50 | Glaxo Wellcome | 50% | 75% | O10-O16 | |||||
1356 | lamivudiin | J05AB10 | EPIVIR tablett 150mg N60 | Glaxo Wellcome | 50% | |||||||
1357 | lamivudiin | J05AF05 | ZEFFIX tablett 100mg N28 | Glaxo Wellcome | 50% | |||||||
1358 | lamivudiin+ zidovudiin |
J05AB81 | COMBIVIR tablett 150mg+300mg N60 | Glaxo Wellcome | 50% | |||||||
1359 | lamotrigiin | N03AX09 | LAMICTAL lahustuv/närimis- tablett 2mg N30 |
Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1360 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 100 MG tablett 100mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1361 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 100 MG tablett 100mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1362 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 25 MG tablett 25mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1363 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 25 MG tablett 25mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1364 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 50 MG tablett 50mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1365 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 50 MG tablett 50mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1366 | lansoprasool | A02BC03 | LANZUL kapsel 30mg N14 | KRKA, d.d. | 50% | |||||||
1367 | latanoprost | S01EX03 | XALATAN silmatilgad 0,005% 2.5ml N1 | Pharmacia Enterprises | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kui monoteraapia beeta-adreno- blokaatori ja karboanhüdraasi inhibiitoriga ei ole langetanud piisavalt silma siserõhku või mõlema rühma ravimid on vastunäidustatud |
||||
1368 | latanoprost | S01EX03 | XALATAN silmatilgad 0,005% 2.5ml N3 | Pharmacia Enterprises | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kui monoteraapia beeta-adreno- blokaatori ja karboanhüdraasi inhibiitoriga ei ole langetanud piisavalt silma siserõhku või mõlema rühma ravimid on vastunäidustatud |
||||
1369 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N14 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1370 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N28 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1371 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N56 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1372 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N14 | Berlin-Chemie | 50% | |||||||
1373 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N28 | Berlin-Chemie | 50% | |||||||
1374 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N7 | Berlin-Chemie | 50% | |||||||
1375 | letrosool | L02BG04 | FEMARA tablett 2,5mg N30 | Novartis Pharma | 50% | |||||||
1376 | levamisool | P02CE01 | DECARIS 150 MG TABLET tablett 150mg N1 | Richter | 50% | |||||||
1377 | levamisool | P02CE01 | DECARIS 50 MG TABLET tablett 50mg N2 | Richter | 50% | |||||||
1378 | levlunomiid | L04AA13 | ARAVA 10 MG tablett 10mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1379 | levlunomiid | L04AA13 | ARAVA 10 MG tablett 10mg N30 | Aventis Pharma Deutschland | 50% | |||||||
1380 | levlunomiid | L04AA13 | ARAVA 100 MG tablett 100mg N3 | Aventis Pharma Deutschland | 50% | |||||||
1381 | levlunomiid | L04AA13 | ARAVA 20 MG tablett 20mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1382 | levlunomiid | L04AA13 | ARAVA 20 MG tablett 20mg N30 | Aventis Pharma Deutschland | 50% | |||||||
1383 | levocarnitiin | A16AA01 | NEFROCARNIT, SYRUP siirup 1g 3.3ml 50ml N1 | Medice | 50% | |||||||
1384 | levocarnitiin | A16AA01 | NEFROCARNIT, SYRUP siirup 1g 3.3ml 50ml N3 | Medice | 50% | |||||||
1385 | levodopa+ benserasiid |
N04BA80 | DOPA-MERZ 100/25 tablett 100mg+25mg N30 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
1386 | levodopa+ benserasiid |
N04BA80 | DOPA-MERZ 100/25 tablett 100mg+25mg N90 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
1387 | levodopa+ benserasiid |
N04BA80 | MADOPAR 250 tablett 200mg+50mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1388 | levodopa+ benserasiid |
N04BA80 | MADOPAR DISPERSIBLE lahustuv tablett 100mg+25mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1389 | levodopa+ benserasiid |
N04BA80 | MADOPAR DISPERSIBLE lahustuv tablett 100mg+25mg N30 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1390 | levodopa+ benserasiid |
N04BA80 | MADOPAR HBS tablett 100mg+25mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1391 | levodopa+karbidopa | N04BA81 | SINEMET 25/100 tablett 100mg+25mg N30 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1392 | levodopa+ karbidopa |
N04BA81 | SINEMET CR 250 tablett 200mg+50mg N100 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1393 | levodopa+ karbidopa |
N04BA81 | SINEMET tablett 250mg+25mg N100 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1394 | Levodro- propisiin |
R05DB80 | LEVOPRONT siirup 6mg/ml 120ml N1 | H. Mack | 50% | |||||||
1395 | Levodro- propisiin |
R05DB80 | LEVOPRONT siirup 6mg/ml 60ml N1 | H. Mack | 50% | |||||||
1396 | levokabastiin | R01AC02 | LIVOSTIN ninasprei 0,05%/ml 10ml N1 | KRKA, d.d. | 50% | |||||||
1397 | levokabastiin | R01AC02 | LIVOSTIN ninasprei 0,05%/ml 15ml N1 | KRKA, d.d. | 50% | |||||||
1398 | levokabastiin | S01GX02 | LIVOSTIN silmasuspensioon 0,05% 4ml N1 | KRKA, d.d. | 50% | |||||||
1399 | levonorgestreel | G03AC03 | MIKRO-30 WYETH tablett 30mcg N105 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
1400 | levonorgestreel | G03AC03 | MIKRO-30 WYETH tablett 30mcg N35 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
1401 | levonorgestreel | G03AC03 | POSTINOR tablett 0,75mg N4 | Richter | 50% | |||||||
1402 | levonorgestreel+etünüülöstr- adiool |
G03AA07 | FERTILAN tablett 0,25mg+0,05mg N4 | Richter | 50% | |||||||
1403 | levonorgestreel+etünüülöst- radiool |
G03AA07 | MICROGYNON tablett 0,15mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
1404 | levonorgestreel+etünüülöst- radiool |
G03AA07 | MINISISTON tablett 0,125mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
1405 | levonorgestreel+östrogeen | G03AB03 | TRIQUILAR drazhee N21 | Schering AG | 50% | 75% | Z30 | |||||
1406 | levonorgestreel+östrogeen | G03AB03 | TRI-REGOL tablett N63 | Richter | 50% | 75% | Z30 | |||||
1407 | levonorgestreel+östrogeen | G03AB03 | TRISISTON tablett -1+-1 N21 | Jenapharm | 50% | 75% | Z30 | |||||
1408 | levonorgestreel+östrogeen | G03AB03 | TRISISTON tablett -1+-1 N63 | Jenapharm | 50% | 75% | Z30 | |||||
1409 | levonorgestreel+östrogeen | G03FA11 | CLIMARA DUO TTS N8 | Schering AG | 50% | |||||||
1410 | levonorgestreel+östrogeen | G03FA11 | KLIMONORM tablett N21 | Jenapharm | 50% | |||||||
1411 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 100 BERLIN-CHEMIE tablett 100mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1412 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 100 BERLIN-CHEMIE tablett 100mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1413 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 150 BERLIN-CHEMIE tablett 150mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1414 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 150 BERLIN-CHEMIE tablett 150mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1415 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1416 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N30 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1417 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1418 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N84 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1419 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N10 | Pharmacia Enterprises | 50% | |||||||
1420 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N20 | Pharmacia Enterprises | 50% | |||||||
1421 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N30 | Pharmacia Enterprises | 50% | |||||||
1422 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N10 | Pharmacia Enterprises | 50% | |||||||
1423 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N20 | Pharmacia Enterprises | 50% | |||||||
1424 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N30 | Pharmacia Enterprises | 50% | |||||||
1425 | lisinopriil | C09AA03 | DIROTON tablett 10mg N28 | Richter | 50% | |||||||
1426 | lisinopriil | C09AA03 | DIROTON tablett 20mg N28 | Richter | 50% | |||||||
1427 | lisinopriil | C09AA03 | DIROTON tablett 5mg N28 | Richter | 50% | |||||||
1428 | lisinopriil | C09AA03 | PRINIVIL tablett 10mg N28 | MSD | 50% | |||||||
1429 | lisinopriil | C09AA03 | PRINIVIL tablett 20mg N28 | MSD | 50% | |||||||
1430 | lisinopriil | C09AA03 | PRINIVIL tablett 5mg N28 | MSD | 50% | |||||||
1431 | lodoksamiid | S01GX05 | ALOMIDE silmatilgad 0,1% 10ml N1 | Alcon | 50% | |||||||
1432 | lomefloksatsiin | S01AX17 | OKACIN silmatilgad 0,3%/ml 5ml N1 | NOVARTIS Ophthalmics | 50% | |||||||
1433 | loperamiid | A07DA03 | IMODIUM kapsel 2mg N20 | Janssen | 50% | |||||||
1434 | loperamiid | A07DA03 | LOPEDIUM ISO kihisev tablett 2mg N20 | Hexal AG | 50% | |||||||
1435 | loperamiid | A07DA03 | LOPEDIUM kapsel 2mg N30 | Hexal AG | 50% | |||||||
1436 | loperamiid | A07DA03 | LOPEDIUM kapsel 2mg N50 | Hexal AG | 50% | |||||||
1437 | loperamiid | A07DA03 | LOPERAMID-RATIOPHARM FILMTABLETTEN tablett 2mg N20 | ratiopharm | 50% | |||||||
1438 | loperamiid | A07DA03 | LOPERAMID-RATIOPHARM FILMTABLETTEN tablett 2mg N50 | ratiopharm | 50% | |||||||
1439 | lopinaviir+ ritonaviir |
J05AE80 | KALETRA kapsel 133,3mg+33,3mg N180 | ABBOTT LABORATORIES Ltd. | 50% | |||||||
1440 | lopinaviir+ ritonaviir |
J05AE80 | KALETRA suukaudne lahus 80mg+20mg/ml 60ml N5 | ABBOTT LABORATORIES Ltd. | 50% | |||||||
1441 | loratadiin | R06AX13 | CLARITINE FAST suukaudne lüofilisaat 10mg 1annus N100 | Schering-Plough | 50% | |||||||
1442 | loratadiin | R06AX13 | CLARITINE FAST suukaudne lüofilisaat 10mg 1annus N30 | Schering-Plough | 50% | |||||||
1443 | loratadiin | R06AX13 | CLARITINE siirup 1mg/ml 120ml N1 | Schering-Plough | 50% | |||||||
1444 | loratadiin | R06AX13 | CLARITINE tablett 10mg N100 | Schering-Plough | 50% | |||||||
1445 | loratadiin | R06AX13 | CLARITINE tablett 10mg N30 | Schering-Plough | 50% | |||||||
1446 | lornoksikaam | M01AC05 | XEFO tablett 4 mg N20 | Nycomed SEFA | 50% | |||||||
1447 | lornoksikaam | M01AC05 | XEFO tablett 8 mg N20 | Nycomed SEFA | 50% | |||||||
1448 | losartaan | C09CA01 | COZAAR tablett 100mg N14 | MSD | 50% | |||||||
1449 | losartaan | C09CA01 | COZAAR tablett 100mg N28 | MSD | 50% | |||||||
1450 | losartaan | C09CA01 | COZAAR tablett 12,5mg N21 | MSD | 50% | |||||||
1451 | losartaan | C09CA01 | COZAAR tablett 12,5mg N28 | MSD | 50% | |||||||
1452 | losartaan | C09CA01 | COZAAR tablett 50mg N14 | MSD | 50% | |||||||
1453 | losartaan | C09CA01 | COZAAR tablett 50mg N28 | MSD | 50% | |||||||
1454 | losartaan+ hüdro- klorotiasiid |
C09DA01 | FORTZAAR tablett 100mg+25mg N28 | MSD | 50% | |||||||
1455 | losartaan+ hüdro- klorotiasiid |
C09DA01 | HYZAAR tablett 50mg+12,5mg N28 | MSD | 50% | |||||||
1456 | lovastatiin | C10AA02 | HOLETAR tablett 20mg N20 | KRKA, d.d. | 50% | |||||||
1457 | lovastatiin | C10AA02 | HOLETAR tablett 40mg N30 | KRKA, d.d. | 50% | |||||||
1458 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N1 |
Serono Europe Ltd. | 50% | |||||||
1459 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N10 |
Serono Europe Ltd. | 50% | |||||||
1460 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N3 |
Serono Europe Ltd. | 50% | |||||||
1461 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM PENFILL süstelahus 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1462 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM PENFILL süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1463 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM süstelahus 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1464 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID INNOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1465 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1466 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMAJECT REGULAR süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1467 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG HUMAJECT süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1468 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG MIX50 PEN süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1469 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG MIX50 süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1470 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG PEN süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1471 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1472 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1473 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1474 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1475 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1476 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1477 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1478 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1479 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1480 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMAJECT 70/30 süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1481 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMALOG MIX25 PEN süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1482 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMALOG MIX25 süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1483 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN (30/70) süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1484 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN (MIX 70/30) süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1485 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN M (MIX 70/30) süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1486 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1487 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1488 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1489 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1490 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1491 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 20 HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1492 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 HM PENFILL süstesuspensioon 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1493 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1494 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 INNOLET süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1495 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1496 | lünöstrenool | G03DC03 | ORGAMETRIL tablett 5mg N30 | N.V. ORGANON | 50% | |||||||
1497 | lünöstrenool | G03DC03 | ORGAMETRIL tablett 5mg N90 | N.V. ORGANON | 50% | |||||||
1498 | mebendasool | P02CA01 | MEBENDAZOLS 100 MG TABLETES tablett 100mg N6 | Grindeks | 50% | |||||||
1499 | mebendasool | P02CA01 | VERMOX 100 MG TABLETS tablett 100mg N6 | Richter | 50% | |||||||
1500 | medroksü- progesteroon |
G03DA02 | CYKRINA tablett 10mg N42 | WYETH LEDERLE PHARMA GmbH | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1501 | medroksü- progesteroon |
G03DA02 | CYKRINA tablett 5mg N42 | WYETH LEDERLE PHARMA GmbH | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1502 | medroksü- progesteroon |
G03DA02 | DEPO-PROVERA süstesuspensioon 150mgml 1ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1503 | medroksü- progesteroon |
G03DA02 | DEPO-PROVERA süstesuspensioon 150mgml 3.3ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1504 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 10mg N100 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1505 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 10mg N40 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1506 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 5mg N24 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1507 | medroksü- progesteroon |
L02AB02 | DEPO-PROVERA süstesuspensioon 150mg/ml 1ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1508 | medroksü- progesteroon |
L02AB02 | DEPO-PROVERA süstesuspensioon 150mg/ml 3.3ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1509 | medroksü- progesteroon+Konjugeeritud östrogeenid |
G03FB80 | PREMELLE SEKVENS tablett N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1510 | medroksü- progesteroon+Konjugeeritud östrogeenid |
G03FB80 | PREMPAC SEKVENS tablett N42x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1511 | medroksü- progesteroon+östrageen |
G03FB06 | DIVINA tablett N21 | Orion | 50% | |||||||
1512 | megestrool | L02AB01 | MEGACE 160 tablett 160mg N30 | Bristol-Myers Squibb | 50% | |||||||
1513 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 120ml N1 | Bristol-Myers Squibb | 50% | |||||||
1514 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 240ml N1 | Bristol-Myers Squibb | 50% | |||||||
1515 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 480ml N1 | Bristol-Myers Squibb | 50% | |||||||
1516 | melfalaan | L01AA03 | ALKERAN INJECTION injektsiooni- substants 50mg N1 |
Glaxo Wellcome | 50% | |||||||
1517 | melfalaan | L01AA03 | ALKERAN TABLETS tablett 2mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1518 | meloksikaam | M01AC06 | MOVALIS tablett 15mg N20 | Boehringer Ingelheim | 50% | |||||||
1519 | meloksikaam | M01AC06 | MOVALIS tablett 15mg N50 | Boehringer Ingelheim | 50% | |||||||
1520 | meloksikaam | M01AC06 | MOVALIS tablett 7,5mg N20 | Boehringer Ingelheim | 50% | |||||||
1521 | meloksikaam | M01AC06 | MOVALIS tablett 7,5mg N50 | Boehringer Ingelheim | 50% | |||||||
1522 | melperoon | N05AD03 | BURONIL drazhee 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1523 | melperoon | N05AD03 | BURONIL drazhee 50mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1524 | merkaptopuriin | L01BB02 | PURI-NETHOL TABLETS tablett 50mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1525 | mesalasiin | A07EC02 | PENTASA retardtablett 500mg N100 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1526 | mesalasiin | A07EC02 | SALOFALK 250 TABLETS Gastroresistentne tablett 250mg N100 | Falk | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1527 | mesalasiin | A07EC02 | SALOFALK 250 TABLETS Gastroresistentne tablett 250mg N50 | Falk | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1528 | mesalasiin | A07EC02 | SALOFALK 500 TABLETS Gastroresistentne tablett 500mg N100 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1529 | mesalasiin | A07EC02 | SALOFALK 500 TABLETS Gastroresistentne tablett 500mg N50 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1530 | mesalasiin | A07EC02 | PENTASA rektaalsuspensioon 1g N7 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1531 | mesalasiin | A07EC02 | PENTASA suposiit 1g N28 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1532 | mesalasiin | A07EC02 | SALOFALK 250 SUPPOSITORIES suposiit 250mg N10 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1533 | mesalasiin | A07EC02 | SALOFALK 250 SUPPOSITORIES suposiit 250mg N30 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1534 | mesalasiin | A07EC02 | SALOFALK 500 SUPPOSITORIES suposiit 500mg N10 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1535 | mesalasiin | A07EC02 | SALOFALK 500 SUPPOSITORIES suposiit 500mg N30 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1536 | mesna | V03AF01 | UROMITEXAN tablett 400mg N10 | Asta Medica | 50% | |||||||
1537 | mesna | V03AF01 | UROMITEXAN tablett 400mg N20 | Asta Medica | 50% | |||||||
1538 | mesna | V03AF01 | UROMITEXAN tablett 400mg N30 | Asta Medica | 50% | |||||||
1539 | mesna | V03AF01 | UROMITEXAN tablett 400mg N50 | Asta Medica | 50% | |||||||
1540 | mesna | V03AF01 | UROMITEXAN tablett 600mg N10 | Asta Medica | 50% | |||||||
1541 | mesna | V03AF01 | UROMITEXAN tablett 600mg N20 | Asta Medica | 50% | |||||||
1542 | mesna | V03AF01 | UROMITEXAN tablett 600mg N200 | Asta Medica | 50% | |||||||
1543 | mesna | V03AF01 | UROMITEXAN tablett 600mg N30 | Asta Medica | 50% | |||||||
1544 | mesna | V03AF01 | UROMITEXAN tablett 600mg N50 | Asta Medica | 50% | |||||||
1545 | metadoon | N02AC02 | METADON DAK 1 MG/ML suukaudne lahus 1mg/ml 1000ml N1 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1546 | metadoon | N02AC02 | METADON DAK tablett 20mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1547 | metadoon | N02AC02 | METADON DAK tablett 5mg N10 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1548 | metadoon | N02AC02 | METHADON 10 MG/ML süstelahus 10mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1549 | metformiin | A10BA02 | GLUFORMIN tablett 850 N30 | Pliva | 50% | |||||||
1550 | metformiin | A10BA02 | GLUFORMIN tablett 850 N60 | Pliva | 50% | |||||||
1551 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N120 | Berlin-Chemie | 50% | |||||||
1552 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N30 | Berlin-Chemie | 50% | |||||||
1553 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N60 | Berlin-Chemie | 50% | |||||||
1554 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N120 | Berlin-Chemie | 50% | |||||||
1555 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N30 | Berlin-Chemie | 50% | |||||||
1556 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N60 | Berlin-Chemie | 50% | |||||||
1557 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N100 | ALPHARMA | 50% | |||||||
1558 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N28 | ALPHARMA | 50% | |||||||
1559 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N30 | ALPHARMA | 50% | |||||||
1560 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 850 MG tablett 850mg N50 | ALPHARMA | 50% | |||||||
1561 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 850 MG tablett 850mg N56 | ALPHARMA | 50% | |||||||
1562 | metformiin | A10BA02 | METFORMIN-HEXAL tablett 500mg N100 | Hexal AG | 50% | |||||||
1563 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 500 MG tablett 500mg N120 | ratiopharm | 50% | |||||||
1564 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 500 MG tablett 500mg N30 | ratiopharm | 50% | |||||||
1565 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 850 MG tablett 850mg N120 | ratiopharm | 50% | |||||||
1566 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 850 MG tablett 850mg N30 | ratiopharm | 50% | |||||||
1567 | metoklo- pramiid |
A03FA01 | CERUCAL tablett 10mg N50 | AWD | 50% | 100% | C00-D48 | |||||
1568 | metoklo- pramiid |
A03FA01 | METOCLOPRAMIDE ALPHARMA TABLETS 10 MG tablett 10mg N20 | ALPHARMA | 50% | 100% | C00-D48 | |||||
1569 | metoklo- pramiid |
A03FA01 | MCP-RATIOPHARM 10 suposiit 10mg N5 | ratiopharm | 50% | 100% | C00-D48 | |||||
1570 | metoklo- pramiid |
A03FA01 | METOCLOPRAMIDE INJECTION BP süstelahus 5mg/ml 2ml N100 | Biologici | 50% | 100% | C00-D48 | |||||
1571 | metoklo- pramiid |
A03FA01 | SOL. METOCLOPRAMIDI 10MG süstelahus 5mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1572 | metoklo- pramiid |
A03FA01 | SOL. METOCLOPRAMIDI 10MG süstelahus 5mg/ml 2ml N100 | Ilsanta | 50% | 100% | C00-D48 | |||||
1573 | metoklo- pramiid |
A03FA01 | CERUCAL süstelahus 5mg/ml 2ml N10 | AWD | 50% | 100% | C00-D48 | |||||
1574 | metoklo- pramiid |
A03FA01 | MCP-RATIOPHARM SF süstelahus 5mg/ml 2ml N5 | ratiopharm | 50% | 100% | C00-D48 | |||||
1575 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N14 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1576 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1577 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N98 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1578 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 100mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1579 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 100mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1580 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 200mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1581 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 200mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1582 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 50mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1583 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 50mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1584 | metoprolool | C07AB02 | EMZOK tablett 100mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1585 | metoprolool | C07AB02 | EMZOK tablett 100mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1586 | metoprolool | C07AB02 | EMZOK tablett 200mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1587 | metoprolool | C07AB02 | EMZOK tablett 200mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1588 | metoprolool | C07AB02 | EMZOK tablett 50mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1589 | metoprolool | C07AB02 | EMZOK tablett 50mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1590 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1591 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N20 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1592 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1593 | metoprolool | C07AB02 | METOPROLOL 200 STADA RETARD retardtablett 200mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1594 | metoprolool | C07AB02 | METOPROLOL 200 STADA RETARD retardtablett 200mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1595 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1596 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N20 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1597 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1598 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1599 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1600 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1601 | metoprolool | C07AB02 | VASOCARDIN 100 tablett 100mg N20 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1602 | metoprolool | C07AB02 | VASOCARDIN 100 tablett 100mg N50 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1603 | metoprolool | C07AB02 | VASOCARDIN 50 tablett 50mg N20 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1604 | metoprolool | C07AB02 | VASOCARDIN 50 tablett 50mg N50 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1605 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 100mg+10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1606 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 100mg+10mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1607 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 50mg+5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1608 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 50mg+5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1609 | metotreksaat | L01BA01 | TREXAN tablett 2,5mg N100 | Orion | 50% | 75% | L40*; M07**; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatovene- roloogil ja reuma- toloogil; **rv reumatoloogil |
100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | |
1610 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 15g N1 | Galderma | 50% | |||||||
1611 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 30g N1 | Galderma | 50% | |||||||
1612 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 50g N1 | Galderma | 50% | |||||||
1613 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 5g N1 | Galderma | 50% | |||||||
1614 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 15g N1 | Galderma | 50% | |||||||
1615 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 30g N1 | Galderma | 50% | |||||||
1616 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 50g N1 | Galderma | 50% | |||||||
1617 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 5g N1 | Galderma | 50% | |||||||
1618 | metronidasool | G01AF01 | FLAGYL vaginaalsuposiit 500mg N10 | LABORATOIRE AVENTIS | 50% | |||||||
1619 | metronidasool | J01XD01 | APO-METRONIDAZOLE tablett 250mg N20 | Apotex | 50% | |||||||
1620 | metronidasool | J01XD01 | APO-METRONIDAZOLE tablett 250mg N40 | Apotex | 50% | |||||||
1621 | metronidasool | J01XD01 | ARILIN 500 tablett 500mg N10 | Wolff | 50% | |||||||
1622 | metronidasool | J01XD01 | ARILIN 500 tablett 500mg N20 | Wolff | 50% | |||||||
1623 | metronidasool | J01XD01 | ARILIN KOMBIPACKUNG tabl/vagin supp N24 | Wolff | 50% | |||||||
1624 | metronidasool | J01XD01 | EFLORAN tablett 400mg N10 | KRKA, d.d. | 50% | |||||||
1625 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 250mg N20 | Nycomed SEFA | 50% | |||||||
1626 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | |||||||
1627 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 500mg N100 | Nycomed SEFA | 50% | |||||||
1628 | metronidasool | P01AB01 | METRONIDAZOL NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | |||||||
1629 | metronidasool | P01AB01 | METRONIDAZOL NYCOMED tablett 500mg N100 | Nycomed SEFA | 50% | |||||||
1630 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 1ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1631 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 2ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1632 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 5ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1633 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 16mg N50 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1634 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 4mg N100 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1635 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 4mg N30 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1636 | metüül- prednisoloon |
H02AB04 | SOLOMET depooinj 40mgml 1ml N1 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1637 | metüül- prednisoloon |
H02AB04 | SOLOMET depooinj 40mgml 5ml N1 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1638 | metüül- prednisoloon |
H02AB04 | SOLOMET tablett 4mg N100 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1639 | metüül- prednisoloon |
H02AB04 | SOLOMET tablett 4mg N30 | Orion | 50% | 75% | K50*; K51*; K73*; K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroenteroloogil; **rev reumatoloogil; ***rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1640 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 1000mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1641 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 125mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1642 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 250mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1643 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 40mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1644 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 500mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1645 | metüül- predniso- loonatseponaat |
D07AC14 | ADVANTAN kreem 0,1%/ 15g N1 | Schering AG | 50% | |||||||
1646 | metüül- predniso- loonatseponaat |
D07AC14 | ADVANTAN salv 0,1% 15g N1 | Schering AG | 50% | |||||||
1647 | mikonasool | A01AB09 | DAKTARIN suugeel 20mg/ml 40g N1 | Janssen | 50% | |||||||
1648 | mikonasool | D01AC02 | DAKTARIN kreem 2%/g 15g N1 | Janssen | 50% | |||||||
1649 | mikonasool | D01AC02 | DAKTARIN kreem 2%/g 30g N1 | Janssen | 50% | |||||||
1650 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 1200mg N1 | Janssen | 50% | |||||||
1651 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 200mg N7 | Janssen | 50% | |||||||
1652 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 400mg N3 | Janssen | 50% | |||||||
1653 | mikonasool+ masipredoon |
D01AX01 | MYCOSOLON OINTMENT salv 2%+0,25% 15g N1 | Richter | 50% | |||||||
1654 | milnatsipraan | N06AX17 | IXEL kapsel 50mg N56 | Pierre Fabre Medicament | 50% | |||||||
1655 | miltefosiin | L01XX09 | MILTEX lahus paikseks kasutamiseks 60mg/ml 10ml N1 | Asta Medica | 50% | |||||||
1656 | miltefosiin | L01XX09 | MILTEX lahus paikseks kasutamiseks 60mg/ml 10ml N5 | Asta Medica | 50% | |||||||
1657 | mirtasapiin | N06AX11 | REMERON tablett 15mg N100 | N.V. ORGANON | 50% | |||||||
1658 | mirtasapiin | N06AX11 | REMERON tablett 15mg N30 | N.V. ORGANON | 50% | |||||||
1659 | mirtasapiin | N06AX11 | REMERON tablett 15mg N60 | N.V. ORGANON | 50% | |||||||
1660 | mirtasapiin | N06AX11 | REMERON tablett 15mg N90 | N.V. ORGANON | 50% | |||||||
1661 | mirtasapiin | N06AX11 | REMERON tablett 30mg N100 | N.V. ORGANON | 50% | |||||||
1662 | mirtasapiin | N06AX11 | REMERON tablett 30mg N30 | N.V. ORGANON | 50% | |||||||
1663 | mirtasapiin | N06AX11 | REMERON tablett 30mg N60 | N.V. ORGANON | 50% | |||||||
1664 | mirtasapiin | N06AX11 | REMERON tablett 30mg N90 | N.V. ORGANON | 50% | |||||||
1665 | mirtasapiin | N06AX11 | REMERON tablett 45mg N100 | N.V. ORGANON | 50% | |||||||
1666 | mirtasapiin | N06AX11 | REMERON tablett 45mg N30 | N.V. ORGANON | 50% | |||||||
1667 | mirtasapiin | N06AX11 | REMERON tablett 45mg N60 | N.V. ORGANON | 50% | |||||||
1668 | mirtasapiin | N06AX11 | REMERON tablett 45mg N90 | N.V. ORGANON | 50% | |||||||
1669 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N10 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1670 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N15 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1671 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1672 | modafiniil | N06BA07 | MODIODAL tablett 100mg N30 | Merckle | 50% | |||||||
1673 | moklobemiid | N06AG02 | AURORIX tablett 150mg N30 | Roche | 50% | |||||||
1674 | moksonidiin | C02AC05 | PHYSIOTENS 0,2 tablett 0,2 mg N28 | Solvay | 50% | |||||||
1675 | moksonidiin | C02AC05 | PHYSIOTENS 0,3 mg N28 | Solvay | 50% | |||||||
1676 | moksonidiin | C02AC05 | PHYSIOTENS 0,4 mg N28 | Solvay | 50% | |||||||
1677 | mometasoon | D07AC13 | ELOCON kreem 0,1% 20g N1 | Schering-Plough | 50% | |||||||
1678 | mometasoon | D07AC13 | ELOCON kreem 0,1% 50g N1 | Schering-Plough | 50% | |||||||
1679 | mometasoon | D07AC13 | ELOCON nahalahus 0,1% 20ml N1 | Schering-Plough | 50% | |||||||
1680 | mometasoon | D07AC13 | ELOCON nahalahus 0,1% 50ml N1 | Schering-Plough | 50% | |||||||
1681 | mometasoon | D07AC13 | ELOCON salv 0,1% 20g N1 | Schering-Plough | 50% | |||||||
1682 | mometasoon | D07AC13 | ELOCON salv 0,1% 50g N1 | Schering-Plough | 50% | |||||||
1683 | mometasoon | R01AD09 | NASONEX ninasprei 0,5mg/ml 18g N140 | Schering-Plough | 50% | |||||||
1684 | montelukast | R03DC03 | SINGULAIR 4 MG närimistablett 4mg 1TABL N14 | MSD | 50% | |||||||
1685 | montelukast | R03DC03 | SINGULAIR 4 MG närimistablett 4mg 1TABL N28 | MSD | 50% | |||||||
1686 | montelukast | R03DC03 | SINGULAIR närimistablett 5mg N14 | MSD | 50% | |||||||
1687 | montelukast | R03DC03 | SINGULAIR närimistablett 5mg N28 | MSD | 50% | |||||||
1688 | montelukast | R03DC03 | SINGULAIR tablett 10mg N14 | MSD | 50% | |||||||
1689 | montelukast | R03DC03 | SINGULAIR tablett 10mg N28 | MSD | 50% | |||||||
1690 | morfiin | N02AA01 | DOLTARD retardtablett 30mg N20 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1691 | morfiin | N02AA01 | DOLTARD retardtablett 60mg N20 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1692 | morfiin | N02AA01 | MORFIN DAK 20 MG/ML süstelahus 20mg/ml 1ml N10 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1693 | morfiin | N02AA01 | MORFIN DAK süstelahus 0,4mg/ml 10ml N5 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1694 | morfiin | N02AA01 | MORFIN NYCOMED 30 MG tablett 30mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1695 | morfiin | N02AA01 | MORPHINE 10 MG/ML süstelahus 10mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1696 | morfiin | N02AA01 | MORPHINE 10 MG/ML süstelahus 10mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1697 | morfiin | N02AA01 | MS CONTIN 100 MG suposiit 100mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1698 | morfiin | N02AA01 | MS CONTIN 200 MG suposiit 200mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1699 | morfiin | N02AA01 | MS CONTIN 30 MG suposiit 30mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1700 | morfiin | N02AA01 | MS CONTIN 60 MG suposiit 60mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1701 | morfiin | N02AA01 | MSI 10 MUNDIPHARMA süstelahus 10mg/ml 1ml N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1702 | morfiin | N02AA01 | MSI 100 MUNDIPHARMA süstelahus 100mg 5ml 5 ml N5 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1703 | morfiin | N02AA01 | MSI 20 MUNDIPHARMA süstelahus 20mg/ml 1ml N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1704 | morfiin | N02AA01 | MSI 200 MUNDIPHARMA süstelahus 200mg 10ml 10ml N5 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1705 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1706 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1707 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1708 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1709 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1710 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1711 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1712 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1713 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1714 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1715 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1716 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1717 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1718 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1719 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1720 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1721 | morfiin | N02AA01 | MST CONTINUS retardtablett 100mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1722 | morfiin | N02AA01 | MST CONTINUS retardtablett 10mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1723 | morfiin | N02AA01 | MST CONTINUS retardtablett 200mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1724 | morfiin | N02AA01 | MST CONTINUS retardtablett 30mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1725 | morfiin | N02AA01 | MST CONTINUS retardtablett 60mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1726 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1727 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1728 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1729 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1730 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1731 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1732 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1733 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1734 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1735 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1736 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1737 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1738 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1739 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1740 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1741 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1742 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1743 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1744 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1745 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1746 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1747 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1748 | morfiin | N02AA01 | SEVREDOL tablett 10mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1749 | morfiin | N02AA01 | SEVREDOL tablett 10mg N56 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1750 | morfiin | N02AA01 | SEVREDOL tablett 20mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1751 | morfiin | N02AA01 | SEVREDOL tablett 20mg N56 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1752 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N10 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1753 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N20 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1754 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N60 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1755 | morfiin | N02AA01 | VENDAL RETARD 10 MG retardtablett 10mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1756 | morfiin | N02AA01 | VENDAL RETARD 100 MG retardtablett 100mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1757 | morfiin | N02AA01 | VENDAL RETARD 200 MG retardtablett 200mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1758 | morfiin | N02AA01 | VENDAL RETARD 30 MG retardtablett 30mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1759 | morfiin | N02AA01 | VENDAL RETARD 60 MG retardtablett 60mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1760 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N100 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1761 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1762 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1763 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N100 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1764 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1765 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1766 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON kapsel N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1767 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON kapsel N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1768 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1769 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1770 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1771 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1772 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N20 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1773 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1774 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1775 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1776 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N20 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1777 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1778 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1779 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANZYNORM FORTE enterotablett N30 | KRKA, d.d. | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1780 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANZYTRAT 10000 kapsel 10000TÜ N20 | Abbott GmbH & Co. KG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1781 | müko- fenoolhape |
L04AA06 | CELLCEPT kapsel 250mg N100 | Roche | 50% | |||||||
1782 | müko- fenoolhape |
L04AA06 | CELLCEPT kapsel 250mg N300 | Roche | 50% | |||||||
1783 | müko- fenoolhape |
L04AA06 | CELLCEPT pulber suspensiooniks 200mg/ml 110g N1 | Roche | 50% | |||||||
1784 | müko- fenoolhape |
L04AA06 | CELLCEPT tablett 500mg N150 | Roche | 50% | |||||||
1785 | müko- fenoolhape |
L04AA06 | CELLCEPT tablett 500mg N50 | Roche | 50% | |||||||
1786 | nabumetoon | M01AX01 | RELIFEX kihisev tablett 1g N100 | GlaxoSmithKline | 50% | |||||||
1787 | nabumetoon | M01AX01 | RELIFEX kihisev tablett 1g N20 | GlaxoSmithKline | 50% | |||||||
1788 | nabumetoon | M01AX01 | RELIFEX tablett 500mg N100 | GlaxoSmithKline | 50% | |||||||
1789 | nabumetoon | M01AX01 | RELIFEX tablett 500mg N20 | GlaxoSmithKline | 50% | |||||||
1790 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 11400TÜ anti Xa 0.6ml 0.6ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1791 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 11400TÜ anti Xa 0.6ml 0.6ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1792 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 15200TÜ anti Xa 0.8ml 0.8ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1793 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 15200TÜ anti Xa 0.8ml 0.8ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1794 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 19000TÜ anti Xa/ml 1ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1795 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 19000TÜ anti Xa/ml 1ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1796 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 3800TÜ anti Xa 0.4ml 0.4ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1797 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 3800TÜ anti Xa 0.4ml 0.4ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1798 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 5700TÜ anti Xa 0.6ml 0.6ml N1 | Sanofi | 50% | 75% | O99.8 | |||||
1799 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 5700TÜ anti Xa 0.6ml 0.6ml N6 | Sanofi | 50% | 75% | O99.8 | |||||
1800 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 7600TÜ anti Xa 0.8ml 0.8ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1801 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 7600TÜ anti Xa 0.8ml 0.8ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1802 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 0.3ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1803 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 0.3ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1804 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 1ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1805 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 1ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1806 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 15g N1 | Biochemie GmbH | 50% | |||||||
1807 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 200g N1 | Biochemie GmbH | 50% | |||||||
1808 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 30g N1 | Biochemie GmbH | 50% | |||||||
1809 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 5g N1 | Biochemie GmbH | 50% | |||||||
1810 | naftifiin | D01AE22 | EXODERIL SOLUTION lahus 1% 10ml N1 | Biochemie GmbH | 50% | |||||||
1811 | naftifiin | D01AE22 | EXODERIL SOLUTION lahus 1% 20ml N1 | Biochemie GmbH | 50% | |||||||
1812 | nandroloon | A14AB01 | RETABOLIL süstelahus 50mg/ml 1ml N1 | Richter | 50% | |||||||
1813 | nandroloon | A14AB01 | RETABOLIL süstelahus 50mg/ml 1ml N25 | Richter | 50% | |||||||
1814 | naprokseen | M01AE02 | ALEVE tablett 220mg N10 | Roche | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1815 | naprokseen | M01AE02 | NALGESIN FORTE tablett 550mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1816 | naprokseen | M01AE02 | NALGESIN tablett 275mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1817 | naprokseen | M01AE02 | NAPROKSENS 250 MG tablett 250mg N30 | Grindeks | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1818 | naprokseen | M01AE02 | NAPROKSENS 500 MG tablett 500mg N30 | Grindeks | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1819 | naprokseen | M01AE02 | NAPROSYN 250 tablett 250mg N30 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1820 | naprokseen | M01AE02 | NAPROSYN 250 tablett 250mg N50 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1821 | naprokseen | M01AE02 | NAPROSYN 500 suposiit 500mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1822 | naprokseen | M01AE02 | NAPROXEN ALPHARMA TABLETS 250 MG tablett 250mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1823 | naprokseen | M01AE02 | NAPROXEN ALPHARMA TABLETS 250 MG tablett 250mg N56 | ALPHARMA | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1824 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N2 | Glaxo Wellcome | 50% | |||||||
1825 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N4 | Glaxo Wellcome | 50% | |||||||
1826 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N6 | Glaxo Wellcome | 50% | |||||||
1827 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N12 | Novartis Pharma | 50% | |||||||
1828 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N120 | Novartis Pharma | 50% | |||||||
1829 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N24 | Novartis Pharma | 50% | |||||||
1830 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N30 | Novartis Pharma | 50% | |||||||
1831 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N360 | Novartis Pharma | 50% | |||||||
1832 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N60 | Novartis Pharma | 50% | |||||||
1833 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N84 | Novartis Pharma | 50% | |||||||
1834 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N12 | Novartis Pharma | 50% | |||||||
1835 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N120 | Novartis Pharma | 50% | |||||||
1836 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N24 | Novartis Pharma | 50% | |||||||
1837 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N30 | Novartis Pharma | 50% | |||||||
1838 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N360 | Novartis Pharma | 50% | |||||||
1839 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N60 | Novartis Pharma | 50% | |||||||
1840 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N84 | Novartis Pharma | 50% | |||||||
1841 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N12 | Novartis Pharma | 50% | |||||||
1842 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N120 | Novartis Pharma | 50% | |||||||
1843 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N24 | Novartis Pharma | 50% | |||||||
1844 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N30 | Novartis Pharma | 50% | |||||||
1845 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N360 | Novartis Pharma | 50% | |||||||
1846 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N60 | Novartis Pharma | 50% | |||||||
1847 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N84 | Novartis Pharma | 50% | |||||||
1848 | nebivolool | C07AB12 | NEBILET tablett 5mg N14 | Berlin-Chemie | 50% | |||||||
1849 | nebivolool | C07AB12 | NEBILET tablett 5mg N28 | Berlin-Chemie | 50% | |||||||
1850 | nebivolool | C07AB12 | NEBILET tablett 5mg N7 | Berlin-Chemie | 50% | |||||||
1851 | nelfinaviir | J05AE04 | VIRACEPT kaetud tablett 250mg N270 | Roche | 50% | |||||||
1852 | nelfinaviir | J05AE04 | VIRACEPT tablett 250mg N270 | Roche | 50% | |||||||
1853 | nevirapiin | J05AX03 | VIRAMUNE suspensioon 50mg 5ml 240ml N1 | Boehringer Ingelheim | 50% | |||||||
1854 | nevirapiin | J05AX03 | VIRAMUNE tablett 200mg N100 | Boehringer Ingelheim | 50% | |||||||
1855 | nevirapiin | J05AX03 | VIRAMUNE tablett 200mg N60 | Boehringer Ingelheim | 50% | |||||||
1856 | nifedipiin | C08CA05 | ADALAT 10 RETARD retardtablett 10mg N100 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1857 | nifedipiin | C08CA05 | ADALAT 10 RETARD retardtablett 10mg N50 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1858 | nifedipiin | C08CA05 | ADALAT OROS 30 MG DEPOT TABLETS retardtablett 30mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1859 | nifedipiin | C08CA05 | ADALAT OROS 30 MG DEPOT TABLETS retardtablett 30mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1860 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 20mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1861 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 20mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1862 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 60mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1863 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 60mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1864 | nifedipiin | C08CA05 | CORDIPIN RETARD retardtablett 20mg N30 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1865 | nifedipiin | C08CA05 | CORDIPIN tablett 10mg N50 | KRKA, d.d. | 50% | |||||||
1866 | nifedipiin | C08CA05 | CORDIPIN XL tablett 40mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1867 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N100 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1868 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N30 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1869 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N50 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1870 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N100 | AWD | 50% | |||||||
1871 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N30 | AWD | 50% | |||||||
1872 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N50 | AWD | 50% | |||||||
1873 | nifedipiin | C08CA05 | NIFECARD retardtablett 20mg N50 | LEK d.d | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1874 | nifedipiin | C08CA05 | NIFEDEKS tablett 10mg N30 | Grindeks | 50% | |||||||
1875 | nifedipiin | C08CA05 | NIFEDEKS tablett 10mg N50 | Grindeks | 50% | |||||||
1876 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N100 | ratiopharm | 50% | |||||||
1877 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N30 | ratiopharm | 50% | |||||||
1878 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N50 | ratiopharm | 50% | |||||||
1879 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1880 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1881 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1882 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N100 | ratiopharm | 50% | |||||||
1883 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N30 | ratiopharm | 50% | |||||||
1884 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N50 | ratiopharm | 50% | |||||||
1885 | nifedipiin | C08CA05 | NIFEHEXAL RETARD retardtablett 20mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1886 | nifedipiin | C08CA05 | NIFETARD-TFT retardtablett 20mg N20 | TFT | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1887 | nifedipiin | C08CA05 | NYCOPIN retardtablett 40mg N30 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1888 | nifluumhape | M02AA17 | NIFLURIL kreem 3% 60g N1 | Laboratoires Upsa | 50% | |||||||
1889 | nimodipiin | C08CA06 | DILCEREN tablett 30mg N50 | Slovakofarma | 50% | |||||||
1890 | nimodipiin | C08CA06 | NIMOTOP 30 MG TABLETS tablett 30mg N100 | Bayer AG | 50% | |||||||
1891 | nitrendipiin | C08CA08 | LUSOPRESS tablett 20mg N28 | Lusofarmaco | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1892 | nitrendipiin | C08CA08 | UNIPRES 10 tablett 10mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1893 | nitrendipiin | C08CA08 | UNIPRES 20 tablett 20mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1894 | nitrofurantoiin | G04AC01 | NITROFURANTOIN NYCOMED tablett 50mg N20 | Nycomed SEFA | 50% | |||||||
1895 | noretisteroon | G03AC01 | MICRONOR tablett 0,35mg N84 | Cilag | 50% | 75% | Z30 | |||||
1896 | noretisteroon | G03DC02 | NORCOLUT tablett 5mg N20 | Richter | 50% | |||||||
1897 | noretisteroon+etünüül- östradiool |
G03AA05 | NON-OVLON drazhee 1mg+0,05mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
1898 | noretisteroon+östradiool | G03FA01 | ACTIVELLE tablett 0,5mg+1mg N28 | Novo Nordisk | 50% | |||||||
1899 | noretisteroon+östradiool | G03FA01 | ESTRACOMB TTS TTS N8 | Novartis Pharma | 50% | |||||||
1900 | noretisteroon+östradiool | G03FA01 | KLIANE tablett 1mg+2mg N28 | Schering AG | 50% | |||||||
1901 | noretisteroon+östradiool | G03FA01 | KLIANE tablett 1mg+2mg N84 | Schering AG | 50% | |||||||
1902 | noretisteroon+östradiool | G03FA01 | KLIOGEST tablett 1mg+2mg N28 | Novo Nordisk | 50% | |||||||
1903 | noretisteroon+östradiool | G03FA01 | SYSTEN CONTI TTS 11,2mg+3,2mg N8 | Cilag | 50% | |||||||
1904 | noretisteroon+östradiool | G03FA01 | SYSTEN SEQUI TTS N8 | Cilag | 50% | |||||||
1905 | norfloksatsiin | J01MA06 | NOLICIN tablett 400mg N20 | KRKA, d.d. | 50% | |||||||
1906 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N10 | ratiopharm | 50% | |||||||
1907 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N20 | ratiopharm | 50% | |||||||
1908 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N50 | ratiopharm | 50% | |||||||
1909 | norfloksatsiin | S01AX12 | CHIBROXIN silmatilgad 0,3% 5 ml N1 | MSD | 50% | |||||||
1910 | norgestimaat+etünüül- östradiool |
G03AA11 | CILEST tablett 0,25mg+0,03mg N21 | Cilag | 50% | 75% | Z30 | |||||
1911 | norgestimaat+etünüül- östradiool |
G03AA11 | CILEST tablett 0,25mg+0,03mg N63 | Cilag | 50% | 75% | Z30 | |||||
1912 | norgestreel+ östrageen |
G03FA10 | CYCLO-PROGYNOVA drazhee N21 | Schering AG | 50% | |||||||
1913 | nortriptüliin | N06AA10 | NORITREN tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1914 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N10 | Aventis Pharma Deutschland | 50% | |||||||
1915 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1916 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N3 | Aventis Pharma Deutschland | 50% | |||||||
1917 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N100 | Desitin | 50% | |||||||
1918 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N200 | Desitin | 50% | |||||||
1919 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N50 | Desitin | 50% | |||||||
1920 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N100 | Desitin | 50% | |||||||
1921 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N200 | Desitin | 50% | |||||||
1922 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N50 | Desitin | 50% | |||||||
1923 | okskarbasepiin | N03AF02 | TRILEPTAL 150 kaetud tablett 150mg N100 | Novartis Pharma | 50% | |||||||
1924 | okskarbasepiin | N03AF02 | TRILEPTAL 150 kaetud tablett 150mg N50 | Novartis Pharma | 50% | |||||||
1925 | okskarbasepiin | N03AF02 | TRILEPTAL 300 kaetud tablett 300mg N100 | Novartis Pharma | 50% | |||||||
1926 | okskarbasepiin | N03AF02 | TRILEPTAL 300 kaetud tablett 300mg N50 | Novartis Pharma | 50% | |||||||
1927 | okskarbasepiin | N03AF02 | TRILEPTAL 300 tablett 300mg N50 | Novartis Pharma | 50% | |||||||
1928 | okskarbasepiin | N03AF02 | TRILEPTAL 600 kaetud tablett 600mg N100 | Novartis Pharma | 50% | |||||||
1929 | okskarbasepiin | N03AF02 | TRILEPTAL 600 kaetud tablett 600mg N50 | Novartis Pharma | 50% | |||||||
1930 | okskarbasepiin | N03AF02 | TRILEPTAL 600 tablett 600mg N50 | Novartis Pharma | 50% | |||||||
1931 | oksübutüniin | G04BD04 | DRIPTANE tablett 5mg N60 | LABORATOIRES FOURNIER S.A | 50% | 75% | N31* | *rv neuroloogil ja urolooogil | ||||
1932 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N25 | Mundipharma Austria | 50% | |||||||
1933 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N100 | Mundipharma Austria | 50% | |||||||
1934 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N28 | Mundipharma Austria | 50% | |||||||
1935 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N56 | Mundipharma Austria | 50% | |||||||
1936 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N25 | Mundipharma Austria | 50% | |||||||
1937 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N100 | Mundipharma Austria | 50% | |||||||
1938 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N28 | Mundipharma Austria | 50% | |||||||
1939 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N56 | Mundipharma Austria | 50% | |||||||
1940 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N25 | Mundipharma Austria | 50% | |||||||
1941 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N100 | Mundipharma Austria | 50% | |||||||
1942 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N28 | Mundipharma Austria | 50% | |||||||
1943 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N56 | Mundipharma Austria | 50% | |||||||
1944 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N100 | Mundipharma Austria | 50% | |||||||
1945 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N25 | Mundipharma Austria | 50% | |||||||
1946 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N28 | Mundipharma Austria | 50% | |||||||
1947 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N56 | Mundipharma Austria | 50% | |||||||
1948 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 10mg N1 | Novartis Pharma | 50% | |||||||
1949 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 20mg N1 | Novartis Pharma | 50% | |||||||
1950 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 30mg N1 | Novartis Pharma | 50% | |||||||
1951 | oktreotiid | H01CB02 | SANDOSTATIN süstelahus 0,05mgml 1ml N5 | Novartis Pharma | 50% | |||||||
1952 | oktreotiid | H01CB02 | SANDOSTATIN süstelahus 0,1mgml 1ml N5 | Novartis Pharma | 50% | |||||||
1953 | olansapiin | N05AH03 | ZYPREXA tablett 10mg N28 | Eli Lilly Export S.A. | 50% | |||||||
1954 | olansapiin | N05AH03 | ZYPREXA tablett 5mg N28 | Eli Lilly Export S.A. | 50% | |||||||
1955 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N14 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1956 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N28 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1957 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N7 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1958 | omeprasool | A02BC01 | LOMAC-20 kapsel 20mg N10 | Cipla | 50% | 75% | (K25-K27)* | *(3) | ||||
1959 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1960 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1961 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1962 | omeprasool | A02BC01 | LOSEC kapsel 10mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1963 | omeprasool | A02BC01 | LOSEC kapsel 10mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1964 | omeprasool | A02BC01 | LOSEC kapsel 10mg N56 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1965 | omeprasool | A02BC01 | LOSEC kapsel 40mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1966 | omeprasool | A02BC01 | LOSEC kapsel 40mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1967 | omeprasool | A02BC01 | LOSEC kapsel 40mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1968 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1969 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1970 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1971 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1972 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1973 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1974 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1975 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 40mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1976 | omeprasool | A02BC01 | OMEP 20 kapsel 20mg N14 | Hexal AG | 50% | 75% | (K25-K27)* | *(3) | ||||
1977 | omeprasool | A02BC01 | OMEP 20 kapsel 20mg N15 | Hexal AG | 50% | 75% | (K25-K27)* | *(3) | ||||
1978 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N100 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1979 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N15 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1980 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N30 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1981 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N60 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1982 | omeprasool | A02BC01 | ULCEX enterokapsel 20mg N14 | Grindeks | 50% | 75% | (K25-K27)* | *(3) | ||||
1983 | omeprasool | A02BC01 | ULCEX enterokapsel 20mg N7 | Grindeks | 50% | 75% | (K25-K27)* | *(3) | ||||
1984 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 150mg N6 | Biogal | 50% | |||||||
1985 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 300mg N3 | Biogal | 50% | |||||||
1986 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 900mg N1 | Biogal | 50% | |||||||
1987 | ondansetroon | A04AA01 | EMETRON tablett 4mg N10 | Richter | 50% | |||||||
1988 | ondansetroon | A04AA01 | EMETRON tablett 8mg N10 | Richter | 50% | |||||||
1989 | ondansetroon | A04AA01 | ZOFRAN tablett 8mg N10 | Glaxo Wellcome | 50% | |||||||
1990 | ondansetroon | A04AA01 | ZOFRAN süstelahus 2mg/ml 2ml N5 | Glaxo Wellcome | 50% | |||||||
1991 | ondansetroon | A04AA01 | ZOFRAN süstelahus 2mg/ml 4ml N5 | Glaxo Wellcome | 50% | |||||||
1992 | ondansetroon | A04AA01 | EMETRON süstelahus 2mg/ml 2ml N5 | Richter | 50% | |||||||
1993 | ondansetroon | A04AA01 | EMETRON süstelahus 2mg/ml 4ml N5 | Richter | 50% | |||||||
1994 | orfenadriin | M03BC01 | NORFLEX tablett 100mg N60 | 3M Health Care | 50% | |||||||
1995 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N100 | 3M Health Care | 50% | |||||||
1996 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N30 | 3M Health Care | 50% | |||||||
1997 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N60 | 3M Health Care | 50% | |||||||
1998 | ornidasool | P01AB03 | TIBERAL tablett 500mg N10 | Roche | 50% | |||||||
1999 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N100 | Byk Gulden | 50% | |||||||
2000 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N14 | Byk Gulden | 50% | |||||||
2001 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N28 | Byk Gulden | 50% | |||||||
2002 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N56 | Byk Gulden | 50% | |||||||
2003 | pantoprasool | A02BC02 | CONTROLOC 40 MG enterotablett 40mg N14 | Byk Gulden | 50% | |||||||
2004 | pantoprasool | A02BC02 | CONTROLOC 40 MG enterotablett 40mg N28 | Byk Gulden | 50% | |||||||
2005 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE lahustuv tablett 500mg+30mg N16 | Laboratoires Upsa | 50% | |||||||
2006 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE lahustuv tablett 500mg+30mg N8 | Laboratoires Upsa | 50% | |||||||
2007 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE tablett 500mg+30mg N16 | Laboratoires Upsa | 50% | |||||||
2008 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE tablett 500mg+30mg N8 | Laboratoires Upsa | 50% | |||||||
2009 | paratsetamool+kodeiin | N02BE92 | PRODEINE 30 tablett 500mg+30mg N100 | Sanofi | 50% | |||||||
2010 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N100 | GlaxoSmithKline | 50% | |||||||
2011 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N14 | GlaxoSmithKline | 50% | |||||||
2012 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N20 | GlaxoSmithKline | 50% | |||||||
2013 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N30 | GlaxoSmithKline | 50% | |||||||
2014 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 100mcg N1 |
Schering-Plough | 50% | |||||||
2015 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 120mcg N1 |
Schering-Plough | 50% | |||||||
2016 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 50mcg N1 |
Schering-Plough | 50% | |||||||
2017 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 80mcg N1 |
Schering-Plough | 50% | |||||||
2018 | pentoksüveriin | R05DB05 | TOCLASE siirup 1,5mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
2019 | pentoksüveriin | R05DB05 | TOCLASE tablett 50mg 1Tabl N25 | UCB Pharma Oy Finland | 50% | |||||||
2020 | pergoliid | N04BC02 | PERMAX tablett 0,05mg N100 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2021 | pergoliid | N04BC02 | PERMAX tablett 0,05mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2022 | pergoliid | N04BC02 | PERMAX tablett 0,25mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2023 | pergoliid | N04BC02 | PERMAX tablett 1mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2024 | perindopriil | C09AA04 | COVEREX tablett 4mg N30 | Egis | 50% | |||||||
2025 | perindopriil | C09AA04 | PRESTARIUM tablett 4mg N30 | Servier | 50% | |||||||
2026 | perindopriil+ indapamiid |
C09BA80 | NOLIPREL FORTE tablett 4mg+1,25mg N30 | Servier | 50% | |||||||
2027 | perindopriil+ indapamiid |
C09BA80 | NOLIPREL tablett 2mg+0,625mg N30 | Servier | 50% | |||||||
2028 | petidiin | N02AB02 | PETHIDINE 50 MG/ML süstelahus 50mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
2029 | petidiin | N02AB02 | PETHIDINE 50 MG/ML süstelahus 50mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
2030 | piimhape+ naatrium- laktaat |
G01AD80 | VAGISAN vaginaalsuposiit 167mg+100mg N7 | Wolff | 50% | |||||||
2031 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN LENTE süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2032 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN N PEN süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2033 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2034 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2035 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2036 | pilokarpiin | S01EB01 | ISOPTO CARPINE silmatilgad 2% 15 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2037 | pilokarpiin | S01EB01 | ISOPTO CARPINE silmatilgad 4% 15 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2038 | pilokarpiin | S01EB01 | OFTAN PILOCARPIN silmatilgad 1% 10 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2039 | pilokarpiin+ timolool |
S01EB80 | FOTIL FORTE silmatilgad 4%+0,5% 5 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2040 | pilokarpiin+ timolool |
S01EB80 | FOTIL silmatilgad 2%+0,5% 5 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2041 | pilokarpiin+ timolool |
S01EB80 | FOTIL silmatilgad üksikannustena 2%+0,5% 0.25 ml N60 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2042 | pindolool | C07AA03 | VISKEN tablett 5mg N30 | Novartis Pharma | 50% | |||||||
2043 | pioglitasoon | A10BG03 | ACTOS tablett 15mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2044 | pioglitasoon | A10BG03 | ACTOS tablett 30mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2045 | pioglitasoon | A10BG03 | ACTOS tablett 45mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2046 | piratsetaam | N06BX03 | CEREBRYL 1200 MG tablett 1200mg N60 | Kwizda | 50% | |||||||
2047 | piratsetaam | N06BX03 | CEREBRYL tablett 800mg N60 | Kwizda | 50% | |||||||
2048 | piratsetaam | N06BX03 | NOOTROPIL suukaudne lahus 330mg/ml 125ml N1 | UCB Pharma Oy Finland | 50% | |||||||
2049 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N100 | UCB Pharma Oy Finland | 50% | |||||||
2050 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N20 | UCB Pharma Oy Finland | 50% | |||||||
2051 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N60 | UCB Pharma Oy Finland | 50% | |||||||
2052 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N30 | UCB Pharma Oy Finland | 50% | |||||||
2053 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N60 | UCB Pharma Oy Finland | 50% | |||||||
2054 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N90 | UCB Pharma Oy Finland | 50% | |||||||
2055 | piratsetaam | N06BX03 | PIRACETAM TFT kapsel 400mg N30 | TFT | 50% | |||||||
2056 | piratsetaam | N06BX03 | PIRACETAM TFT kapsel 400mg N60 | TFT | 50% | |||||||
2057 | piroksikaam | M01AC01 | BREXIN pulber lahuseks 20mg N20 | Chiesi | 50% | |||||||
2058 | piroksikaam | M01AC01 | BREXIN tablett 20mg N20 | Chiesi | 50% | |||||||
2059 | piroksikaam | M01AC01 | PIROXICAM 10 STADA TABS tablett 10mg N20 | Stada | 50% | |||||||
2060 | piroksikaam | M01AC01 | PIROXICAM 10 STADA TABS tablett 10mg N50 | Stada | 50% | |||||||
2061 | piroksikaam | M01AC01 | PIROXICAM 20 STADA TABS tablett 20mg N20 | Stada | 50% | |||||||
2062 | piroksikaam | M01AC01 | PIROXICAM 20 STADA TABS tablett 20mg N50 | Stada | 50% | |||||||
2063 | piroksikaam | M01AC01 | PIROXICAM ALPHARMA CAPSULES 20MG kapsel 20mg N20 | ALPHARMA | 50% | |||||||
2064 | piroksikaam | M01AC01 | PIROXICAM TFT tablett 20mg N20 | TFT | 50% | |||||||
2065 | piroksikaam | M01AC01 | PIROXICAM TFT tablett 20mg N25 | TFT | 50% | |||||||
2066 | Plastic IUD+progesto-geenid | G02BA03 | MIRENA emakasisene süsteem 20mcg 24h N1 | Schering AG | 50% | |||||||
2067 | podofül- lotoksiin |
D06BB04 | WARTEC kreem 0,15% 5 g | Stiefel | 50% | |||||||
2068 | podofül- lotoksiin |
D06BB04 | WARTEC lahus 5mgml 3ml N1 | Stiefel | 50% | |||||||
2069 | polüstüreen- sulfonaat |
V03AE01 | ANTI-POTASSIUM graanulid lahuseks 880mg/g 15g N20 | Medice | 50% | 75% | N18 | |||||
2070 | polüstüreen- sulfonaat |
V03AE01 | ANTI-POTASSIUM graanulid lahuseks 880mg/g 15g N50 | Medice | 50% | 75% | N18 | |||||
2071 | polüvidoon- jodiid+ allantoiin |
R02AA89 | JOX lahus 8,5%+0,1%/ 50ml N1 | IVAX - CR a.s. | 50% | |||||||
2072 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,125mg N100 | Pharmacia Enterprises | 50% | |||||||
2073 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,125mg N30 | Pharmacia Enterprises | 50% | |||||||
2074 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,25mg N100 | Pharmacia Enterprises | 50% | |||||||
2075 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,25mg N30 | Pharmacia Enterprises | 50% | |||||||
2076 | pramipeksool | N04BC05 | MIRAPEXIN tablett 1mg N100 | Pharmacia Enterprises | 50% | |||||||
2077 | pramipeksool | N04BC05 | MIRAPEXIN tablett 1mg N30 | Pharmacia Enterprises | 50% | |||||||
2078 | prasosiin | C02CA01 | PRASOSIN tablett 1mg N25 | TFT | 50% | |||||||
2079 | pravastatiin | C10AA03 | LIPOSTAT 40 MG tablett 40mg N28 | Bristol-Myers Squibb | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(4) | ||||
2080 | pravastatiin | C10AA03 | LIPOSTAT tablett 20mg N28 | Bristol-Myers Squibb | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(4) | ||||
2081 | prednisoloon | C05AA81 | AUROBIN salv 0,2%/ 20g N1 | Richter | 50% | |||||||
2082 | prednisoloon | D07AA03 | LINOLA-H N kreem 0,4% 250g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2083 | prednisoloon | D07AA03 | LINOLA-H N kreem 0,4% 25g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2084 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 100g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2085 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 250g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2086 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 25g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2087 | prednisoloon | H02AB06 | PREDNISOLON tablett 5mg N100 | Richter | 50% | 75% | K50*; K51*; K73*; K74*; L10*; L12*; L13.0*; L20*; L23*; L40**; M07**; M05***; M06***; M08***; (M30-M33)***; M35***; M45***; M46***; (N00-N08)**** | *rv gastroentero- loogil; **rv dermatovene- roloogil ja reumatoloogil; ***rev reumato- loogil; ****rv nefroloogil ja pediaatril |
100% | (C00-D48)*; D59**; (D60-D64)**; D69**; E23***; E25***; E27***; E89.3***; E89.6***; G70**** | *rv hematoloogil, onkoloogil ja uroloogil; **rv hematoloogil; ***rev endokrinoloogil; ****rev neuroloogil | |
2088 | prednisoloon | H02AB06 | PREDNISOLON tablett 5mg N20 | Richter | 50% | 75% | K50*; K51*; K73*; K74*; L10*; L12*; L13.0*; L20*; L23*; L40**; M07**; M05***; M06***; M08***; (M30-M33)***; M35***; M45***; M46***; (N00-N08)**** | *rv gastroentero- loogil; **rv dermatovene- roloogil ja reumatoloogil; ***rev reumato- loogil; ****rv nefroloogil ja pediaatril |
100% | (C00-D48)*; D59**; (D60-D64)**; D69**; E23***; E25***; E27***; E89.3***; E89.6***; G70**** | *rv hematoloogil, onkoloogil ja uroloogil; **rv hematoloogil; ***rev endokrinoloogil; ****rev neuroloogil | |
2089 | prednisoloon+salitsüülhape | D07XA81 | ALPICORT lahus paikseks kasut. 0,2%+0,4% 100ml N1 | Wolff | 50% | |||||||
2090 | primidoon | N03AA03 | LISKANTIN tablett 250mg N100 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2091 | primidoon | N03AA03 | LISKANTIN tablett 250mg N200 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2092 | primidoon | N03AA03 | LISKANTIN tablett 250mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2093 | proksü- metakaiin |
S01HA04 | ALCAINE silmatilgad 0,5% 15ml N1 | Alcon | 50% | |||||||
2094 | propafenoon | C01BC03 | PROPANORM 150 MG tablett 150mg N50 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2095 | propafenoon | C01BC03 | RYTMONORM tablett 150mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2096 | propafenoon | C01BC03 | RYTMONORM tablett 300mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2097 | propranolool | C07AA05 | PROPRANOLOL ALPHARMA TABLETS 40 MG tablett 40mg N50 | ALPHARMA | 50% | |||||||
2098 | propranolool | C07AA05 | PROPRANOLOL ALPHARMA TABLETS 40 MG tablett 40mg N28 | ALPHARMA | ||||||||
2099 | propranolool | C07AA05 | PROPRA-RATIOPHARM tablett 40mg N100 | ratiopharm | 50% | |||||||
2100 | propranolool | C07AA05 | PROPRA-RATIOPHARM tablett 40mg N50 | ratiopharm | 50% | |||||||
2101 | propüül- tiouratsiil |
H03BA02 | TIOTIL tablett 50mg N100 | ABIGO MEDICAL AB | 50% | |||||||
2102 | pseudoefedriin+loratadiin | R01BA89 | CLARINASE retardtablett 240mg+10mg N7 | Schering-Plough | 50% | |||||||
2103 | püridostigmiin | N07AA02 | KALYMIN 60 N tablett 60mg N100 | AWD | 50% | 100% | G70* | *rev neuroloogil | ||||
2104 | püridostigmiin | N07AA02 | KALYMIN 60 N tablett 60mg N50 | AWD | 50% | 100% | G70* | *rev neuroloogil | ||||
2105 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N14 | Janssen | 50% | |||||||
2106 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N15 | Janssen | 50% | |||||||
2107 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N28 | Janssen | 50% | |||||||
2108 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N30 | Janssen | 50% | |||||||
2109 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N7 | Janssen | 50% | |||||||
2110 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N14 | Janssen | 50% | |||||||
2111 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N15 | Janssen | 50% | |||||||
2112 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N28 | Janssen | 50% | |||||||
2113 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N30 | Janssen | 50% | |||||||
2114 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N7 | Janssen | 50% | |||||||
2115 | raloxifeen | G03XC01 | EVISTA tablett 60mg N14 | Eli Lilly Export S.A. | 50% | |||||||
2116 | raloxifeen | G03XC01 | EVISTA tablett 60mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2117 | ramipriil | C09AA05 | CARDACE 1,25 MG tablett 1,25mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2118 | ramipriil | C09AA05 | CARDACE 1,25 MG tablett 1,25mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2119 | ramipriil | C09AA05 | CARDACE 2,5 MG tablett 2,5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2120 | ramipriil | C09AA05 | CARDACE 2,5 MG tablett 2,5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2121 | ramipriil | C09AA05 | CARDACE 5 MG tablett 5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2122 | ramipriil | C09AA05 | CARDACE 5 MG tablett 5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2123 | ramipriil | C09AA05 | CARDACE tablett 10mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2124 | ramipriil | C09AA05 | CARDACE tablett 10mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2125 | ramipriil+ hüdro- klorotiasiid |
C09BA05 | CARDACE COMP tablett 2,5mg+12,5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2126 | ramipriil+ hüdro- klorotiasiid |
C09BA05 | CARDACE COMP tablett 2,5mg+12,5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2127 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N100 | Berlin-Chemie | 50% | |||||||
2128 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N20 | Berlin-Chemie | 50% | |||||||
2129 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N50 | Berlin-Chemie | 50% | |||||||
2130 | ranitidiin | A02BA02 | RANIBERL 300 tablett 300mg N20 | Berlin-Chemie | 50% | |||||||
2131 | ranitidiin | A02BA02 | RANIBERL 300 tablett 300mg N50 | Berlin-Chemie | 50% | |||||||
2132 | ranitidiin | A02BA02 | RANISAN 150 MG tablett 150mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2133 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N100 | ratiopharm | 50% | |||||||
2134 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N20 | ratiopharm | 50% | |||||||
2135 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N50 | ratiopharm | 50% | |||||||
2136 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N100 | ratiopharm | 50% | |||||||
2137 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N20 | ratiopharm | 50% | |||||||
2138 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N50 | ratiopharm | 50% | |||||||
2139 | ranitidiin | A02BA02 | RANITIDINE ALPHARMA TABLETS 150 MG tablett 150mg N30 | ALPHARMA | 50% | |||||||
2140 | ranitidiin | A02BA02 | ZANTAC EFFERVESCENT TABLETS 150 MG lahustuv tablett 150mg N10 | Glaxo Wellcome | 50% | |||||||
2141 | ranitidiin | A02BA02 | ZANTAC tablett 150mg N20 | Glaxo Wellcome | 50% | |||||||
2142 | ranitidiin | A02BA02 | ZANTAC tablett 150mg N60 | Glaxo Wellcome | 50% | |||||||
2143 | ranitidiin | A02BA02 | ZANTAC tablett 300mg N10 | Glaxo Wellcome | 50% | |||||||
2144 | ranitidiin | A02BA02 | ZANTAC tablett 300mg N30 | Glaxo Wellcome | 50% | |||||||
2145 | ranitidiin vismuttsitraat | A02BA07 | PYLORID tablett 400mg N14 | Glaxo Wellcome | 50% | |||||||
2146 | raud jt. | RS | TOT’HEMA suukaudne lahus 10 ml N20 | INNOTECH INTERNATIONAL | 75% | D50 | ||||||
2147 | raudaspartaat | B03AA09 | SPARTOCINE tablett 250 mg N40 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2148 | raudaspartaat | B03AA09 | SPARTOCINE tablett 250 mg N100 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2149 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 350 mg N14 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2150 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 350 mg N30 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2151 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 105 mg N14 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2152 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 105 mg N30 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2153 | raudpolü- maltoos |
B03AC04 | FERRUM LEK närimistablett 100mg N30 | LEK d.d | 50% | 75% | D50 | |||||
2154 | raudpolü- maltoos |
B03AC04 | FERRUM LEK siirup 10mg/ml 100ml N1 | LEK d.d | 50% | 75% | D50 | |||||
2155 | raudsulfaat | B03AA07 | RETAFER retardtablett 100 mg N30 | ORION CORPORATION ORION PHARMA | 75% | D50 | ||||||
2156 | raudsulfaat | B03AA07 | RETAFER retardtablett 100 mg N100 | ORION CORPORATION ORION PHARMA | 75% | D50 | ||||||
2157 | reboksetiin | N06AX18 | EDRONAX tablett 4mg N20 | Pharmacia Enterprises | 50% | |||||||
2158 | reboksetiin | N06AX18 | EDRONAX tablett 4mg N60 | Pharmacia Enterprises | 50% | |||||||
2159 | repagliniid | A10BX02 | NOVONORM tablett 0,5mg N30 | Novo Nordisk | 50% | |||||||
2160 | repagliniid | A10BX02 | NOVONORM tablett 0,5mg N90 | Novo Nordisk | 50% | |||||||
2161 | repagliniid | A10BX02 | NOVONORM tablett 1mg N30 | Novo Nordisk | 50% | |||||||
2162 | repagliniid | A10BX02 | NOVONORM tablett 1mg N90 | Novo Nordisk | 50% | |||||||
2163 | repagliniid | A10BX02 | NOVONORM tablett 2mg N30 | Novo Nordisk | 50% | |||||||
2164 | repagliniid | A10BX02 | NOVONORM tablett 2mg N90 | Novo Nordisk | 50% | |||||||
2165 | retinool+ dekspantenool |
S01XA80 | OFTAN A-PANT silmasalv 20TÜ+20mg/g 3.5g N1 | Santen | 50% | |||||||
2166 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N140 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2167 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N168 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2168 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N84 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2169 | rilusool | N07XX02 | RILUTEK tablett 50mg N56 | Aventis Pharma SA | 50% | |||||||
2170 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 10mg N2 | MSD | 50% | |||||||
2171 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 10mg N6 | MSD | 50% | |||||||
2172 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 5mg N2 | MSD | 50% | |||||||
2173 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 5mg N6 | MSD | 50% | |||||||
2174 | risedroonhape | M05BA07 | ACTONEL 30 MG kaetud tablett 30mg N28 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2175 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N14 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2176 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N28 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2177 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N84 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2178 | risperidoon | N05AX08 | RISPOLEPT suukaudne lahus 1mg/ml 100ml N1 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)* (F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2179 | risperidoon | N05AX08 | RISPOLEPT tablett 1mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2180 | risperidoon | N05AX08 | RISPOLEPT tablett 1mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2181 | risperidoon | N05AX08 | RISPOLEPT tablett 2mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2182 | risperidoon | N05AX08 | RISPOLEPT tablett 2mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2183 | risperidoon | N05AX08 | RISPOLEPT tablett 3mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2184 | risperidoon | N05AX08 | RISPOLEPT tablett 3mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2185 | risperidoon | N05AX08 | RISPOLEPT tablett 4mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2186 | risperidoon | N05AX08 | RISPOLEPT tablett 4mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2187 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N112 | Novartis Pharma | 50% | |||||||
2188 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N14 | Novartis Pharma | 50% | |||||||
2189 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N28 | Novartis Pharma | 50% | |||||||
2190 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N56 | Novartis Pharma | 50% | |||||||
2191 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N112 | Novartis Pharma | 50% | |||||||
2192 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N14 | Novartis Pharma | 50% | |||||||
2193 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N28 | Novartis Pharma | 50% | |||||||
2194 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N56 | Novartis Pharma | 50% | |||||||
2195 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N112 | Novartis Pharma | 50% | |||||||
2196 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N14 | Novartis Pharma | 50% | |||||||
2197 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N28 | Novartis Pharma | 50% | |||||||
2198 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N56 | Novartis Pharma | 50% | |||||||
2199 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N112 | Novartis Pharma | 50% | |||||||
2200 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N14 | Novartis Pharma | 50% | |||||||
2201 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N28 | Novartis Pharma | 50% | |||||||
2202 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N56 | Novartis Pharma | 50% | |||||||
2203 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N112 | Novartis Pharma | 50% | |||||||
2204 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N14 | Novartis Pharma | 50% | |||||||
2205 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N28 | Novartis Pharma | 50% | |||||||
2206 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N56 | Novartis Pharma | 50% | |||||||
2207 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N112 | Novartis Pharma | 50% | |||||||
2208 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N14 | Novartis Pharma | 50% | |||||||
2209 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N28 | Novartis Pharma | 50% | |||||||
2210 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N56 | Novartis Pharma | 50% | |||||||
2211 | rivastigmiin | N07AA80 | EXELON suukaudne lahus 2mg/ml 120ml N1 | Novartis Pharma | 50% | |||||||
2212 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N10 | MSD | 50% | |||||||
2213 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N2 | MSD | 50% | |||||||
2214 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N5 | MSD | 50% | |||||||
2215 | rofekoksiib | M01AH02 | VIOXX suspensioon 2,5mg/ml 150ml N1 | MSD | 50% | |||||||
2216 | rofekoksiib | M01AH02 | VIOXX suspensioon 5mg/ml 150ml N1 | MSD | 50% | |||||||
2217 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N14 | MSD | 50% | |||||||
2218 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N28 | MSD | 50% | |||||||
2219 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N7 | MSD | 50% | |||||||
2220 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N14 | MSD | 50% | |||||||
2221 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N28 | MSD | 50% | |||||||
2222 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N7 | MSD | 50% | |||||||
2223 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N112 | GlaxoSmithKline | 50% | |||||||
2224 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N28 | GlaxoSmithKline | 50% | |||||||
2225 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N56 | GlaxoSmithKline | 50% | |||||||
2226 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N7 | GlaxoSmithKline | 50% | |||||||
2227 | sakvinaviir | J05AE01 | FORTOVASE kapsel 200mg N180 | Roche | 50% | |||||||
2228 | salbutamool | R03AC02 | AIROMIR inhal aeros 100mcg/annuses 200annust N1 | 3M Health Care | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2229 | salbutamool | R03AC02 | BUVENTOL EASYHALER inhalatsioonipulber 100mcg/annuses 200annust N1 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2230 | salbutamool | R03AC02 | BUVENTOL EASYHALER inhalatsioonipulber 200mcg/annuses 200annust N1 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2231 | salbutamool | R03AC02 | ECOSAL EASI-BREATHE aerosool 0,1mg/annuses 200annust N1 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2232 | salbutamool | R03AC02 | ECOSAL EASI-BREATHE aerosool 0,1mg/annuses 200annust N3 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2233 | salbutamool | R03AC02 | ECOSAL inhal aeros 0,1mg/annuses 200annust N1 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2234 | salbutamool | R03AC02 | SALBUTAMOL NYCOMED inhal aeros 0,1mg/annuses 300annust N1 | Nycomed SEFA | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2235 | salbutamool | R03AC02 | VENTOLIN DISKUS inhalatsioonipulber 200mcg/annuses N60 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2236 | salbutamool | R03AC02 | VENTOLIN inhal aeros 0,1mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2237 | salbutamool | R03AC02 | VENTOLIN NEBULES inhalatsioonilahus 1mg/ml 2.5ml N20 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2238 | salbutamool | R03AC02 | VENTOLIN RESPIRATOR SOLUTION inhalatsioonilahus 5mg/ml 20ml N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2239 | salbutamool | R03CC02 | VENTOLIN SYRUP siirup 0,4mg/ml 150ml N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2240 | salbutamool | R03CC02 | VOLMAX retardtablett 4mg 1TABL N14 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2241 | salbutamool | R03CC02 | VOLMAX retardtablett 8mg 1TABL N14 | Byk Gulden | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2242 | salbutamool+ ipratroopium- bromiid |
R03AK81 | COMBIVENT inhal aeros 0,12mg+0,02mg/annuses 200annust N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2243 | salitsüülhape | D01AE12 | PSORIMED lahus paikseks kasut. 10% 100ml N1 | Wolff | 50% | |||||||
2244 | salmeterool | R03AC12 | SEREVENT DISKUS 50 MCG inhalatsioonipulber 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2245 | salmeterool | R03AC12 | SEREVENT inhal aeros 0,025mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2246 | salmeterool+flutikasoonpropionaat | R03AK82 | SERETIDE DISKUS 100 inhalatsioonipulber 50mcg+100mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rv alla 18.a lapsele, rev pediaatril ja pulmonoloogil | ||||
2247 | salmeterool+flutikasoonpropionaat | R03AK82 | SERETIDE DISKUS 250 inhalatsioonipulber 50mcg+250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rv alla 18.a lapsele, rev pediaatril ja pulmonoloogil | ||||
2248 | sanamiviir | J05AH01 | RELENZA inhalatsioonipulber 5mg N5 | Glaxo Wellcome | 50% | |||||||
2249 | selegiliin | N04BD01 | ELDEPRYL tablett 5mg N100 | Orion | 50% | |||||||
2250 | sertindool | N05AE03 | SERDOLECT tablett 12mg N100 | Lundbeck | 50% | |||||||
2251 | sertindool | N05AE03 | SERDOLECT tablett 12mg N28 | Lundbeck | 50% | |||||||
2252 | sertindool | N05AE03 | SERDOLECT tablett 16mg N100 | Lundbeck | 50% | |||||||
2253 | sertindool | N05AE03 | SERDOLECT tablett 16mg N28 | Lundbeck | 50% | |||||||
2254 | sertindool | N05AE03 | SERDOLECT tablett 20mg N100 | Lundbeck | 50% | |||||||
2255 | sertindool | N05AE03 | SERDOLECT tablett 20mg N28 | Lundbeck | 50% | |||||||
2256 | sertindool | N05AE03 | SERDOLECT tablett 4mg N100 | Lundbeck | 50% | |||||||
2257 | sertindool | N05AE03 | SERDOLECT tablett 4mg N30 | Lundbeck | 50% | |||||||
2258 | sertraliin | N06AB06 | ZOLOFT tablett 50mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
2259 | simvastatiin | C10AA01 | SIMGAL tablett 10mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2260 | simvastatiin | C10AA01 | SIMGAL tablett 20mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2261 | simvastatiin | C10AA01 | SIMGAL tablett 40mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2262 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2263 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N30 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2264 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2265 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2266 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N30 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2267 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2268 | simvastatiin | C10AA01 | SIMVOR tablett 40mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2269 | simvastatiin | C10AA01 | SIMVOR tablett 40mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2270 | simvastatiin | C10AA01 | SIMVOR tablett 5mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2271 | simvastatiin | C10AA01 | SIMVOR tablett 5mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2272 | simvastatiin | C10AA01 | ZOCOR 10 MG tablett N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2273 | simvastatiin | C10AA01 | ZOCOR 10 MG tablett N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2274 | simvastatiin | C10AA01 | ZOCOR 20 MG tablett 20mg N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2275 | simvastatiin | C10AA01 | ZOCOR 20 MG tablett 20mg N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2276 | simvastatiin | C10AA01 | ZOCOR FORTE 40 tablett 40mg N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2277 | simvastatiin | C10AA01 | ZOCOR FORTE 40 tablett 40mg N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2278 | simvastatiin | C10AA01 | ZOCOR FORTE XL 80 MG tablett N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2279 | simvastatiin | C10AA01 | VASILIP tablett 10mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2280 | simvastatiin | C10AA01 | VASILIP tablett 20mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2281 | simvastatiin | C10AA01 | VASILIP tablett 40mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2282 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 150ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2283 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 1ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2284 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 2ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2285 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 5ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2286 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 60ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2287 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 16TÜ N1 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2288 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 16TÜ N5 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2289 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 36TÜ N1 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2290 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 36TÜ N5 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2291 | somatropiin | H01AC01 | HUMATROPE injektsioonisubstants 16TÜ N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2292 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18IU N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2293 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18TÜ N10 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2294 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18TÜ N5 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2295 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2296 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N10 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2297 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N5 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2298 | somatropiin | H01AC01 | NORDITROPIN 12IU injektsiooni- substants 12TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2299 | somatropiin | H01AC01 | NORDITROPIN 4IU injektsiooni- substants 4TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2300 | somatropiin | H01AC01 | NORDITROPIN PENSET 12 injektsiooni- substants 12TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2301 | somatropiin | H01AC01 | SAIZEN 24 IU (8 MG) EASYJECT injektsiooni- substants 24TÜ N1 |
ARES TRADING SA | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2302 | somatropiin | H01AC01 | SAIZEN 24 IU (8 MG) EASYJECT injektsiooni- substants 24TÜ N5 |
ARES TRADING SA | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2303 | somatropiin | H01AC01 | ZOMACTON injektsiooni- substants 12 TÜ N1 |
Ferring GmbH | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2304 | sotalool | C07AA07 | LORITMIK 160 tablett 160mg N20 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2305 | sotalool | C07AA07 | LORITMIK 160 tablett 160mg N50 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2306 | sotalool | C07AA07 | LORITMIK 80 tablett 80mg N20 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2307 | sotalool | C07AA07 | LORITMIK 80 tablett 80mg N50 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2308 | sotalool | C07AA07 | SOTAHEXAL 160 tablett 160mg N20 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2309 | sotalool | C07AA07 | SOTAHEXAL 160 tablett 160mg N50 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2310 | sotalool | C07AA07 | SOTAHEXAL 80 tablett 80mg N20 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2311 | sotalool | C07AA07 | SOTAHEXAL 80 tablett 80mg N50 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2312 | sotalool | C07AA07 | SOTALEX 160 tablett 160mg N30 | Bristol-Myers Squibb | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2313 | sotalool | C07AA07 | SOTALEX MITE tablett 80mg N30 | Bristol-Myers Squibb | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2314 | sotalool | C07AA07 | SOTALOL 160-SL tablett 160mg N100 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2315 | sotalool | C07AA07 | SOTALOL 160-SL tablett 160mg N20 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2316 | sotalool | C07AA07 | SOTALOL 80-SL tablett 80mg N100 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2317 | sotalool | C07AA07 | SOTALOL 80-SL tablett 80mg N20 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2318 | spiramütsiin | J01FA02 | ROVAMYCINE tablett 1500000TÜ N16 | LABORATOIRE AVENTIS | 50% | |||||||
2319 | spiramütsiin | J01FA02 | ROVAMYCINE tablett 3000000TÜ N10 | LABORATOIRE AVENTIS | 50% | |||||||
2320 | spirapriil | C09AA11 | QUADROPRIL tablett 6mg N30 | AWD | 50% | |||||||
2321 | spironolaktoon | C03DA01 | SPIRIX 100 MG tablett 100mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2322 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
2323 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2324 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N60 | Nycomed SEFA | 50% | 75% | I50 | |||||
2325 | spironolaktoon | C03DA01 | SPIRIX 50 MG tablett 50mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
2326 | spironolaktoon | C03DA01 | SPIRIX 50 MG tablett 50mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2327 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I50 | |||||
2328 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N20 | ratiopharm | 50% | 75% | I50 | |||||
2329 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I50 | |||||
2330 | spironolaktoon | C03DA01 | VEROSPIRON CAPSULES 100 MG kapsel 100mg N30 | Richter | 50% | 75% | I50 | |||||
2331 | spironolaktoon | C03DA01 | VEROSPIRON CAPSULES 50 MG kapsel 50mg N30 | Richter | 50% | 75% | I50 | |||||
2332 | spironolaktoon | C03DA01 | VEROSPIRON tablett 25mg N20 | Richter | 50% | 75% | I50 | |||||
2333 | stavudiin | J05AX04 | ZERIT kapsel 15mg N56 | Bristol-Myers Squibb | 50% | |||||||
2334 | stavudiin | J05AX04 | ZERIT kapsel 15mg N60 | Bristol-Myers Squibb | 50% | |||||||
2335 | stavudiin | J05AX04 | ZERIT kapsel 20mg N56 | Bristol-Myers Squibb | 50% | |||||||
2336 | stavudiin | J05AX04 | ZERIT kapsel 20mg N60 | Bristol-Myers Squibb | 50% | |||||||
2337 | stavudiin | J05AX04 | ZERIT kapsel 30mg N56 | Bristol-Myers Squibb | 50% | |||||||
2338 | stavudiin | J05AX04 | ZERIT kapsel 30mg N60 | Bristol-Myers Squibb | 50% | |||||||
2339 | stavudiin | J05AX04 | ZERIT kapsel 40mg N56 | Bristol-Myers Squibb | 50% | |||||||
2340 | stavudiin | J05AX04 | ZERIT kapsel 40mg N60 | Bristol-Myers Squibb | 50% | |||||||
2341 | stavudiin | J05AX04 | ZERIT pulber lahuseks 1mgml 200ml N1 | Bristol-Myers Squibb | 50% | |||||||
2342 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 200mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2343 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 200mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2344 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 500mg/ml 1ml N5 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2345 | suklopentiksool | N05AF05 | CISORDINOL tablett 10mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2346 | suklopentiksool | N05AF05 | CISORDINOL tablett 25mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2347 | suklopentiksool | N05AF05 | CISORDINOL tablett 2mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2348 | suklopentiksool | N05AF05 | CISORDINOL tablett 2mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2349 | suklopentiksool | N05AF05 | CISORDINOL-ACUTARD süstelahus 50mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2350 | suklopentiksool | N05AF05 | CISORDINOL-ACUTARD süstelahus 50mg/ml 2ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2351 | sulfadiasiinhõbe | D06BA01 | DERMAZIN 1% CREAM kreem 1% 50g N1 | LEK d.d | 50% | |||||||
2352 | sulfadiasiinhõbe | D06BA01 | SULFARGIN salv 1%/g 50g N1 | TFT | 50% | |||||||
2353 | sulfadimetoksiin | J01ED01 | SULFADIMETOXIN tablett 500mg N10 | TFT | 50% | |||||||
2354 | sulfametoksasool+trimetoprim | J01EE01 | APO-SULFATRIM tablett 400mg+80mg N20 | Apotex | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2355 | sulfametoksasool+trimetoprim | J01EE01 | APO-SULFATRIM tablett 400mg+80mg N40 | Apotex | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2356 | sulfametoksasool+trimetoprim | J01EE01 | BACTRIM FORTE tablett 800mg+160mg N10 | Roche | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2357 | sulfametoksasool+trimetoprim | J01EE01 | BACTRIM SYRUP siirup 40mg+8mgml 100ml N1 | Roche | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2358 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 240 suspensioon 40mg+8mgml 100ml N1 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2359 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 480 suspensioon 80mg+16mgml 100ml N1 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2360 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 480 tablett 400mg+80mg N20 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2361 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 960 tablett 800mg+160mg N20 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2362 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLE 480 MG tablett 400mg+80mg N20 | Ilsanta | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2363 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLS tablett 400mg+80mg N20 | Grindeks | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2364 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLS tablett 400mg+80mg N40 | Grindeks | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2365 | sulfametoksasool+trimetoprim | J01EE01 | SULFOTRIM tablett 400mg+80mg N100 | Bristol-Myers Squibb | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2366 | sulfametoksasool+trimetoprim | J01EE01 | SULFOTRIM tablett 400mg+80mg N20 | Bristol-Myers Squibb | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2367 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM FORTE tablett 800mg+160mg N10 | Nycomed SEFA | 50% | |||||||
2368 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM SUSPENSIOON suspensioon 40mg+8mgml 100ml N1 | Nycomed SEFA | 50% | |||||||
2369 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM tablett 400mg+80mg N20 | Nycomed SEFA | 50% | |||||||
2370 | sulfasalasiin | A07EC01 | SALAZOPYRIN enterotablett 500mg N100 | Pharmacia Enterprises | 50% | 75% | K50*; K51*;M05**; M06**; M08**; M45**; M46** | *rv gastroenteroloogil; **rv reumatoloogil | ||||
2371 | sulpiriid | N05AL01 | BETAMAKS tablett 100mg N30 | Grindeks | 50% | |||||||
2372 | sulpiriid | N05AL01 | BETAMAKS tablett 200mg N30 | Grindeks | 50% | |||||||
2373 | sulpiriid | N05AL01 | BETAMAKS tablett 50mg N30 | Grindeks | 50% | |||||||
2374 | sulpiriid | N05AL01 | EGLONYL kapsel 50mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2375 | sulpiriid | N05AL01 | EGLONYL tablett 200mg N12 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2376 | sulpiriid | N05AL01 | EGLONYL tablett 200mg N60 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2377 | sultamitsilliin | J01CR04 | UNASYN suspensioonigraanulid 50mgml 30ml N1 | Pfizer H.C.P. Corporation | 50% | |||||||
2378 | sultamitsilliin | J01CR04 | UNASYN tablett 375mg N12 | Pfizer H.C.P. Corporation | 50% | |||||||
2379 | sumatriptaan | N02CC01 | IMIGRAN ninasprei 20mg/annuses N1 | Glaxo Wellcome | 50% | |||||||
2380 | sumatriptaan | N02CC01 | IMIGRAN tablett 100mg N2 | Glaxo Wellcome | 50% | |||||||
2381 | sumatriptaan | N02CC01 | IMIGRAN tablett 50mg N2 | Glaxo Wellcome | 50% | |||||||
2382 | zafirlukast | R03DC01 | ACCOLATE tablett 20mg 1TABL N28 | AstraZeneca UK Ltd. | 50% | |||||||
2383 | zafirlukast | R03DC01 | ACCOLATE tablett 20mg 1TABL N56 | AstraZeneca UK Ltd. | 50% | |||||||
2384 | zafirlukast | R03DC01 | ACCOLATE tablett 40mg 1TABL N28 | AstraZeneca UK Ltd. | 50% | |||||||
2385 | zafirlukast | R03DC01 | ACCOLATE tablett 40mg 1TABL N56 | AstraZeneca UK Ltd. | 50% | |||||||
2386 | zidovudiin | J05AB05 | RETROVIR CAPSULES 100 MG kapsel 100mg N100 | Glaxo Wellcome | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2387 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N18 | AstraZeneca UK Ltd. | 50% | |||||||
2388 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N3 | AstraZeneca UK Ltd. | 50% | |||||||
2389 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N6 | AstraZeneca UK Ltd. | 50% | |||||||
2390 | tamoksifeen | L02BA01 | NOLVADEX D tablett 20mg N30 | AstraZeneca UK Ltd. | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2391 | tamoksifeen | L02BA01 | NOLVADEX tablett 10mg N30 | AstraZeneca UK Ltd. | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2392 | tamoksifeen | L02BA01 | ZITAZONIUM 20 MG tablett 20mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2393 | tamoksifeen | L02BA01 | ZITAZONIUM 20 MG tablett 20mg N60 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2394 | tamoksifeen | L02BA01 | ZITAZONIUM 30 MG tablett 30mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2395 | tamoksifeen | L02BA01 | ZITAZONIUM 40 MG tablett 40mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2396 | tamoksifeen | L02BA01 | TAMOFEN tablett 10mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2397 | tamoksifeen | L02BA01 | TAMOFEN tablett 10mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2398 | tamoksifeen | L02BA01 | TAMOFEN tablett 20mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2399 | tamoksifeen | L02BA01 | TAMOFEN tablett 20mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2400 | tamoksifeen | L02BA01 | TAMOFEN tablett 30mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2401 | tamoksifeen | L02BA01 | TAMOFEN tablett 30mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2402 | tamoksifeen | L02BA01 | TAMOXIFEN-EBEWE tablett 10mg N30 | Ebewe | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2403 | tamoksifeen | L02BA01 | TAMOXIFEN-EBEWE tablett 20mg N30 | Ebewe | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2404 | tamsulosiin | G04CA02 | OMNIC retardkapsel 0,4mg N30 | Yamanouchi | 50% | |||||||
2405 | tamsulosiin | G04CA02 | OMNIC retardkapsel 0,4mg N90 | Yamanouchi | 50% | |||||||
2406 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N14 | Boehringer Ingelheim | 50% | |||||||
2407 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N28 | Boehringer Ingelheim | 50% | |||||||
2408 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N56 | Boehringer Ingelheim | 50% | |||||||
2409 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N98 | Boehringer Ingelheim | 50% | |||||||
2410 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N14 | Boehringer Ingelheim | 50% | |||||||
2411 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N28 | Boehringer Ingelheim | 50% | |||||||
2412 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N56 | Boehringer Ingelheim | 50% | |||||||
2413 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N98 | Boehringer Ingelheim | 50% | |||||||
2414 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N14 | Boehringer Ingelheim | 50% | |||||||
2415 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N28 | Boehringer Ingelheim | 50% | |||||||
2416 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N56 | Boehringer Ingelheim | 50% | |||||||
2417 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N98 | Boehringer Ingelheim | 50% | |||||||
2418 | telmisartaan | C09CA07 | PRITOR tablett 20mg N14 | Glaxo Wellcome | 50% | |||||||
2419 | telmisartaan | C09CA07 | PRITOR tablett 20mg N28 | Glaxo Wellcome | 50% | |||||||
2420 | telmisartaan | C09CA07 | PRITOR tablett 20mg N56 | Glaxo Wellcome | 50% | |||||||
2421 | telmisartaan | C09CA07 | PRITOR tablett 20mg N98 | Glaxo Wellcome | 50% | |||||||
2422 | telmisartaan | C09CA07 | PRITOR tablett 40mg N14 | Glaxo Wellcome | 50% | |||||||
2423 | telmisartaan | C09CA07 | PRITOR tablett 40mg N28 | Glaxo Wellcome | 50% | |||||||
2424 | telmisartaan | C09CA07 | PRITOR tablett 40mg N280 | Glaxo Wellcome | 50% | |||||||
2425 | telmisartaan | C09CA07 | PRITOR tablett 40mg N56 | Glaxo Wellcome | 50% | |||||||
2426 | telmisartaan | C09CA07 | PRITOR tablett 40mg N98 | Glaxo Wellcome | 50% | |||||||
2427 | telmisartaan | C09CA07 | PRITOR tablett 80mg N14 | Glaxo Wellcome | 50% | |||||||
2428 | telmisartaan | C09CA07 | PRITOR tablett 80mg N28 | Glaxo Wellcome | 50% | |||||||
2429 | telmisartaan | C09CA07 | PRITOR tablett 80mg N280 | Glaxo Wellcome | 50% | |||||||
2430 | telmisartaan | C09CA07 | PRITOR tablett 80mg N56 | Glaxo Wellcome | 50% | |||||||
2431 | telmisartaan | C09CA07 | PRITOR tablett 80mg N98 | Glaxo Wellcome | 50% | |||||||
2432 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 200mg 1TABL N100 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2433 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 200mg 1TABL N30 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2434 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 300mg 1TABL N100 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2435 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 300mg 1TABL N30 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2436 | teofülliin | R03DA04 | TEOTARD retardkapsel 200mg N40 | KRKA, d.d. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2437 | teofülliin | R03DA04 | TEOTARD retardkapsel 350mg N40 | KRKA, d.d. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2438 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 15g N1 | Novartis Consumer Health | 50% | |||||||
2439 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 30g N1 | Novartis Consumer Health | 50% | |||||||
2440 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 5g N1 | Novartis Consumer Health | 50% | |||||||
2441 | terbinafiin | D01AE15 | LAMISIL kreem 1% 15g N1 | Novartis Consumer Health | 50% | |||||||
2442 | terbinafiin | D01AE15 | LAMISIL lahus paikseks kasut. 1% 15 ml N1 | Novartis Consumer Health | 50% | |||||||
2443 | terbinafiin | D01AE15 | LAMISIL lahus paikseks kasut. 1% 30ml N1 | Novartis Consumer Health | 50% | |||||||
2444 | terbinafiin | D01AE15 | LAMISIL nahasprei 1% 30ml N1 | Novartis Consumer Health | 50% | |||||||
2445 | terbinafiin | D01AE15 | TERBISIL 1% KREEM kreem 1%/g 15g N1 | Richter | 50% | |||||||
2446 | terbinafiin | D01AE15 | TERBISIL tablett 250 mg N14 | Richter | 50% | |||||||
2447 | terbinafiin | D01AE15 | TERBISIL tablett 250 mg N28 | Richter | 50% | |||||||
2448 | terbinafiin | D01AE15 | TERBISIL tablett 125 mg N14 | Richter | 50% | |||||||
2449 | terbinafiin | D01BA02 | LAMISIL tablett 125mg N28 | Novartis Pharma | 50% | |||||||
2450 | terbinafiin | D01BA02 | LAMISIL tablett 250mg N14 | Novartis Pharma | 50% | |||||||
2451 | terbinafiin | D01BA02 | LAMISIL tablett 250mg N28 | Novartis Pharma | 50% | |||||||
2452 | terbutaliin | R03AC03 | BRICANYL inhal aeros 0,25mg/annuses 400annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2453 | terbutaliin | R03AC03 | BRICANYL TURBUHALER inhalatsioonipulber 0,5mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2454 | terfenadiin | R06AX12 | HISFEDIN SAFT suspensioon 6mg/ml 120ml N1 | Wolff | 50% | |||||||
2455 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N100 | Wolff | 50% | |||||||
2456 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N20 | Wolff | 50% | |||||||
2457 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N50 | Wolff | 50% | |||||||
2458 | terfenadiin | R06AX12 | TERIDIN FORTE tablett 120mg N20 | KRKA, d.d. | 50% | |||||||
2459 | terfenadiin | R06AX12 | TERIDIN suspensioon 6mg/ml 100ml N1 | KRKA, d.d. | 50% | |||||||
2460 | terfenadiin | R06AX12 | TERIDIN tablett 60mg N20 | KRKA, d.d. | 50% | |||||||
2461 | testosteroon | G03BA03 | PANTESTON kapsel 40mg N60 | N.V. ORGANON | 50% | 100% | (C00-D48)*; E23**; E29.1**; E89.5**; Q98** | *rv hematoloogil, onkoloogil ja uroloogil; **rv endokrinoloogil ja günekoloogil | ||||
2462 | testosteroon | G03BA03 | SUSTANON “250" süstelahus 250mgml 1ml N1 | N.V. ORGANON | 50% | 100% | (C00-D48)*; E23**; E29.1**; E89.5**; Q98** | *rv hematoloogil, onkoloogil ja uroloogil; **rv endokrinoloogil ja günekoloogil | ||||
2463 | tetratsükliin | D06AA04 | IMEX salv 3% 20g N1 | Merz+Co | 50% | |||||||
2464 | tetratsükliin | J01AA07 | TETRACYCLIN NYCOMED tablett 250mg N24 | Nycomed SEFA | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
2465 | tetratsükliin | S01AA09 | TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT 1% silmasalv 1% 5g | Troge | 50% | |||||||
2466 | tianeptiin | N06AA80 | COAXIL tablett 12,5mg N30 | Servier | 50% | |||||||
2467 | tiboloon | G03DC05 | LIVIAL tablett 2,5mg N28 | N.V. ORGANON | 50% | |||||||
2468 | tiboloon | G03DC05 | LIVIAL tablett 2,5mg N84 | N.V. ORGANON | 50% | |||||||
2469 | tiklopidiin | B01AC05 | APO-TICLOPIDINE tablett 250 mg N30 | Apotex | 50% | |||||||
2470 | tiklopidiin | B01AC05 | APO-TICLOPIDINE tablett 250 mg N60 | Apotex | 50% | |||||||
2471 | tiklopidiin | B01AC05 | TICLOPIN tablett 250 mg N30 | Nycomed SEFA | 50% | |||||||
2472 | tiklopidiin | B01AC05 | TICLOPIN tablett 250 mg N60 | Nycomed SEFA | 50% | |||||||
2473 | tiklopidiin | B01AC05 | TAGREN tablett 250mg N30 | KRKA, d.d. | 50% | |||||||
2474 | tiklopidiin | B01AC05 | TICLID tablett 250mg N20 | Sanofi | 50% | |||||||
2475 | tiklopidiin | B01AC05 | TICLOPIDIN-RATIOPHARM tablett 250mg N30 | ratiopharm | 50% | |||||||
2476 | tiklopidiin | B01AC05 | TICLOPIDIN-RATIOPHARM tablett 250mg N90 | ratiopharm | 50% | |||||||
2477 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,25% 5 ml N1 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2478 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,25% 5 ml N3 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2479 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,5% 5ml N1 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2480 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,5% 5ml N3 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2481 | timolool | S01ED01 | NYOLOL silmatilgad 0,25% 3ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2482 | timolool | S01ED01 | NYOLOL silmatilgad 0,25% 5ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2483 | timolool | S01ED01 | NYOLOL silmatilgad 0,5% 3ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2484 | timolool | S01ED01 | NYOLOL silmatilgad 0,5% 5ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2485 | timolool | S01ED01 | OFTAN TIMOLOL silmatilgad 0,25% 5ml N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2486 | timolool | S01ED01 | OFTAN TIMOLOL silmatilgad 0,5% 5ml N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2487 | timolool | S01ED01 | TIMOPTIC 0,25% silmatilgad 0,25% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2488 | timolool | S01ED01 | TIMOPTIC 0,5% silmatilgad 0,5% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2489 | timolool | S01ED01 | TIMOPTIC XE silmatilgad 0,25% 2.5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2490 | timolool | S01ED01 | TIMOPTIC XE silmatilgad 0,5% 2.5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2491 | timolool | S01ED01 | TIMOSAN silmageel 0,1% 5g N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2492 | timolool+dorsolamiid | S01ED80 | COSOPT silmatilgad 2%+0,5% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kombinatsioonpreparaate kasutatakse juhul, kui monoteraapia beeta-adrenoblokaatori, lokaalse karboanhüdraasi inhibiitori või prostaglandiini analoogiga ei ole langetanud piisavalt siserõhku | ||||
2493 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/0,5 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.5ml N2 | Leo | 50% | 75% | O99.8 | |||||
2494 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/ML VIALS 2 ML süstelahus 10000TÜ anti Xa/ml 2ml N1 | Leo | 50% | 75% | O99.8 | |||||
2495 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/ML VIALS 2 ML süstelahus 10000TÜ anti Xa/ml 2ml N10 | Leo | 50% | 75% | O99.8 | |||||
2496 | tinsapariin | B01AB10 | INNOHEP 14000 ANTI-XA IU/0,7 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.7ml N2 | Leo | 50% | 75% | O99.8 | |||||
2497 | tinsapariin | B01AB10 | INNOHEP 18000 ANTI-XA IU/0,9 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.9ml N2 | Leo | 50% | 75% | O99.8 | |||||
2498 | tinsapariin | B01AB10 | INNOHEP 20000 ANTI-XA IU/ML VIALS 2 ML süstelahus 20000TÜ anti Xa/ml 2ml N1 | Leo | 50% | 75% | O99.8 | |||||
2499 | tinsapariin | B01AB10 | INNOHEP 20000 ANTI-XA IU/ML VIALS 2 ML süstelahus 20000TÜ anti Xa/ml 2ml N10 | Leo | 50% | 75% | O99.8 | |||||
2500 | tinsapariin | B01AB10 | INNOHEP 2500 ANTI-XA IU/0,25 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.25ml N10 | Leo | 50% | 75% | O99.8 | |||||
2501 | tinsapariin | B01AB10 | INNOHEP 3500 ANTI-XA IU/0,35 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.35ml N10 | Leo | 50% | 75% | O99.8 | |||||
2502 | tinsapariin | B01AB10 | INNOHEP 3500 ANTI-XA IU/0,35 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.35ml N2 | Leo | 50% | 75% | O99.8 | |||||
2503 | tinsapariin | B01AB10 | INNOHEP 4500 ANTI-XA IU/0,45 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.45ml N10 | Leo | 50% | 75% | O99.8 | |||||
2504 | tinsapariin | B01AB10 | INNOHEP 4500 ANTI-XA IU/0,45 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.45ml N2 | Leo | 50% | 75% | O99.8 | |||||
2505 | tioguaniin | L01BB03 | LANVIS tablett 40mg N25 | Glaxo Wellcome | 50% | |||||||
2506 | tioridasiin | N05AC02 | MELLERIL tablett 100mg N30 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)* (F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2507 | tioridasiin | N05AC02 | MELLERIL tablett 10mg N30 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2508 | tisanidiin | M03BX02 | SIRDALUD tablett 2mg N30 | Novartis Pharma | 50% | 75% | G81; G82 | |||||
2509 | tisanidiin | M03BX02 | SIRDALUD tablett 4mg N30 | Novartis Pharma | 50% | 75% | G81; G82 | |||||
2510 | tobramütsiin | S01AA12 | TOBREX silmasalv 3% 3.5g N1 | Alcon | 50% | |||||||
2511 | tobramütsiin | S01AA12 | TOBREX silmatilgad 0,3% 5 ml N1 | Alcon | 50% | |||||||
2512 | toitained ilma fenüül- alaniinita |
V06CA80 | XP ANALOG pulber 400g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2513 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMAID (ORANGE FLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2514 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMAID (UNFLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2515 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMUM (ORANGE FLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2516 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMUM (UNFLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2517 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N100 | Bristol-Myers Squibb | 50% | |||||||
2518 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N20 | Bristol-Myers Squibb | 50% | |||||||
2519 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N50 | Bristol-Myers Squibb | 50% | |||||||
2520 | tolterodiin | G04BD07 | DETRUSITOL 1 MG tablett 1mg N28 | Pharmacia Enterprises | 50% | |||||||
2521 | tolterodiin | G04BD07 | DETRUSITOL 1 MG tablett 1mg N56 | Pharmacia Enterprises | 50% | |||||||
2522 | tolterodiin | G04BD07 | DETRUSITOL 2 MG tablett 2mg N28 | Pharmacia Enterprises | 50% | |||||||
2523 | tolterodiin | G04BD07 | DETRUSITOL 2 MG tablett 2mg N56 | Pharmacia Enterprises | 50% | |||||||
2524 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsio- naalsetele antiepileptilistele ravimitele resistentse epilepsia näidustustel |
||||
2525 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2526 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2527 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2528 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2529 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2530 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2531 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2532 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2533 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2534 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2535 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2536 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2537 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2538 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2539 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2540 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2541 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2542 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2543 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2544 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2545 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2546 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2547 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2548 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2549 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2550 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2551 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2552 | topiramaat | N03AX11 | TOPAMAX SPRINKLE CAPSULES 15 MG kapsel 15mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2553 | topiramaat | N03AX11 | TOPAMAX SPRINKLE CAPSULES 25MG kapsel 25mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2554 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N100 | Berlin-Chemie | 50% | |||||||
2555 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N30 | Berlin-Chemie | 50% | |||||||
2556 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N50 | Berlin-Chemie | 50% | |||||||
2557 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N100 | Berlin-Chemie | 50% | |||||||
2558 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N30 | Berlin-Chemie | 50% | |||||||
2559 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N50 | Berlin-Chemie | 50% | |||||||
2560 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N100 | Berlin-Chemie | 50% | |||||||
2561 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N30 | Berlin-Chemie | 50% | |||||||
2562 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N50 | Berlin-Chemie | 50% | |||||||
2563 | tramadool | N02AX02 | ADAMON SR 100 MG retardkapsel 100mg N20 | Asta Medica | 50% | |||||||
2564 | tramadool | N02AX02 | ADAMON SR 150 MG retardkapsel 150mg N20 | Asta Medica | 50% | |||||||
2565 | tramadool | N02AX02 | ADAMON SR 200 MG retardkapsel 200mg N20 | Asta Medica | 50% | |||||||
2566 | tramadool | N02AX02 | ADAMON SR 50 MG retardkapsel 50mg N20 | Asta Medica | 50% | |||||||
2567 | tramadool | N02AX02 | DOLOL kapsel 50mg N20 | Nycomed SEFA | 50% | |||||||
2568 | tramadool | N02AX02 | DOLOL kapsel 50mg N30 | Nycomed SEFA | 50% | |||||||
2569 | tramadool | N02AX02 | DOLOL kapsel 50mg N60 | Nycomed SEFA | 50% | |||||||
2570 | tramadool | N02AX02 | LANALGET RETARD 150 MG TAB retardtablett 150 mg N10 | Lannacher | 50% | |||||||
2571 | tramadool | N02AX02 | LANALGET RETARD 150 MG TAB retardtablett 150 mg N30 | Lannacher | 50% | |||||||
2572 | tramadool | N02AX02 | LANALGET RETARD 200 MG TAB retardtablett 200 mg N10 | Lannacher | 50% | |||||||
2573 | tramadool | N02AX02 | LANALGET RETARD 200 MG TAB retardtablett 200 mg N30 | Lannacher | 50% | |||||||
2574 | tramadool | N02AX02 | MABRON kapsel 50mg N10 | Medochemie | 50% | |||||||
2575 | tramadool | N02AX02 | MABRON kapsel 50mg N20 | Medochemie | 50% | |||||||
2576 | tramadool | N02AX02 | PROTRADON kapsel 50mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2577 | tramadool | N02AX02 | PROTRADON kapsel 50mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2578 | tramadool | N02AX02 | TRAMADOL 100-SLOVAKOFARMA suposiit 100mg N10 | Slovakofarma | 50% | |||||||
2579 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N10 | Stada | 50% | |||||||
2580 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N30 | Stada | 50% | |||||||
2581 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N50 | Stada | 50% | |||||||
2582 | tramadool | N02AX02 | TRAMADOL 50-SLOVAKOFARMA kapsel 50mg N10 | Slovakofarma | 50% | |||||||
2583 | tramadool | N02AX02 | TRAMADOL 50-SLOVAKOFARMA kapsel 50mg N20 | Slovakofarma | 50% | |||||||
2584 | tramadool | N02AX02 | TRAMADOL kapsel 50mg N20 | KRKA, d.d. | 50% | |||||||
2585 | tramadool | N02AX02 | TRAMADOL ALPHARMA CAPSULES 50 MG kapslid 50 mg N30 | ALPHARMA | 50% | |||||||
2586 | tramadool | N02AX02 | TRAMADOL LANNACHER retardtablett 100mg N10 | Lannacher | 50% | |||||||
2587 | tramadool | N02AX02 | TRAMADOL LANNACHER retardtablett 100mg N30 | Lannacher | 50% | |||||||
2588 | tramadool | N02AX02 | TRAMADOL LANNACHER SOL. tilgad 100mg/ml 10ml N1 | Lannacher | 50% | |||||||
2589 | tramadool | N02AX02 | TRAMADOL LANNACHER SUPP. suposiit 100mg N5 | Lannacher | 50% | |||||||
2590 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N1000 | Lannacher | 50% | |||||||
2591 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N1100 | Lannacher | 50% | |||||||
2592 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N20 | Lannacher | 50% | |||||||
2593 | tramadool | N02AX02 | TRAMADOL RETARD retardtablett 100mg N30 | KRKA, d.d. | 50% | |||||||
2594 | tramadool | N02AX02 | TRAMADOL- SLOVAKOFARMA suukaudne lahus 100mg/ml 10ml N1 | Slovakofarma | 50% | |||||||
2595 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 100ml N1 | Stada | 50% | |||||||
2596 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 10ml N1 | Stada | 50% | |||||||
2597 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 20ml N1 | Stada | 50% | |||||||
2598 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 50ml N1 | Stada | 50% | |||||||
2599 | tramadool | N02AX02 | TRAMADOL suposiit 100mg N5 | KRKA, d.d. | 50% | |||||||
2600 | tramadool | N02AX02 | TRAMADOL tilgad 100mg/ml 10ml N1 | KRKA, d.d. | 50% | |||||||
2601 | tramadool | N02AX02 | TRAMADOL tilgad 100mg/ml 96ml N1 | KRKA, d.d. | 50% | |||||||
2602 | tramadool | N02AX02 | TRAMAL kapsel 50mg N20 | Grünenthal GmbH | 50% | |||||||
2603 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N10 | Grünenthal GmbH | 50% | |||||||
2604 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N20 | Grünenthal GmbH | 50% | |||||||
2605 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N30 | Grünenthal GmbH | 50% | |||||||
2606 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N50 | Grünenthal GmbH | 50% | |||||||
2607 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N10 | Grünenthal GmbH | 50% | |||||||
2608 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N30 | Grünenthal GmbH | 50% | |||||||
2609 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N50 | Grünenthal GmbH | 50% | |||||||
2610 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N10 | Grünenthal GmbH | 50% | |||||||
2611 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N30 | Grünenthal GmbH | 50% | |||||||
2612 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N50 | Grünenthal GmbH | 50% | |||||||
2613 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N10 | Grünenthal GmbH | 50% | |||||||
2614 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N30 | Grünenthal GmbH | 50% | |||||||
2615 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N50 | Grünenthal GmbH | 50% | |||||||
2616 | tramadool | N02AX02 | TRAMAL suposiit 100mg N5 | Grünenthal GmbH | 50% | |||||||
2617 | tramadool | N02AX02 | TRAMAL tilgad 100mg/ml 10ml N1 | Grünenthal GmbH | 50% | |||||||
2618 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N10 | Mundipharma Austria | 50% | |||||||
2619 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N20 | Mundipharma Austria | 50% | |||||||
2620 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N30 | Mundipharma Austria | 50% | |||||||
2621 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N50 | Mundipharma Austria | 50% | |||||||
2622 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N100 | Abbott GmbH & Co. KG | 50% | |||||||
2623 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N20 | Abbott GmbH & Co. KG | 50% | |||||||
2624 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N28 | Abbott GmbH & Co. KG | 50% | |||||||
2625 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2626 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N60 | Abbott GmbH & Co. KG | 50% | |||||||
2627 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N98 | Abbott GmbH & Co. KG | 50% | |||||||
2628 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N100 | Abbott GmbH & Co. KG | 50% | |||||||
2629 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N20 | Abbott GmbH & Co. KG | 50% | |||||||
2630 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N28 | Abbott GmbH & Co. KG | 50% | |||||||
2631 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2632 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N60 | Abbott GmbH & Co. KG | 50% | |||||||
2633 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N98 | Abbott GmbH & Co. KG | 50% | |||||||
2634 | traneksaam- hape |
B02AA02 | CYKLOKAPRON süstelahus 100mg/ml 5ml N10 | Pharmacia Enterprises | 50% | |||||||
2635 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N100 | Pharmacia Enterprises | 50% | |||||||
2636 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N20 | Pharmacia Enterprises | 50% | |||||||
2637 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N50 | Pharmacia Enterprises | 50% | |||||||
2638 | travoprost | S01EX80 | TRAVATAN silmatilgad 40mcg/ml 2.5ml N3 | Alcon UK | 50% | |||||||
2639 | tretinoiin | D10AD01 | RETIN-A kreem 0,05% 30g N1 | Cilag | 50% | |||||||
2640 | triamtsinoloon | D07AB09 | FTOROCORT 0,1% OINTMENT salv 0,1% 15g N1 | Richter | 50% | 75% | L20*; L23*; L40**; M07** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2641 | triamtsinoloon | H02AB08 | KENALOG 40 süstesuspensioon 40mg/ml 1ml N5 | KRKA, d.d. | 50% | |||||||
2642 | triamtsinoloon | H02AB08 | LEDERSPAN süstesuspensioon 20mgml 1ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2643 | triamtsinoloon | H02AB08 | LEDERSPAN süstesuspensioon 20mgml 5ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2644 | triamtsinoloon | R01AD80 | NASACORT ninasprei 55mcg/annuses 120annust N1 | Aventis Pharma Ltd. | 50% | |||||||
2645 | triamtsinoloon+ekonasool | D07BB81 | PEVISONE kreem 0,1%+1% 15g N1 | Cilag | 50% | |||||||
2646 | triheksüfe- nidüül |
N04AA01 | CYCLODOL tablett 2mg N50 | TFT | 50% | |||||||
2647 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 2 tablett 2mg N100 | Hexal AG | 50% | |||||||
2648 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 2 tablett 2mg N50 | Hexal AG | 50% | |||||||
2649 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 5 tablett 5mg N100 | Hexal AG | 50% | |||||||
2650 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 5 tablett 5mg N50 | Hexal AG | 50% | |||||||
2651 | trimetasidiin | C01DX17 | PREDUCTAL tablett 20mg N60 | Servier | 50% | |||||||
2652 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N100 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2653 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N200 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2654 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N30 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2655 | triptoreliin | L02AE04 | DECAPEPTYL DEPOT mikrokapslid süstimiseks 3,75mg N1 | Ferring GmbH | 50% | |||||||
2656 | triptoreliin | L02AE04 | DECAPEPTYL DEPOT mikrokapslid süstimiseks 3,75mg N3 | Ferring GmbH | 50% | |||||||
2657 | triptoreliin | L02AE04 | DIPHERELINE 0,1 MG injektsioonisubstants 0,1mg N7 | Beaufour Ipsen Int | 50% | |||||||
2658 | triptoreliin | L02AE04 | DIPHERELINE 3,75 MG injektsioonisubstants 3,75mg N1 | Beaufour Ipsen Int | 50% | |||||||
2659 | tromantadiin | D06BB02 | VIRU-MERZ SEROL, GEL geel 1% 2g N1 | Merz+Co | 50% | |||||||
2660 | tromantadiin | D06BB02 | VIRU-MERZ SEROL, GEL geel 1% 5g N1 | Merz+Co | 50% | |||||||
2661 | tropikamiid | S01FA06 | MYDRIACYL silmatilgad 0,5% 15ml N1 | Alcon | 50% | |||||||
2662 | tropisetroon | A04AA03 | NAVOBAN 2 MG/2 ML süstelahus 2mg 2ml 2ml N1 | Novartis Pharma | 50% | |||||||
2663 | tropisetroon | A04AA03 | NAVOBAN 5 MG/5 ML süstelahus 1mg/ml 5ml N1 | Novartis Pharma | 50% | |||||||
2664 | tropisetroon | A04AA03 | NAVOBAN 5 MG/5 ML süstelahus 1mg/ml 5ml N10 | Novartis Pharma | 50% | |||||||
2665 | tropisetroon | A04AA03 | NAVOBAN kapsel 5mg N5 | Novartis Pharma | 50% | |||||||
2666 | tsefadroksiil | J01DA09 | DURACEF kapsel 250mg N100 | Bristol-Myers Squibb | 50% | (6) | ||||||
2667 | tsefadroksiil | J01DA09 | DURACEF kapsel 250mg N12 | Bristol-Myers Squibb | 50% | (6) | ||||||
2668 | tsefadroksiil | J01DA09 | DURACEF kapsel 250mg N50 | Bristol-Myers Squibb | 50% | (6) | ||||||
2669 | tsefadroksiil | J01DA09 | DURACEF kapsel 500mg N100 | Bristol-Myers Squibb | 50% | (6) | ||||||
2670 | tsefadroksiil | J01DA09 | DURACEF kapsel 500mg N12 | Bristol-Myers Squibb | 50% | (6) | ||||||
2671 | tsefadroksiil | J01DA09 | DURACEF kapsel 500mg N50 | Bristol-Myers Squibb | 50% | (6) | ||||||
2672 | tsefadroksiil | J01DA09 | DURACEF lahustuv tablett 1g N10 | Bristol-Myers Squibb | 50% | (6) | ||||||
2673 | tsefadroksiil | J01DA09 | DURACEF suspensioonigraanulid 50mgml 100ml N1 | Bristol-Myers Squibb | 50% | (6) | ||||||
2674 | tsefadroksiil | J01DA09 | DURACEF suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | (6) | ||||||
2675 | tsefakloor | J01DA08 | CEFACLOR STADA 500 kapsel 500mg N10 | Stada | 50% | (6) | ||||||
2676 | tsefakloor | J01DA08 | CEFACLOR STADA 500 kapsel 500mg N20 | Stada | 50% | (6) | ||||||
2677 | tsefakloor | J01DA08 | CEFACLOR STADA TS 250 graanulid 50mgml 100ml N1 | Stada | 50% | (6) | ||||||
2678 | tsefaleksiin | J01DA01 | CEFALEKSINS kapsel 250mg N30 | Grindeks | 50% | (6) | ||||||
2679 | tsefaleksiin | J01DA01 | CEFALEKSINS kapsel 250mg N500 | Grindeks | 50% | (6) | ||||||
2680 | tsefaleksiin | J01DA01 | CEFALEKSINS kapsel 500mg N20 | Grindeks | 50% | (6) | ||||||
2681 | tsefaleksiin | J01DA01 | KEFLEX kapsel 250mg N20 | Eli Lilly Export S.A. | 50% | (6) | ||||||
2682 | tsefaleksiin | J01DA01 | KEFLEX suspensioonigraanulid 25mgml 100ml N1 | Eli Lilly Export S.A. | 50% | (6) | ||||||
2683 | tsefaleksiin | J01DA01 | KEFLEX suspensioonigraanulid 50mgml 100ml N1 | Eli Lilly Export S.A. | 50% | (6) | ||||||
2684 | tsefaleksiin | J01DA01 | OSPEXIN 1000 MG tablett 1000mg N12 | Biochemie GmbH | 50% | (6) | ||||||
2685 | tsefaleksiin | J01DA01 | OSPEXIN 250 MG CAPSULES kapsel 250mg N100 | Biochemie GmbH | 50% | (6) | ||||||
2686 | tsefaleksiin | J01DA01 | OSPEXIN 250 MG CAPSULES kapsel 250mg N12 | Biochemie GmbH | 50% | (6) | ||||||
2687 | tsefaleksiin | J01DA01 | OSPEXIN 500 MG CAPSULES kapsel 500mg N10 | Biochemie GmbH | 50% | (6) | ||||||
2688 | tsefaleksiin | J01DA01 | OSPEXIN 500 MG CAPSULES kapsel 500mg N12 | Biochemie GmbH | 50% | (6) | ||||||
2689 | tsefprosiil | J01DA41 | CEFZIL suspensioonigraanulid 25mgml 60ml N1 | Bristol-Myers Squibb | 50% | (6) | ||||||
2690 | tsefprosiil | J01DA41 | CEFZIL suspensioonigraanulid 50mgml 100ml N1 | Bristol-Myers Squibb | 50% | (6) | ||||||
2691 | tsefprosiil | J01DA41 | CEFZIL suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | (6) | ||||||
2692 | tsefprosiil | J01DA41 | CEFZIL tablett 250mg N10 | Bristol-Myers Squibb | 50% | (6) | ||||||
2693 | tsefprosiil | J01DA41 | CEFZIL tablett 250mg N16 | Bristol-Myers Squibb | 50% | (6) | ||||||
2694 | tsefprosiil | J01DA41 | CEFZIL tablett 250mg N20 | Bristol-Myers Squibb | 50% | (6) | ||||||
2695 | tsefprosiil | J01DA41 | CEFZIL tablett 250mg N8 | Bristol-Myers Squibb | 50% | (6) | ||||||
2696 | tsefprosiil | J01DA41 | CEFZIL tablett 500mg N10 | Bristol-Myers Squibb | 50% | (6) | ||||||
2697 | tsefprosiil | J01DA41 | CEFZIL tablett 500mg N16 | Bristol-Myers Squibb | 50% | (6) | ||||||
2698 | tsefprosiil | J01DA41 | CEFZIL tablett 500mg N20 | Bristol-Myers Squibb | 50% | (6) | ||||||
2699 | tsefprosiil | J01DA41 | CEFZIL tablett 500mg N8 | Bristol-Myers Squibb | 50% | (6) | ||||||
2700 | tsefuroksiim | J01DA06 | ZINNAT suspensioonigraanulid 25mgml 100ml N1 | Glaxo Wellcome | 50% | (6) | ||||||
2701 | tsefuroksiim | J01DA06 | ZINNAT suspensiooni- graanulid 25mgml 50ml N1 |
Glaxo Wellcome | 50% | (6) | ||||||
2702 | tsefuroksiim | J01DA06 | ZINNAT tablett 250mg N10 | Glaxo Wellcome | 50% | (6) | ||||||
2703 | tsefuroksiim | J01DA06 | ZINNAT tablett 500mg N10 | Glaxo Wellcome | 50% | (6) | ||||||
2704 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N10 | Pfizer H.C.P. Corporation | 50% | |||||||
2705 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N100 | Pfizer H.C.P. Corporation | 50% | |||||||
2706 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N2 | Pfizer H.C.P. Corporation | 50% | |||||||
2707 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N20 | Pfizer H.C.P. Corporation | 50% | |||||||
2708 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
2709 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N40 | Pfizer H.C.P. Corporation | 50% | |||||||
2710 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N50 | Pfizer H.C.P. Corporation | 50% | |||||||
2711 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N6 | Pfizer H.C.P. Corporation | 50% | |||||||
2712 | tselekoksiib | M01AH01 | CELEBREX kapsel 100mg N60 | Pfizer H.C.P. Corporation | 50% | |||||||
2713 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N10 | Pfizer H.C.P. Corporation | 50% | |||||||
2714 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N100 | Pfizer H.C.P. Corporation | 50% | |||||||
2715 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N2 | Pfizer H.C.P. Corporation | 50% | |||||||
2716 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N20 | Pfizer H.C.P. Corporation | 50% | |||||||
2717 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
2718 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N40 | Pfizer H.C.P. Corporation | 50% | |||||||
2719 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N50 | Pfizer H.C.P. Corporation | 50% | |||||||
2720 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N6 | Pfizer H.C.P. Corporation | 50% | |||||||
2721 | tselekoksiib | M01AH01 | CELEBREX kapsel 200mg N60 | Pfizer H.C.P. Corporation | 50% | |||||||
2722 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 100 tablett 100mg N100 | LÉCIVA a.s. | 50% | |||||||
2723 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 100 tablett 100mg N30 | LÉCIVA a.s. | 50% | |||||||
2724 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 200 tablett 200mg N100 | LÉCIVA a.s. | 50% | |||||||
2725 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 200 tablett 200mg N30 | LÉCIVA a.s. | 50% | |||||||
2726 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 400 tablett 400mg N100 | LÉCIVA a.s. | 50% | |||||||
2727 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 400 tablett 400mg N30 | LÉCIVA a.s. | 50% | |||||||
2728 | tseliprolool- vesinikkloriid |
C07AB08 | CELIPROL 400 tablett 400mg N50 | LÉCIVA a.s. | 50% | |||||||
2729 | tsertopariin | B01AB80 | TROPARIN süstelahus 3000TÜ anti Xa 0.3ml 0.3ml N5 | Biochemie GmbH | 50% | |||||||
2730 | tsetirisiin | R06AE07 | CETIRIZINE ALPHARMA TABLETS 10 MG tabletid 10 mg N30 | ALPHARMA | 50% | |||||||
2731 | tsetirisiin | R06AE07 | LETIZEN tablett 10mg N20 | KRKA, d.d. | 50% | |||||||
2732 | tsetirisiin | R06AE07 | LETIZEN tablett 10mg N30 | KRKA, d.d. | 50% | |||||||
2733 | tsetirisiin | R06AE07 | ZODAC tablett 10mg N30 | LÉCIVA a.s. | 50% | |||||||
2734 | tsetirisiin | R06AE07 | ZYRTEC tablett 10mg N100 | UCB Pharma Oy Finland | 50% | |||||||
2735 | tsetirisiin | R06AE07 | ZYRTEC tablett 10mg N30 | UCB Pharma Oy Finland | 50% | |||||||
2736 | tsetirisiin | R06AE07 | ZYRTEC tilgad 10mg/ml 20ml N1 | UCB Pharma Oy Finland | 50% | |||||||
2737 | tsetirisiin+pseudoefedriin | R06AE81 | CIRRUS tabl + pellet 5mg+120mg N14 | UCB Pharma Oy Finland | 50% | |||||||
2738 | tsetroreliks | H01CC02 | CETROTIDE 0,25 MG injektsioonisubstants 0,25mg N1 | Ares-Serono | 50% | |||||||
2739 | tsetroreliks | H01CC02 | CETROTIDE 0,25 MG injektsioonisubstants 0,25mg N7 | Ares-Serono | 50% | |||||||
2740 | tsetroreliks | H01CC02 | CETROTIDE 3 MG injektsioonisubstants 3mg N1 | Ares-Serono | 50% | |||||||
2741 | tsimetidiin | A02BA01 | ACINIL tablett 200mg N100 | Bristol-Myers Squibb | 50% | 75% | K25-K27 | |||||
2742 | tsimetidiin | A02BA01 | ACINIL tablett 200mg N50 | Bristol-Myers Squibb | 50% | 75% | K25-K27 | |||||
2743 | tsimetidiin | A02BA01 | ACINIL tablett 400mg N100 | Bristol-Myers Squibb | 50% | 75% | K25-K27 | |||||
2744 | tsimetidiin | A02BA01 | ACINIL tablett 400mg N50 | Bristol-Myers Squibb | 50% | 75% | K25-K27 | |||||
2745 | tsimetidiin | A02BA01 | CIMETIDIN 200 STADA tablett 200mg N100 | Stada | 50% | 75% | K25-K27 | |||||
2746 | tsimetidiin | A02BA01 | CIMETIDIN 400 STADA tablett 400mg N100 | Stada | 50% | 75% | K25-K27 | |||||
2747 | tsimetidiin | A02BA01 | CIMETIDIN 400 STADA tablett 400mg N20 | Stada | 50% | 75% | K25-K27 | |||||
2748 | tsimetidiin | A02BA01 | CIMETIDIN 400 STADA tablett 400mg N50 | Stada | 50% | 75% | K25-K27 | |||||
2749 | tsimetidiin | A02BA01 | CIMETIDIN 800 STADA tablett 800mg N20 | Stada | 50% | 75% | K25-K27 | |||||
2750 | tsimetidiin | A02BA01 | CIMETIDIN 800 STADA tablett 800mg N50 | Stada | 50% | 75% | K25-K27 | |||||
2751 | tsimetidiin | A02BA01 | CIMETIDINS 200 MG tablett 200mg N60 | Grindeks | 50% | 75% | K25-K27 | |||||
2752 | tsimetidiin | A02BA01 | CIMETIDINS 400 MG tablett 400mg N30 | Grindeks | 50% | 75% | K25-K27 | |||||
2753 | tsimetidiin | A02BA01 | HISTODIL 200 MG TABLETS tablett 200mg N50 | Richter | 50% | 75% | K25-K27 | |||||
2754 | tsimetidiin | A02BA01 | ULCOMET 200 tablett 200mg N100 | Medochemie | 50% | 75% | K25-K27 | |||||
2755 | tsimetidiin | A02BA01 | ULCOMET 200 tablett 200mg N500 | Medochemie | 50% | 75% | K25-K27 | |||||
2756 | tsinnarisiin | N07CA02 | STUGERON FORTE kapsel 75mg N20 | Janssen | 50% | |||||||
2757 | tsinnarisiin | N07CA02 | STUGERON tablett 25mg N50 | Janssen | 50% | |||||||
2758 | tsiprofibraat | C10AB08 | LIPANOR kapsel 100mg N30 | Sanofi | 50% | |||||||
2759 | tsiprofloksat- siin |
J01MA02 | BACTIFLOX-250 tablett 250mg N10 | MEPHA Ltd. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2760 | tsiprofloksat- siin |
J01MA02 | BACTIFLOX-500 tablett 500mg N10 | MEPHA Ltd. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2761 | tsiprofloksat- siin |
J01MA02 | BACTIFLOX-750 LACTAB tablett 750mg N10 | MEPHA Ltd. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2762 | tsiprofloksat- siin |
J01MA02 | CIFLOXINAL tablett 250mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2763 | tsiprofloksat- siin |
J01MA02 | CIFLOXINAL tablett 250mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2764 | tsiprofloksat- siin |
J01MA02 | CIPRINOL 250 tablett 250mg N10 | KRKA, d.d. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2765 | tsiprofloksat- siin |
J01MA02 | CIPRINOL 500 tablett 500mg N10 | KRKA, d.d. | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2766 | tsiprofloksat- siin |
J01MA02 | CIPROXIN tablett 250mg N10 | Bayer AG | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2767 | tsiprofloksat- siin |
J01MA02 | CIPROXIN tablett 250mg N100 | Bayer AG | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2768 | tsiprofloksat- siin |
J01MA02 | CIPROXIN tablett 250mg N20 | Bayer AG | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2769 | tsiprofloksat- siin |
J01MA02 | CIPROXIN tablett 500mg N10 | Bayer AG | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2770 | tsiprofloksat- siin |
J01MA02 | CIPROXIN tablett 500mg N20 | Bayer AG | 50% | (6) | 100% | (D60-D64)*; E84** | *rv hematoloogil; rv pulmonoloogil | |||
2771 | tsiprofloksat- siin |
S01AX13 | CILOXAN silmatilgad 0,3% 5 ml N1 | Alcon | 50% | (6) | ||||||
2772 | tsitalopraam | N06AB04 | CIPRAMIL 10 MG tablett 10mg N14 | Lundbeck | 50% | |||||||
2773 | tsitalopraam | N06AB04 | CIPRAMIL 10 MG tablett 10mg N28 | Lundbeck | 50% | |||||||
2774 | tsitalopraam | N06AB04 | CIPRAMIL 20 MG tablett N14 | Lundbeck | 50% | |||||||
2775 | tsitalopraam | N06AB04 | CIPRAMIL 20 MG tablett N28 | Lundbeck | 50% | |||||||
2776 | tsitalopraam | N06AB04 | CIPRAMIL 20 MG tablett N56 | Lundbeck | 50% | |||||||
2777 | tsitalopraam | N06AB04 | CIPRAMIL 20 MG tablett N100 | Lundbeck | 50% | |||||||
2778 | tsitalopraam | N06AB04 | CIPRAMIL 40 MG tablett N28 | Lundbeck | 50% | |||||||
2779 | tsitalopraam | N06AB04 | CIPRAMIL 40 MG tablett N100 | Lundbeck | 50% | |||||||
2780 | tsüklofosfamiid | L01AA01 | ENDOXAN drazhee 50mg N100 | Asta Medica | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rv reumatoloogil; **rv nefroloogil ja pediaatril | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | |
2781 | tsüklofosfamiid | L01AA01 | ENDOXAN drazhee 50mg N50 | Asta Medica | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rv reumatoloogil; **rv nefroloogil ja pediaatril | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | |
2782 | tsüklofosfamiid | L01AA01 | SYKLOFOSFAMID tablett 50mg N100 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rv reumatoloogil; **rv nefroloogil ja pediaatril | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | |
2783 | tsüklopentolaat | S01FA04 | CYCLOGYL silmatilgad 1% 15ml N1 | Alcon | 50% | |||||||
2784 | tsüklosporiin | L04AA01 | SANDIMMUN NEORAL kapsel 100mg N50 | Novartis Pharma | 50% | 75% | L40*; M05**; M06**; M07*; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatoveneroloogil ja reumatoloogil; **rv reumatoloogil | 100% | (D60-D61)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | |
2785 | tsüklosporiin | L04AA01 | SANDIMMUN NEORAL kapsel 25mg N50 | Novartis Pharma | 50% | 75% | L40*; M05**; M06**; M07*; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatovene- roloogil ja reumatoloogil; **rv reumatoloogil |
100% | (D60-D61)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | |
2786 | tsüklosporiin | L04AA01 | SANDIMMUN NEORAL kapsel 50mg N50 | Novartis Pharma | 50% | 75% | L40*; M05**; M06**; M07*; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatovene- roloogil ja reumatoloogil; **rv reumatoloogil |
100% | (D60-D61)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | |
2787 | tsüklosporiin | L04AA01 | SANDIMMUN NEORAL suukaudne lahus 100mg/ml 50ml N1 | Novartis Pharma | 50% | 75% | L40*; M05**; M06**; M07*; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatovene- roloogil ja reumatoloogil; **rv reumatoloogil |
100% | (D60-D61)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | |
2788 | tsüproteroon | G03HA01 | ANDROCUR 50 tablett 50mg N20 | Schering AG | 50% | 100% | (C00-D48)* | *rv hematoloogil,onkoloogil ja uroloogil | ||||
2789 | tsüproteroon | G03HA01 | ANDROCUR 50 tablett 50mg N25 | Schering AG | 50% | 100% | (C00-D48)* | *rv hematoloogil,onkoloogil ja uroloogil | ||||
2790 | tsüproteroon | G03HA01 | ANDROCUR 50 tablett 50mg N50 | Schering AG | 50% | 100% | (C00-D48)* | *rv hematoloogil,onkoloogil ja uroloogil | ||||
2791 | tsüproteroon | G03HA01 | ANDROCUR-10 tablett 10mg N15 | Schering AG | 50% | 100% | (C00-D48)* | *rv hematoloogil,onkoloogil ja uroloogil | ||||
2792 | tsüproteroon+östrogeen | G03HB01 | CLIMEN tablett N21 | Schering AG | 50% | |||||||
2793 | tsüproteroon+östrogeen | G03HB01 | DIANE-35 drazhee 2mg+0,035mg N21 | Schering AG | 50% | |||||||
2794 | tsütarabiin | L01BC01 | CITARABINS injektsioonisubstants 100mg N10 | Grindeks | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
2795 | tsütarabiin | L01BC01 | CYTOSAR injektsiooni- substants 1000mg N1 |
Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
2796 | tsütarabiin | L01BC01 | CYTOSAR injektsiooni- substants 100mg N1 |
Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
2797 | tsütarabiin | L01BC01 | CYTOSAR injektsiooni- substants 500mg N1 |
Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
2798 | Tõrvade segu | D05AA84 | POLYTAR LIQUID lahus paikseks kasut. 1% 150ml N1 | Stiefel | 50% | 75% | L40; M07 | |||||
2799 | Tõrvade segu+ tsinkpüritioon |
D05AA82 | FONGITAR shampoon 1%+1% 150ml N1 | Stiefel | 50% | 75% | L40; M07 | |||||
2800 | uratsiil+ tegafuur |
L01BC80 | UFT kapsel 224mg N120 | Bristol-Myers Squibb | 50% | |||||||
2801 | uratsiil+ tegafuur |
L01BC80 | UFT kapsel 224mg N28 | Bristol-Myers Squibb | 50% | |||||||
2802 | ursodeok- sühoolhape |
A05AA02 | URSOFALK CAPSULES kapsel 250mg N100 | Falk | 50% | 75% | K73*; K74* | *rv gastroenteroloogil | ||||
2803 | ursodeok- sühoolhape |
A05AA02 | URSOFALK CAPSULES kapsel 250mg N50 | Falk | 50% | 75% | K73*; K74* | *rv gastroenteroloogil | ||||
2804 | ursodeok- sühoolhape |
A05AA02 | URSOSAN kapsel 250mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | 75% | K73*; K74* | *rv gastroenteroloogil | ||||
2805 | ursodeok- sühoolhape |
A05AA02 | URSOSAN kapsel 250mg N50 | PRO. MED. CS. PRAHA a.s. | 50% | 75% | K73*; K74* | *rv gastroenteroloogil | ||||
2806 | valatsükloviir | J05AB11 | VALTREX tablett 250mg N60 | Glaxo Wellcome | 50% | |||||||
2807 | valatsükloviir | J05AB11 | VALTREX tablett 500mg N10 | Glaxo Wellcome | 50% | |||||||
2808 | valproehape | N03AG01 | APILEPSIN tilgad 300mg/ml 60ml N1 | KRKA, d.d. | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2809 | valproehape | N03AG01 | DEPAKINE CHRONO 300 retardtablett 300mg N100 | Sanofi | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2810 | valproehape | N03AG01 | DEPAKINE CHRONO 500 retardtablett 500mg N30 | Sanofi | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2811 | valproehape | N03AG01 | ORFIRIL 150 enterotablett 150mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2812 | valproehape | N03AG01 | ORFIRIL 150 enterotablett 150mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2813 | valproehape | N03AG01 | ORFIRIL 300 enterotablett 300mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2814 | valproehape | N03AG01 | ORFIRIL 300 enterotablett 300mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2815 | valproehape | N03AG01 | ORFIRIL 300 RETARD enterotablett 300mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2816 | valproehape | N03AG01 | ORFIRIL 300 RETARD enterotablett 300mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2817 | valproehape | N03AG01 | ORFIRIL 600 enterotablett 600mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2818 | valproehape | N03AG01 | ORFIRIL 600 enterotablett 600mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2819 | valproehape | N03AG01 | ORFIRIL LONG 1000 MG retard mini-tabl 1000mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2820 | valproehape | N03AG01 | ORFIRIL LONG 1000 MG retard mini-tabl 1000mg N200 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2821 | valproehape | N03AG01 | ORFIRIL LONG 1000 MG retard mini-tabl 1000mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2822 | valproehape | N03AG01 | ORFIRIL LONG 150 MG retardkapsel 150mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2823 | valproehape | N03AG01 | ORFIRIL LONG 150 MG retardkapsel 150mg N200 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2824 | valproehape | N03AG01 | ORFIRIL LONG 150 MG retardkapsel 150mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2825 | valproehape | N03AG01 | ORFIRIL LONG 300 MG retardkapsel 300mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2826 | valproehape | N03AG01 | ORFIRIL LONG 300 MG retardkapsel 300mg N200 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2827 | valproehape | N03AG01 | ORFIRIL LONG 300 MG retardkapsel 300mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2828 | valproehape | N03AG01 | ORFIRIL LONG 500 MG retard mini-tabl 500mg N100 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2829 | valproehape | N03AG01 | ORFIRIL LONG 500 MG retard mini-tabl 500mg N200 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2830 | valproehape | N03AG01 | ORFIRIL LONG 500 MG retard mini-tabl 500mg N50 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2831 | valproehape | N03AG01 | ORFIRIL siirup 60mg/ml 250ml N1 | Desitin | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-79)*; G40** | *rev psühhiaatril; **rev neuroloogil | ||||
2832 | valsartaan | C09CA03 | DIOVAN kaetud tablett 160mg N14 | Novartis Pharma | 50% | |||||||
2833 | valsartaan | C09CA03 | DIOVAN kaetud tablett 160mg N28 | Novartis Pharma | 50% | |||||||
2834 | valsartaan | C09CA03 | DIOVAN kaetud tablett 160mg N56 | Novartis Pharma | 50% | |||||||
2835 | valsartaan | C09CA03 | DIOVAN kaetud tablett 160mg N98 | Novartis Pharma | 50% | |||||||
2836 | valsartaan | C09CA03 | DIOVAN kaetud tablett 80mg N14 | Novartis Pharma | 50% | |||||||
2837 | valsartaan | C09CA03 | DIOVAN kaetud tablett 80mg N28 | Novartis Pharma | 50% | |||||||
2838 | valsartaan | C09CA03 | DIOVAN kaetud tablett 80mg N56 | Novartis Pharma | 50% | |||||||
2839 | valsartaan | C09CA03 | DIOVAN kaetud tablett 80mg N98 | Novartis Pharma | 50% | |||||||
2840 | valsartaan | C09CA03 | DIOVAN tablett 160mg N14 | Novartis Pharma | 50% | |||||||
2841 | valsartaan | C09CA03 | DIOVAN tablett 160mg N28 | Novartis Pharma | 50% | |||||||
2842 | valsartaan | C09CA03 | DIOVAN tablett 80mg N14 | Novartis Pharma | 50% | |||||||
2843 | valsartaan | C09CA03 | DIOVAN tablett 80mg N28 | Novartis Pharma | 50% | |||||||
2844 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+12,5mg N14 | Novartis Pharma | 50% | |||||||
2845 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+12,5mg N28 | Novartis Pharma | 50% | |||||||
2846 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+12,5mg N56 | Novartis Pharma | 50% | |||||||
2847 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+12,5mg N98 | Novartis Pharma | 50% | |||||||
2848 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+25mg N14 | Novartis Pharma | 50% | |||||||
2849 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+25mg N28 | Novartis Pharma | 50% | |||||||
2850 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+25mg N56 | Novartis Pharma | 50% | |||||||
2851 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 160mg+25mg N98 | Novartis Pharma | 50% | |||||||
2852 | valsartaan+ hüdro- klorotiasiid |
C09DA03 | CO-DIOVAN tablett 80mg+12,5mg N28 | Novartis Pharma | 50% | |||||||
2853 | varfariin | B01AA03 | MAREVAN FORTE tablett 5mg N100 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | 100% | I26; T82 | ||
2854 | varfariin | B01AA03 | MAREVAN tablett 3mg N100 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | 100% | I26; T82 | ||
2855 | venlafaksiin | N06AA22 | EFEXOR 37,5 MG tablett 37,5mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2856 | venlafaksiin | N06AA22 | EFEXOR 37,5 MG tablett 37,5mg N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2857 | venlafaksiin | N06AA22 | EFEXOR 37,5 MG tablett 37,5mg N56 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2858 | venlafaksiin | N06AA22 | EFEXOR 37,5 MG tablett 37,5mg N60 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2859 | venlafaksiin | N06AA22 | EFEXOR 50 MG tablett 50mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2860 | venlafaksiin | N06AA22 | EFEXOR 50 MG tablett 50mg N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2861 | venlafaksiin | N06AA22 | EFEXOR 50 MG tablett 50mg N56 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2862 | venlafaksiin | N06AA22 | EFEXOR 50 MG tablett 50mg N60 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2863 | venlafaksiin | N06AA22 | EFEXOR 75 MG tablett 75mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2864 | venlafaksiin | N06AA22 | EFEXOR 75 MG tablett 75mg N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2865 | venlafaksiin | N06AA22 | EFEXOR 75 MG tablett 75mg N56 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2866 | venlafaksiin | N06AA22 | EFEXOR 75 MG tablett 75mg N60 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2867 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 150mg N14 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2868 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 150mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2869 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 150mg N98 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2870 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 37,5mg N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2871 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 37,5mg N60 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2872 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 75mg N14 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2873 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 75mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2874 | venlafaksiin | N06AA22 | EFEXOR XR retardkapsel 75mg N98 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2875 | verapamiil | C08DA01 | ISOPTIN RETARD 120 MG retardtablett 120mg N100 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2876 | verapamiil | C08DA01 | ISOPTIN RETARD 120 MG retardtablett 120mg N20 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2877 | verapamiil | C08DA01 | ISOPTIN RETARD 120 MG retardtablett 120mg N50 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2878 | verapamiil | C08DA01 | ISOPTIN RETARD retardtablett 240mg N100 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2879 | verapamiil | C08DA01 | ISOPTIN RETARD retardtablett 240mg N20 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2880 | verapamiil | C08DA01 | ISOPTIN RETARD retardtablett 240mg N50 | Abbott GmbH & Co. KG | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2881 | verapamiil | C08DA01 | ISOPTIN tablett 40mg N100 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2882 | verapamiil | C08DA01 | ISOPTIN tablett 40mg N20 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2883 | verapamiil | C08DA01 | ISOPTIN tablett 40mg N50 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2884 | verapamiil | C08DA01 | ISOPTIN tablett 80mg N100 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2885 | verapamiil | C08DA01 | ISOPTIN tablett 80mg N20 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2886 | verapamiil | C08DA01 | ISOPTIN tablett 80mg N50 | Abbott GmbH & Co. KG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2887 | verapamiil | C08DA01 | VERAPAMIL ALPHARMA TABLETS 40 MG tablett 40mg N50 | ALPHARMA | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2888 | verapamiil | C08DA01 | VERAPAMIL- RATIOPHARM N 80 tablett 80mg N100 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2889 | verapamiil | C08DA01 | VERAPAMIL- RATIOPHARM N 80 tablett 80mg N20 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2890 | verapamiil | C08DA01 | VERAPAMIL- RATIOPHARM N 80 tablett 80mg N50 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2891 | verapamiil | C08DA01 | VERAPAMIL-RATIOPHARM N 40 tablett 40mg N100 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2892 | verapamiil | C08DA01 | VERAPAMIL-RATIOPHARM N 40 tablett 40mg N20 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2893 | verapamiil | C08DA01 | VERAPAMIL-RATIOPHARM N 40 tablett 40mg N50 | ratiopharm | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2894 | verapamiil | C08DA01 | VEROGALID ER 240 MG retardtablett 240mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2895 | verapamiil | C08DA01 | VEROGALID ER 240 MG retardtablett 240mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; (I47-I49)* | *rv kardioloogil | ||||
2896 | verapamiil | C08DA01 | VERPAMIL tablett 40mg N100 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2897 | verapamiil | C08DA01 | VERPAMIL tablett 40mg N30 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2898 | verapamiil | C08DA01 | VERPAMIL tablett 80mg N100 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2899 | verapamiil | C08DA01 | VERPAMIL tablett 80mg N30 | Orion | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2900 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N14 | Abbott GmbH & Co. KG | 50% | |||||||
2901 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N28 | Abbott GmbH & Co. KG | 50% | |||||||
2902 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N30 | Abbott GmbH & Co. KG | 50% | |||||||
2903 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2904 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N56 | Abbott GmbH & Co. KG | 50% | |||||||
2905 | verapamiil+trandolapriil | C08DA80 | TARKA retardkapsel 180mg+2mg N98 | Abbott GmbH & Co. KG | 50% | |||||||
2906 | vinblastiin | L01CA01 | VELBE injektsioonisubstants 10mg N1 | Eli Lilly Export S.A. | 50% | |||||||
2907 | vinkristiin | L01CA02 | ONCOVIN süstelahus 1mg/ml 1ml N1 | Eli Lilly Export S.A. | 50% | |||||||
2908 | vinkristiin | L01CA02 | VINCRISTIN LIQUID-RICHTER süstelahus 1mg/ml 1ml N1 | Richter | 50% | |||||||
2909 | vinkristiin | L01CA02 | VINCRISTIN LIQUID-RICHTER süstelahus 1mg/ml 1ml N25 | Richter | 50% | |||||||
2910 | vinkristiin | L01CA02 | VINCRISTIN LIQUID-RICHTER süstelahus 1mg/ml 1ml N5 | Richter | 50% | |||||||
2911 | vinkristiin | L01CA02 | VINCRISTIN-RICHTER injektsioonisubstants 0,5mg N10 | Richter | 50% | |||||||
2912 | vinkristiin | L01CA02 | VINCRISTIN-RICHTER injektsioonisubstants 1mg N10 | Richter | 50% | |||||||
2913 | vismutsubtsitraat | A02BX05 | DE-NOL tablett 120mg N120 | Yamanouchi | 50% | |||||||
2914 | vismutsubtsitraat | A02BX05 | DE-NOL tablett 120mg N40 | Yamanouchi | 50% | |||||||
2915 | vismutsubtsitraat | A02BX05 | DE-NOL tablett 120mg N60 | Yamanouchi | 50% | |||||||
2916 | östradiool | G03CA03 | CLIMARA TTS 3,9mg N12 | Schering AG | 50% | |||||||
2917 | östradiool | G03CA03 | CLIMARA TTS 3,9mg N4 | Schering AG | 50% | |||||||
2918 | östradiool | G03CA03 | DERMESTRIL 100 TTS 100mcg 24h N8 | Rottapharm | 50% | |||||||
2919 | östradiool | G03CA03 | DERMESTRIL 25 TTS 25mcg 24h N26 | Rottapharm | 50% | |||||||
2920 | östradiool | G03CA03 | DERMESTRIL 25 TTS 25mcg 24h N8 | Rottapharm | 50% | |||||||
2921 | östradiool | G03CA03 | DERMESTRIL 50 TTS 50mcg 24h N8 | Rottapharm | 50% | |||||||
2922 | östradiool | G03CA03 | DIVIGEL geel 1mg/g 0.5g N28 | Orion | 50% | |||||||
2923 | östradiool | G03CA03 | DIVIGEL geel 1mgg 1g N28 | Orion | 50% | |||||||
2924 | östradiool | G03CA03 | ESTRADERM TTS 100 TTS 100mcg 24h N24 | Novartis Pharma | 50% | |||||||
2925 | östradiool | G03CA03 | ESTRADERM TTS 100 TTS 100mcg 24h N6 | Novartis Pharma | 50% | |||||||
2926 | östradiool | G03CA03 | ESTRADERM TTS 25 TTS 25mcg 24h N24 | Novartis Pharma | 50% | |||||||
2927 | östradiool | G03CA03 | ESTRADERM TTS 25 TTS 25mcg 24h N6 | Novartis Pharma | 50% | |||||||
2928 | östradiool | G03CA03 | ESTRADERM TTS 50 TTS 50mcg 24h N24 | Novartis Pharma | 50% | |||||||
2929 | östradiool | G03CA03 | ESTRADERM TTS 50 TTS 50mcg 24h N6 | Novartis Pharma | 50% | |||||||
2930 | östradiool | G03CA03 | ESTRIMAX tablett 2 mg N28 | Richter | 50% | |||||||
2931 | östradiool | G03CA03 | ESTRIMAX tablett 2 mg N28x3 | Richter | 50% | |||||||
2932 | östradiool | G03CA03 | ESTROFEM tablett 1mg N28 | Novo Nordisk | 50% | |||||||
2933 | östradiool | G03CA03 | ESTROFEM tablett 2mg N28 | Novo Nordisk | 50% | |||||||
2934 | östradiool | G03CA03 | ESTROGEL geel 0,06% 80g N1 | Leiras | 50% | |||||||
2935 | östradiool | G03CA03 | LINOLADIOL N kreem 0,01%/g 100g N1 | Wolff | 50% | |||||||
2936 | östradiool | G03CA03 | LINOLADIOL N kreem 0,01%/g 25g N1 | Wolff | 50% | |||||||
2937 | östradiool | G03CA03 | LINOLADIOL N kreem 0,01%/g 50g N1 | Wolff | 50% | |||||||
2938 | östradiool | G03CA03 | MENOREST 37,5 TTS 37,5mcg 24h N8 | Novartis Pharma | 50% | |||||||
2939 | östradiool | G03CA03 | MENOREST 50 TTS 50mcg 24h N8 | Novartis Pharma | 50% | |||||||
2940 | östradiool | G03CA03 | MENOREST 75 TTS 75mcg 24h N8 | Novartis Pharma | 50% | |||||||
2941 | östradiool | G03CA03 | OESCLIM TTS 25mcg 24h N8 | LABORATOIRES FOURNIER S.A | 50% | |||||||
2942 | östradiool | G03CA03 | OESCLIM TTS 37,5mcg 24h N8 | LABORATOIRES FOURNIER S.A | 50% | |||||||
2943 | östradiool | G03CA03 | OESCLIM TTS 50mcg 24h N8 | LABORATOIRES FOURNIER S.A | 50% | |||||||
2944 | östradiool | G03CA03 | OESCLIM TTS 75mcg 24h N8 | LABORATOIRES FOURNIER S.A | 50% | |||||||
2945 | östradiool | G03CA03 | PROGYNOVA 21 drazhee 2mg N21 | Schering AG | 50% | |||||||
2946 | östradiool | G03CA03 | SYSTEN 100 TTS 100mcg 24h N6 | Cilag | 50% | |||||||
2947 | östradiool | G03CA03 | SYSTEN 100 TTS 100mcg 24h N8 | Cilag | 50% | |||||||
2948 | östradiool | G03CA03 | SYSTEN 25 TTS 25mcg 24h N6 | Cilag | 50% | |||||||
2949 | östradiool | G03CA03 | SYSTEN 25 TTS 25mcg 24h N8 | Cilag | 50% | |||||||
2950 | östradiool | G03CA03 | SYSTEN 50 TTS 50mcg 24h N6 | Cilag | 50% | |||||||
2951 | östradiool | G03CA03 | SYSTEN 50 TTS 50mcg 24h N8 | Cilag | 50% | |||||||
2952 | östradiool | G03CA03 | SYSTEN 75 TTS 75mcg 24h N6 | Cilag | 50% | |||||||
2953 | östradiool | G03CA03 | SYSTEN 75 TTS 75mcg 24h N8 | Cilag | 50% | |||||||
2954 | östradiool | G03CA03 | VAGIFEM vagin. tablett 25mcg N15 | Novo Nordisk | 50% | |||||||
2955 | östradiool+noretisteroon | G03FB05 | TRIAKLIM tablett N28 | Richter | 50% | |||||||
2956 | östradiool+noretisteroon | G03FB05 | TRIAKLIM tablett N28x3 | Richter | 50% | |||||||
2957 | östradiool+noretisteroon | G03FB05 | TRISEQUENS tablett N28 | Novo Nordisk | 50% | |||||||
2958 | östradiool+prednisoloon | G03CA80 | LINOLADIOL-H N kreem 0,005%+0,4% 25g N1 | Wolff | 50% | |||||||
2959 | östradiool+prednisoloon | G03CA80 | LINOLADIOL-H N kreem 0,005%+0,4% 50g N1 | Wolff | 50% | |||||||
2960 | östramustiin | L01XX11 | ESTRACYT kapsel 140mg N100 | Pharmacia Enterprises | 50% | |||||||
2961 | östriool | G03CA04 | ESTRADOT 100 TTS 100mcg 24 h N24 | Novartis Pharma | 50% | |||||||
2962 | östriool | G03CA04 | ESTRADOT 100 TTS 100mcg 24 h N8 | Novartis Pharma | 50% | |||||||
2963 | östriool | G03CA04 | ESTRADOT 100 TTS 24 h N2 | Novartis Pharma | 50% | |||||||
2964 | östriool | G03CA04 | ESTRADOT 37,5 TTS 37,5mcg 24 h N2 | Novartis Pharma | 50% | |||||||
2965 | östriool | G03CA04 | ESTRADOT 37,5 TTS 37,5mcg 24 h N24 | Novartis Pharma | 50% | |||||||
2966 | östriool | G03CA04 | ESTRADOT 37,5 TTS 37,5mcg 24 h N8 | Novartis Pharma | 50% | |||||||
2967 | östriool | G03CA04 | ESTRADOT 50 TTS 50mcg 24 h N2 | Novartis Pharma | 50% | |||||||
2968 | östriool | G03CA04 | ESTRADOT 50 TTS 50mcg 24 h N24 | Novartis Pharma | 50% | |||||||
2969 | östriool | G03CA04 | ESTRADOT 50 TTS 50mcg 24 h N8 | Novartis Pharma | 50% | |||||||
2970 | östriool | G03CA04 | ESTRADOT 75 TTS 75mcg 24h N2 | Novartis Pharma | 50% | |||||||
2971 | östriool | G03CA04 | ESTRADOT 75 TTS 75mcg 24h N24 | Novartis Pharma | 50% | |||||||
2972 | östriool | G03CA04 | ESTRADOT 75 TTS 75mcg 24h N8 | Novartis Pharma | 50% | |||||||
2973 | östriool | G03CA04 | ORTHO-GYNEST depoo oovulid 3,5mg N6 | Cilag | 50% | |||||||
2974 | östriool | G03CA04 | ORTHO-GYNEST vaginaalkreem 0,01% 80g N1 | Cilag | 50% | |||||||
2975 | östriool | G03CA04 | OVESTIN tablett 1mg N30 | N.V. ORGANON | 50% | |||||||
2976 | östriool | G03CA04 | OVESTIN tablett 1mg N90 | N.V. ORGANON | 50% | |||||||
2977 | östriool | G03CA04 | OVESTIN tablett 2mg N30 | N.V. ORGANON | 50% | |||||||
2978 | östriool | G03CA04 | OVESTIN tablett 2mg N90 | N.V. ORGANON | 50% | |||||||
2979 | östriool | G03CA04 | OVESTIN vaginaalkreem 1mg 15g N1 | N.V. ORGANON | 50% | |||||||
2980 | östriool | G03CA04 | OVESTIN vaginaaloovul 0,5mg N15 | N.V. ORGANON | 50% | |||||||
2981 | östriool | G03CA04 | OVESTIN vaginaaloovul 0,5mg N30 | N.V. ORGANON | 50% |
Lühendite selgitus: rv – ravimi väljakirjutamise õigus
rev - ravimi esmane väljakirjutamise õigus
(1) rv juhul, kui monoteraapia beeta-adrenoblokaatori ja tiasiididiureetikumiga pole olnud efektiivne või on vastunäidustatud
(2) rev endokrinoloogil ja kardioloogil, väljakirjutamise õigus ainult primaarse hüperkolesteroleemia näidustusel, kui dieetravi järgselt pole kolesterooli sisaldus veres vähenenud alla 7,8 mmol/l ning ravi simvastatiiniga pole olnud piisavalt efektiivne
(3) rv Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega
(4) rev endokrinoloogil ja kardioloogil, väljakirjutamise õigus primaarse hüperkolesteroleemia näidustusel, kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 7,8 mmol/l; müokardi infarkti või müokardi revaskulariseeriva protseduuri (koronaarangioplastika ja aortokoronaarne šunteerimine) järgselt, kui kolesterooli sisaldus veres on 5,5 mmol/l või suurem ning ravi simvastatiiniga pole olnud piisavalt efektiivne
(5) rev endokrinoloogil ja kardioloogil, väljakirjutamise õigus primaarse hüperkolesteroleemia näidustusel, kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 7,8 mmol/l; müokardi infarkti või müokardi revaskulariseeriva protseduuri (koronaarangioplastika ja aortokoronaarne šunteerimine) järgselt, kui kolesterooli sisaldus veres on 5,5 mmol/l või suurem
(6) rv juhul, kui ravi teiste antibiootikumidega pole olnud efektiivne või on vastunäidustatud